This is a Validated Antibody Database (VAD) review about human CD4, based on 883 published articles (read how Labome selects the articles), using CD4 antibody in all methods. It is aimed to help Labome visitors find the most suited CD4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD4 synonym: CD4mut

others
  • flow cytometry; human; loading ...; fig e1a, 3h
CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig e1a, 3h). Nature (2019) ncbi
  • flow cytometry; human; loading ...; fig 7c, 7f
CD4 antibody (Biolegend, clone OKT4) was used in flow cytometry on human samples (fig 7c, 7f). Sci Rep (2019) ncbi
Invitrogen
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; 1:200; loading ...
Invitrogen CD4 antibody (eBioscience, 47-0048-42) was used in flow cytometry on human samples at 1:200. Life Sci Alliance (2022) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; loading ...; fig 5g
Invitrogen CD4 antibody (eBioscience, 25-0048-42) was used in flow cytometry on human samples (fig 5g). J Immunother Cancer (2022) ncbi
mouse monoclonal (N1UG0)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s11
Invitrogen CD4 antibody (eBioscience -Thermo Fisher Scientific, 41-2444-82) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s11). Nat Commun (2022) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 1:100; loading ...; fig 2b
Invitrogen CD4 antibody (eBioscience, 61-0049-42) was used in flow cytometry on human samples at 1:100 (fig 2b). Nat Commun (2022) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:10; loading ...; fig 6d
Invitrogen CD4 antibody (Invitrogen, 4B12) was used in immunohistochemistry - paraffin section on human samples at 1:10 (fig 6d). J Neuroinflammation (2022) ncbi
mouse monoclonal (N1UG0)
  • immunohistochemistry; human; loading ...; fig 4d
Invitrogen CD4 antibody (eBioscience, N1UG0) was used in immunohistochemistry on human samples (fig 4d). Front Immunol (2021) ncbi
domestic rabbit recombinant (104)
  • flow cytometry; mouse; loading ...; fig 4d
Invitrogen CD4 antibody (Invitrogen, 104) was used in flow cytometry on mouse samples (fig 4d). Exp Mol Med (2021) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; loading ...; fig s1a
Invitrogen CD4 antibody (eBioscience, OKT4) was used in flow cytometry on human samples (fig s1a). J Immunother Cancer (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 6c
Invitrogen CD4 antibody (eBioscience, 45-0049-42) was used in flow cytometry on human samples (fig 6c). Adv Sci (Weinh) (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen CD4 antibody (eBioscience, 17-0049-41) was used in flow cytometry on mouse samples (fig 2a). Cell Mol Gastroenterol Hepatol (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 5b
Invitrogen CD4 antibody (Thermo Fisher Scientific, RPA-T4) was used in flow cytometry on human samples (fig 5b). ACS Synth Biol (2021) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...
Invitrogen CD4 antibody (Invitrogen, MHCD0418) was used in flow cytometry on human samples . Cell Rep Med (2021) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry; human; 1:50; fig 1
Invitrogen CD4 antibody (Thermo Fisher Scientific, 4B12) was used in immunohistochemistry on human samples at 1:50 (fig 1). Ann Med (2021) ncbi
domestic rabbit recombinant (104)
  • flow cytometry; mouse; loading ...; fig 3c
Invitrogen CD4 antibody (eBiosciences, 104) was used in flow cytometry on mouse samples (fig 3c). Sci Rep (2021) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; 1:200; loading ...; fig 9b
Invitrogen CD4 antibody (eBioscience, 25-0048-42) was used in flow cytometry on human samples at 1:200 (fig 9b). Nat Commun (2021) ncbi
domestic rabbit recombinant (104)
  • flow cytometry; mouse; 1:200; loading ...; fig 5a
Invitrogen CD4 antibody (Thermo Fisher Scientific, 104) was used in flow cytometry on mouse samples at 1:200 (fig 5a). Nat Immunol (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 2
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples (fig 2). Aging Cell (2021) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig s1-1
Invitrogen CD4 antibody (Thermo Fisher Scientific, S3.5) was used in flow cytometry on human samples (fig s1-1). elife (2020) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; loading ...; fig 6c
Invitrogen CD4 antibody (eBioscience, OKT4) was used in flow cytometry on human samples (fig 6c). Cell Death Dis (2020) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; loading ...; fig 2a
Invitrogen CD4 antibody (eBiosciences, OKT4) was used in flow cytometry on human samples (fig 2a). Science (2020) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry; human; fig 4g
Invitrogen CD4 antibody (ThermoFisher Scientific, 4B12) was used in immunohistochemistry on human samples (fig 4g). Nat Commun (2020) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; loading ...; fig 2h
Invitrogen CD4 antibody (ThermoFisher, 17-0048-42) was used in flow cytometry on human samples (fig 2h). elife (2020) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; 1:50; fig 4c
Invitrogen CD4 antibody (Invitrogen, MHCD0405) was used in flow cytometry on human samples at 1:50 (fig 4c). Nature (2019) ncbi
mouse monoclonal (10C12)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1g
Invitrogen CD4 antibody (Thermo Fisher, MA1-10800) was used in immunohistochemistry - paraffin section on human samples (fig 1g). Cancer Med (2020) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; loading ...; fig s1c
Invitrogen CD4 antibody (eBioscience, 11-0048-41) was used in flow cytometry on human samples (fig s1c). Cell (2019) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; 1:200; loading ...; fig 1s1a
Invitrogen CD4 antibody (eBiosciences, 17-0048-42) was used in flow cytometry on human samples at 1:200 (fig 1s1a). elife (2019) ncbi
mouse monoclonal (SK3 (SK-3))
  • flow cytometry; human; loading ...; fig s1b
Invitrogen CD4 antibody (eBioscience, 11-0047-42) was used in flow cytometry on human samples (fig s1b). BMC Cancer (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 1:200; loading ...; fig 1s1a
Invitrogen CD4 antibody (eBiosciences, 47-0049-42) was used in flow cytometry on human samples at 1:200 (fig 1s1a). elife (2019) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig 4a
Invitrogen CD4 antibody (Thermo Fisher Scientific, S3.5) was used in flow cytometry on human samples (fig 4a). J Exp Med (2019) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; 1:200; loading ...; fig 2s1b
Invitrogen CD4 antibody (eBioscience, 45-0048-42) was used in flow cytometry on human samples at 1:200 (fig 2s1b). elife (2019) ncbi
mouse monoclonal (S3.5)
  • immunocytochemistry; human; loading ...; fig 5d
Invitrogen CD4 antibody (Invitrogen, MHCD0417) was used in immunocytochemistry on human samples (fig 5d). J Virol (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 1:100; loading ...
Invitrogen CD4 antibody (ebioscience, RPA-T4) was used in flow cytometry on human samples at 1:100. Nature (2018) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; 1:300; loading ...; fig s1a
Invitrogen CD4 antibody (eBioscience, S3.5) was used in flow cytometry on human samples at 1:300 (fig s1a). Nat Commun (2018) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig 3
Invitrogen CD4 antibody (Invitrogen, MHCD0405) was used in flow cytometry on human samples (fig 3). J Virol (2018) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig 1b
Invitrogen CD4 antibody (Life Technologies, S3.5) was used in flow cytometry on human samples (fig 1b). J Clin Invest (2018) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig s4a
Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig s4a). J Clin Invest (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples (fig 1a). Cancer Res (2018) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; African green monkey; loading ...; fig s1a
Invitrogen CD4 antibody (Thermo Fisher, Q10008) was used in flow cytometry on African green monkey samples (fig s1a). J Clin Invest (2018) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; loading ...; fig 1c
Invitrogen CD4 antibody (eBioscience, OKT4) was used in flow cytometry on human samples (fig 1c). J Clin Invest (2018) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig 1b
Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 1b). J Immunol (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 1:100; loading ...; fig 1a
In order to study the interaction between CD100 and CD72 and its role in T cell proliferation, Invitrogen CD4 antibody (eBiosciences, RPA-T4) was used in flow cytometry on human samples at 1:100 (fig 1a). Front Immunol (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...
In order to study the involvement of bitter taste signaling in caffeine-induced gastric acid secretion, Invitrogen CD4 antibody (Invitrogen, 07-0403) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; loading ...; fig 4b
In order to investigate the effectiveness of a neoantigen vaccine against melanoma, Invitrogen CD4 antibody (eBioscience, OKT-4) was used in flow cytometry on human samples (fig 4b). Nature (2017) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig 1b
In order to study the involvement of interleukin-8 on T lymphocytes growth and function, Invitrogen CD4 antibody (eBioscience, S3.5) was used in flow cytometry on human samples (fig 1b). Int Immunopharmacol (2017) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; loading ...; tbl 1
In order to investigate infiltrating T cells in liver cancer through single-cell sequencing, Invitrogen CD4 antibody (eBioscience, 11-0048-41) was used in flow cytometry on human samples (tbl 1). Cell (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...
In order to find that oral administration of a selective Rho-associated kinase 2 inhibitor, KD025, reduces psoriasis area in 46% of patients with psoriasis vulgaris, Invitrogen CD4 antibody (eBioscience, 45-0049) was used in flow cytometry on human samples . J Immunol (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 5a
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Invitrogen CD4 antibody (Thermo Fisher Scientific, 25-0049) was used in flow cytometry on human samples (fig 5a). Cell Res (2017) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; African green monkey; loading ...; fig 2a
In order to optimize the dosing regimen of neutralizing anti-HIV-1 antibodies, Invitrogen CD4 antibody (invitrogen, S3.5) was used in flow cytometry on African green monkey samples (fig 2a). Nature (2017) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; tbl s2
In order to investigate the fecal microbiomes of HIV-uninfected to HIV-infected individuals on long-term antiretroviral therapy, Invitrogen CD4 antibody (Biolegend, MHCD0418) was used in flow cytometry on human samples (tbl s2). Sci Rep (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3b
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples (fig 3b). J Immunol (2017) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig s1a
In order to use CD49a expression to define subsets of tissue-resident memory T cells in the skin, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig s1a). Immunity (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1
In order to examine the potential of IL-2 to enhance T regulatory cell therapy, Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples (fig 1). Clin Exp Immunol (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1b
In order to characterize the periferal blood lymphocytes phenotype in tacrolimus-treated liver transplanted patients., Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples (fig 1b). Med Princ Pract (2017) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, Invitrogen CD4 antibody (LifeTechnologies/Invitrogen, S3.5) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; rhesus macaque; loading ...; fig s1c
In order to examine the kinetics of SIV-specific CD8+ T cell cytolytic factor expression in peripheral blood, lymph node, spleen, and gut mucosa from early acute infection through chronic infection, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on rhesus macaque samples (fig s1c). PLoS Pathog (2016) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; loading ...; fig 2e
In order to observe that the use of chimeric antigen receptor technology is a clinically applicable refinement of regulatory T cell therapy for organ transplantation, Invitrogen CD4 antibody (eBioscience, OKT4) was used in flow cytometry on human samples (fig 2e). Am J Transplant (2017) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig 3
In order to search for compounds that suppress pro-inflammatory cytokine production in the context of protein kinase C activation, Invitrogen CD4 antibody (Invitrogen, MHCD0404) was used in flow cytometry on human samples (fig 3). Retrovirology (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1
In order to study the restoration of immune function in chronic HIV infection, Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples (fig 1). J Clin Invest (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 1:25; loading ...; fig 1b
In order to explore the role of thrombopoietin signaling in the human primitive hematopoietic stem cell compartment, Invitrogen CD4 antibody (eBiosciences, RPA-T4) was used in flow cytometry on human samples at 1:25 (fig 1b). Cell Transplant (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 1b
In order to identify a role for CK2 in healthy human thymocytes in the selection of the gamma delta T-cell lineage, Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples (fig 1b). Leukemia (2017) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig 1
In order to report the effect of antiretroviral treatment initiation and different antiretroviral treatment regimens on the reconstitution of mucosal T cells within the gut associated lymphoid tissue, Invitrogen CD4 antibody (Invitrogen, MHCD0418) was used in flow cytometry on human samples (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 5c
In order to propose that female sex protects against systemic inflammation-induced endothelial dysfunction, Invitrogen CD4 antibody (eBioscience, 25-0049-42) was used in flow cytometry on human samples (fig 5c). J Clin Invest (2017) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig s1
In order to explore how HIV-1 alters immunity during latent tuberculosis, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig s1). Tuberculosis (Edinb) (2016) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig 1
In order to study the role of PD-1 and Tim-3 crosstalk in the regulation of antitumor T cell responses, Invitrogen CD4 antibody (Life Technologies, MHCD0417) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig 1a
In order to develop a method to assess the capacity of human regulatory T cells to suppress IgM production from an immature human B cell line, Invitrogen CD4 antibody (Invitrogen, MHCD0412) was used in flow cytometry on human samples (fig 1a). J Immunol Methods (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 3
Invitrogen CD4 antibody (eBioscience, 17-0049) was used in flow cytometry on human samples (fig 3). Stem Cell Reports (2016) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...
In order to analyze small-cell lung cancer samples for CD274 mutations, Invitrogen CD4 antibody (Thermo Scientific, 4B12) was used in immunohistochemistry - paraffin section on human samples at 1:100. Clin Cancer Res (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig s3
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples (fig s3). PLoS Pathog (2016) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human
In order to assess programmed cell death 1 and programmed cell death ligand 1 expression in patients with extranodal natural killer/T cell lymphoma, Invitrogen CD4 antibody (Thermo Scientific, 4B12) was used in immunohistochemistry - paraffin section on human samples . Virchows Arch (2016) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig st9
In order to characterize American patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, Invitrogen CD4 antibody (ThermoFisher, S3.5) was used in flow cytometry on human samples (fig st9). JCI Insight (2016) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 5
In order to elucidate the impact of Vpu-mediated tetherin antagonism on HIV infection, Invitrogen CD4 antibody (Invitrogen, MHCD0405) was used in flow cytometry on human samples (fig 5). MBio (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1b
In order to investigate the role of polypyrimidine tract-binding protein 1 in CD4 T cell activation, Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples (fig 1b). PLoS ONE (2016) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig 1a
In order to elucidate the mechanisms by which DRibbles induce T-cell activation, Invitrogen CD4 antibody (Invitrogen, MHCD0404) was used in flow cytometry on human samples (fig 1a). Cell Death Dis (2016) ncbi
mouse monoclonal (SK3 (SK-3))
  • flow cytometry; human; loading ...; fig 9
Invitrogen CD4 antibody (eBiosciences, 17-0047) was used in flow cytometry on human samples (fig 9). Sci Rep (2016) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig 1c
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 1c). PLoS Pathog (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 3
Invitrogen CD4 antibody (eBioscience, 12-0049-42) was used in flow cytometry on human samples (fig 3). Oncoimmunology (2016) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry; mouse; fig 6b
In order to utilize humanized major histocompatibility class I- and class II-deficient NOG mice to assess the antitumor effect of an anti-programmed death-1 antibody, Invitrogen CD4 antibody (Thermo Fisher, 4B12) was used in immunohistochemistry on mouse samples (fig 6b). Clin Cancer Res (2017) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 3
In order to test if CD4 positive T cells expressing immune checkpoint molecules are enriched in HIV-infected cells in patients receiving antiretroviral therapy, Invitrogen CD4 antibody (Invitrogen, Q10008) was used in flow cytometry on human samples (fig 3). PLoS Pathog (2016) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig s1a
Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig s1a). J Immunol (2016) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize B cells and antibody repertoires from injection drug users, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 1a). PLoS ONE (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 1:20; fig st2
Invitrogen CD4 antibody (eBioscience, 47-0049-42) was used in flow cytometry on human samples at 1:20 (fig st2). Nat Commun (2016) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; rhesus macaque; tbl 1
In order to characterize the role of T-cell depletion and macrophage polarization and infection during splenic damage during SIV infection, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on rhesus macaque samples (tbl 1). Am J Pathol (2016) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; rhesus macaque; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, Invitrogen CD4 antibody (ThermoFisher, MHCD0418) was used in flow cytometry on rhesus macaque samples . Nat Med (2016) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; loading ...; fig s3
In order to present the structure of the 14.1Fab fragment in complex with IL-16, Invitrogen CD4 antibody (eBioscience, 13-0048) was used in flow cytometry on human samples (fig s3). J Biol Chem (2016) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; fig s1
In order to show that ATG16L1 and NOD2 are required for Bacteroides fragilis-mediated protection from colitis, Invitrogen CD4 antibody (eBioscience, OKT4) was used in flow cytometry on human samples (fig s1). Science (2016) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...
In order to study the role of T regulatory cells in patients with immune thrombocytopenic purpura, Invitrogen CD4 antibody (Caltag, MHCD0401) was used in flow cytometry on human samples . Turk J Haematol (2016) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; mouse; fig 1
In order to analyze the induction of immune-mediated survival advantage in murine intracranial glioma by agonist anti-GITR monoclonal antibody and stereotactic radation, Invitrogen CD4 antibody (Invitrogen, MHCD0428) was used in flow cytometry on mouse samples (fig 1). J Immunother Cancer (2016) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; 1:50; loading ...; fig s2e
In order to study how retinoic acid-induced HOXA gene expression controls hematopoietic stem/progenitor cells fate, identify, and function, Invitrogen CD4 antibody (Invitrogen, MHCD0405) was used in flow cytometry on human samples at 1:50 (fig s2e). Nat Cell Biol (2016) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 2
In order to utilize flow cytometry to analyze intracellular Ca(2+) mobilization in human NK cell subsets, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 2). Methods Mol Biol (2016) ncbi
mouse monoclonal (SK3 (SK-3))
  • flow cytometry; human; loading ...; fig S1
In order to analyze the dynamics of genome-wide promoter H3K4me2 and H3K4me3 during activation of human naive and memory CD4 T cells, Invitrogen CD4 antibody (eBioscience, 12-0047-42) was used in flow cytometry on human samples (fig S1). Genes Immun (2016) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; loading ...
In order to test if the two hematopoietic systems in patients with mixed chimerism remain functional and study immunological differences, Invitrogen CD4 antibody (eBioscience, OKT-4) was used in flow cytometry on human samples . PLoS ONE (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig s1
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples (fig s1). Cell Rep (2016) ncbi
mouse monoclonal (RPA-T4, BC96)
  • flow cytometry; human; fig s1
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples (fig s1). Cell Rep (2016) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; loading ...; fig 1b
In order to measure DR3 expression on peripheral blood mononuclear cells of patients with inflammatory bowel disease, Invitrogen CD4 antibody (eBiosciences, OKT4) was used in flow cytometry on human samples (fig 1b). Cytometry B Clin Cytom (2017) ncbi
mouse monoclonal (SK3 (SK-3))
  • flow cytometry; human
In order to develop an HLA-A2-specific chimeric antigen receptor and use it to generate alloantigen-specific human T regulatory cells, Invitrogen CD4 antibody (eBioscience, 46-0047-42) was used in flow cytometry on human samples . J Clin Invest (2016) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; fig 7a
Invitrogen CD4 antibody (eBioscience, 48-0048-42) was used in flow cytometry on human samples (fig 7a). Sci Rep (2016) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; loading ...; fig 1c
Invitrogen CD4 antibody (eBioscience, OKT4) was used in flow cytometry on human samples (fig 1c). PLoS Pathog (2016) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; fig 4, 5
Invitrogen CD4 antibody (eBioscience, OKT4) was used in flow cytometry on human samples (fig 4, 5). PLoS Pathog (2016) ncbi
mouse monoclonal (RPA-T4)
  • immunohistochemistry; human; fig 1
In order to determine the role of the toll-like receptor 4-mediated lymphocyte influx as an inducer of neonatal necrotizing enterocolitis, Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in immunohistochemistry on human samples (fig 1). J Clin Invest (2016) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to analyze HIV progression traits of a selective loss of early differentiated and highly functional PD1high CD4 T cells, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse
Invitrogen CD4 antibody (eBiosciences, RPA-T4) was used in flow cytometry on mouse samples . Nature (2016) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; rhesus macaque; fig 4
In order to assess the ability of HIV-1 envelope glycoprotein-specific broadly neutralizing monoclonal antibodies to suppress acute simian-human immunodeficiency virus replication in rhesus macaques, Invitrogen CD4 antibody (Invitrogen, clone S3.5) was used in flow cytometry on rhesus macaque samples (fig 4). J Virol (2016) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; 1:40; fig 3
In order to discuss the HIV rev1-vpu gene fusion, Invitrogen CD4 antibody (Invitrogen, MHCD0405) was used in flow cytometry on human samples at 1:40 (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 1
In order to study factors that specify the Treg lineage, Invitrogen CD4 antibody (eBioscience, 47-0049-42) was used in flow cytometry on human samples (fig 1). elife (2015) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to analyze the control of RNA polymerase II and the epigenetic landscape to transcriptionally reprogram target immune cells by HIV Tat, Invitrogen CD4 antibody (Caltag, MHCD0405) was used in flow cytometry on human samples . elife (2015) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; fig 7
In order to characterize a bispecific scFv antibody targeting of human melanoma made in transgenic cattle called r28M, Invitrogen CD4 antibody (eBioscience, 45?C0048) was used in flow cytometry on human samples (fig 7). PLoS ONE (2015) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; mouse; loading ...
In order to assess the effects of allosteric inhibitors on different mutant forms of isocitrate dehydrogenase 1 in leukemia, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on mouse samples . Nat Chem Biol (2015) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:1; fig 3
In order to characterize human lung cancer stroma for inflammatory and immune cell composition, Invitrogen CD4 antibody (Thermo Fisher, 4B12) was used in immunohistochemistry - paraffin section on human samples at 1:1 (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human
In order to determine the proportions, phenotype, survival, and apoptotic susceptibility of Tregs in sarcoidosis, Invitrogen CD4 antibody (eBiosciences, OKT4) was used in flow cytometry on human samples . Respir Res (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 4a
In order to assess the efficacy of a single vaccination of the Yellow Fever vaccine, Invitrogen CD4 antibody (eBioscience, 47-0049-42) was used in flow cytometry on human samples (fig 4a). Hum Vaccin Immunother (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 1
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human
Invitrogen CD4 antibody (eBioscience, OKT4) was used in flow cytometry on human samples . Science (2015) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to study the dynamics of Ag-specific CD4(+) T cells during antiretroviral therapy, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (SK3 (SK-3))
  • flow cytometry; human; fig 4
In order to discuss the role of T cells in Rasmussen encephalitis, Invitrogen CD4 antibody (eBioscience, SK3) was used in flow cytometry on human samples (fig 4). J Neuroinflammation (2015) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1
In order to determine the periluminal distribution of CD4+ HIV target cells, Invitrogen CD4 antibody (Thermo, 4B12) was used in immunohistochemistry - paraffin section on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig 1b
In order to develop a model that uses cultured central memory CD4 positive T cells and replication-competent HIV-1, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 1b). AIDS Res Hum Retroviruses (2016) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to study T cell subtypes in breast cancer patients with and without high levels of autoimmune thyroid antibodies, Invitrogen CD4 antibody (Caltag Lab, MHCD0401) was used in flow cytometry on human samples . Cent Eur J Immunol (2014) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 4
In order to investigate the role of VAMP8 in exocytosis, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 4). J Cell Biol (2015) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to elucidate regulation of gamma-globin expression in F-cells, Invitrogen CD4 antibody (Life Technologies, S3.5) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 2
Invitrogen CD4 antibody (eBioscience, 25-0049-42) was used in flow cytometry on human samples (fig 2). Oncoimmunology (2015) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to investigate the primary inflammatory and regulatory T cell responses induced by BCG vaccination in adults, Invitrogen CD4 antibody (Invitrogen, clone S3.5) was used in flow cytometry on human samples . Clin Vaccine Immunol (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples . Clin Immunol (2015) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; 1:333; fig 1
In order to study the immune responses of HIV-infected volunteers vaccinated against tuberculosis, Invitrogen CD4 antibody (Invitrogen, Q10008) was used in flow cytometry on human samples at 1:333 (fig 1). Clin Vaccine Immunol (2015) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to optimize detection of IL-2 from live cells, Invitrogen CD4 antibody (Life Sciences/Invitrogen, MHCD0417) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human
In order to describe the clinicopathological features of 15 patients with Epstein-Barr virus-positive nodal T/NK-cell lymphoma, Invitrogen CD4 antibody (Thermo Scientific, 4B12) was used in immunohistochemistry - paraffin section on human samples . Hum Pathol (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 3:100; fig 3d
In order to show that hepatitis B virus exposure in utero enhances immunity to bacterial infections, Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples at 3:100 (fig 3d). Nat Commun (2015) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to measure the memory CD4(+) T-cell responses to each varicella zoster virus protein at baseline and after zoster vaccination, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to study the effect of non-POU domain-containing octamer-binding protein (NonO) on the HIV-1 life cycle in CD4(+) T cells, Invitrogen CD4 antibody (Invitrogen, MHCD0404) was used in flow cytometry on human samples . AIDS Res Hum Retroviruses (2015) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; 1 ul/test
In order to analyze mucosal pinch biopsies collected predominantly during colonoscopies, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples at 1 ul/test. J Immunol Methods (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to study the role of melanoma cell surface-associated calreticulin in melphalan-induced antitumor immunity, Invitrogen CD4 antibody (eBioscience, 25-0049) was used in flow cytometry on human samples . Cancer Res (2015) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; tbl s1
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 1
In order to describe the phenotype and functional potential of metastatic differentiated thyroid cancer-associated PD-1 positive T cells, Invitrogen CD4 antibody (eBioscience, RPAT4) was used in flow cytometry on human samples (fig 1). Cancer Immunol Res (2015) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to show that intermediate DNA methylation is a conserved signature of gene regulation and exon usage, Invitrogen CD4 antibody (Invitrogen, MHCD0406) was used in flow cytometry on human samples . Nat Commun (2015) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry; human
In order to study the role of lymph node in the early rectal cancer, Invitrogen CD4 antibody (NeoMarkers, MS-1528) was used in immunohistochemistry on human samples . Dis Markers (2014) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig 1a
In order to ascertain the impact of cell-intrinsic immunity on the latent reservoir of HIV, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 1a). AIDS (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse; fig 2
In order to analyze how ordered recombination occurs through the proximal J kappa germline-transcript promoter facilitating receptor editing, Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on mouse samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; loading ...; fig 1a
In order to determine the role of IL-10 produced by T regulatory cells in patients with immune thrombocytopenia, Invitrogen CD4 antibody (eBiosciences, 11-0048-42) was used in flow cytometry on human samples (fig 1a). Immunol Res (2015) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to assess the effects of long-term cryopreservation of fixed cells on the measurement of mycobacteria induced CD4 T cell immunity, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples . J Immunol Methods (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples . J Allergy Clin Immunol (2015) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human
Invitrogen CD4 antibody (eBioscience, OKT4) was used in flow cytometry on human samples . Hum Immunol (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples . Chest (2015) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, Invitrogen CD4 antibody (Caltag Medsystems, clone S3.5) was used in flow cytometry on human samples . Chest (2015) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, Invitrogen CD4 antibody (eBioscience, OKT4) was used in flow cytometry on human samples . Chest (2015) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
  • immunocytochemistry; human
In order to test if Nef modifies the composition of exosomes released by T lymphocytes, Invitrogen CD4 antibody (Life Technologies, S3.5) was used in flow cytometry on human samples and in immunocytochemistry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human
Invitrogen CD4 antibody (eBioscience, OKT4) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; tbl 1
Invitrogen CD4 antibody (eBiosciences, RPA-T4) was used in flow cytometry on human samples (tbl 1). J Gen Virol (2015) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to test the safety and immunogenicity of an adenovirus 35-vectored tuberculosis vaccine candidate AERAS-402 in infants, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples . Vaccine (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (RPA-T4)
  • immunocytochemistry; human; fig 2
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in immunocytochemistry on human samples (fig 2). Arch Immunol Ther Exp (Warsz) (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 1
In order to investigate the impact of CCR6(+)CXCR3(+)CCR4(-) cells in latent tuberculosis infection, Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples (fig 1). J Immunol (2014) ncbi
mouse monoclonal (S3.5)
  • immunocytochemistry; rat; 1:500
In order to identify the molecular mechanisms that regulate the enrichment of KCNQ channels at the neuronal axon, Invitrogen CD4 antibody (Invitrogen, MHCD0420) was used in immunocytochemistry on rat samples at 1:500. PLoS ONE (2014) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 5
In order to study the role of plasmacytoid dendritic cells in human immunodeficiency virus type 1 infection and pathogenesis, Invitrogen CD4 antibody (Invitrogen, MHCD0417) was used in flow cytometry on human samples (fig 5). PLoS Pathog (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to study the cell mediated immune response to JCV T-Ag in patients with colorectal adenomatous polyps or cancers, Invitrogen CD4 antibody (eBioscience, 17-0049-42) was used in flow cytometry on human samples . Gut Microbes (2014) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to developed a strategy to expand umbilical cord blood T cells and test their effects after transplantation, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples . Leukemia (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to examine various DC after flu vaccination, Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples . Immunol Invest (2014) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to examine various DC after flu vaccination, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples . Immunol Invest (2014) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:50
Invitrogen CD4 antibody (Thermo Fisher Scientific, 4B12) was used in immunohistochemistry - paraffin section on human samples at 1:50. Br J Dermatol (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human
Invitrogen CD4 antibody (eBioscience, OKT4) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to characterize preterm infants and alterations found in regulatory T cell subpopulations, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to investigate the anti-influenza responses of T cell subsets, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to study virus-specific human memory T-cell activation in response to Dribble-mediated cross-presentation of viral antigens, Invitrogen CD4 antibody (Invitrogen, MHCD0420) was used in flow cytometry on human samples . J Transl Med (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 5
In order to investigate how heme regulates Spic in macrophages, Invitrogen CD4 antibody (Invitrogen, MHCD0404) was used in flow cytometry on human samples (fig 5). Cell (2014) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to characterize the effects of human immunodeficiency virus lncRNA expression, Invitrogen CD4 antibody (Life Technologies, MHCD0405) was used in flow cytometry on human samples . Mol Ther (2014) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to examine human differentiated effector CD4(+) T cells that are defined by low levels of IL-2 and IL-7 receptors, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human
Invitrogen CD4 antibody (Thermo Fisher Scientific, 4b12) was used in immunohistochemistry - paraffin section on human samples . Circ Arrhythm Electrophysiol (2014) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; rat
In order to determine the effect of aging and CMV infection on T cell populations, Invitrogen CD4 antibody (eBioscience, 56-0048-82) was used in flow cytometry on rat samples . J Immunol (2014) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to study CD161 high CD8+ T cells in an HIV and Mycobacterium tuberculosis endemic African setting., Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 2
In order to assess the extent of B cell dysfunction during HIV infection, Invitrogen CD4 antibody (Invitrogen, clone S3.5) was used in flow cytometry on human samples (fig 2). PLoS ONE (2013) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 4
In order to develop microfluidic biochips that count CD4(+) and CD8(+) lymphocytes in whole blood samples to use in third world countries, Invitrogen CD4 antibody (Life Technologies, MHCD0420) was used in flow cytometry on human samples (fig 4). Sci Transl Med (2013) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; crab eating macaque; fig 2
In order to assess subcutaneous administration of rituximab, Invitrogen CD4 antibody (Caltag, clone S3.5) was used in flow cytometry on crab eating macaque samples (fig 2). PLoS ONE (2013) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig 1b
In order to assess the effect of delayed administration of the BCG vaccine on the induced immune response in Ugandan children, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 1b). J Infect Dis (2014) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; rhesus macaque; fig 1
  • western blot; rhesus macaque; fig 1
In order to investigate how chronic morphine exposure affects T cell numbers and functions, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on rhesus macaque samples (fig 1) and in western blot on rhesus macaque samples (fig 1). J Neuroimmunol (2013) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse
Invitrogen CD4 antibody (eBiosciences, RPA-T4) was used in flow cytometry on mouse samples . J Immunol (2013) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse; fig s1
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on mouse samples (fig s1). Nature (2013) ncbi
mouse monoclonal (SK3 (SK-3))
  • flow cytometry; human
Invitrogen CD4 antibody (eBioscience, SK3) was used in flow cytometry on human samples . J Hepatol (2014) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 3
In order to determine the role of conventional and regulatory T cells in protection from HIV-1 infection, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 3). AIDS Res Hum Retroviruses (2013) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 9
In order to characterize T cell responses of HIV-exposed, yet persistently uninfected individuals, Invitrogen CD4 antibody (Invitrogen, Q10008) was used in flow cytometry on human samples (fig 9). J Virol (2013) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 1
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples (fig 1). Ann Rheum Dis (2014) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 2
In order to characterize T cells after MVA85A vaccination, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 2). Eur J Immunol (2013) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 4
In order to develop a novel animal model to study JCV infection, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 4). PLoS ONE (2013) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 2
In order to discuss how Vpu-mediated anti-tetherin activity distinguishes HIV groups, Invitrogen CD4 antibody (Invitrogen, MHCD0405) was used in flow cytometry on human samples (fig 2). Retrovirology (2013) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to study defective cellular immune response to pandemic H1N1 influenza A virus in obese and overweight adult humans, Invitrogen CD4 antibody (Invitrogen, noca) was used in flow cytometry on human samples . Obesity (Silver Spring) (2013) ncbi
mouse monoclonal (S3.5)
  • immunocytochemistry; human; fig 1
In order to assess the effect of immunosuppression used for organ transplantation on immune responses to adeno-associated virus capsid antigens, Invitrogen CD4 antibody (Invitrogen, clone S3.5) was used in immunocytochemistry on human samples (fig 1). Hum Gene Ther (2013) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to study facilitation of HIV-1 transmission to cervico-vaginal tissue ex vivo by interleukin-7, Invitrogen CD4 antibody (Invitrogen, noca) was used in flow cytometry on human samples . PLoS Pathog (2013) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 3
In order to test if impaired human neonatal CD4(+) T cell immunity is due to reduced signaling by naive CD4(+) T cells following engagement of the alphabeta-TCR/CD3 complex and CD28, Invitrogen CD4 antibody (Invitrogen, clone S3.5) was used in flow cytometry on human samples (fig 3). J Immunol (2013) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; African green monkey; loading ...; fig 1c
In order to investigate mucosal dysfunction in relation to HIV/SIV pathogenesis, Invitrogen CD4 antibody (eBioscience, OKT4) was used in flow cytometry on African green monkey samples (fig 1c). J Immunol (2013) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to examine the role of IL-17A-producing multifunctional T cells in the pathogenesis of toxic shock syndrome, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 1). Clin Immunol (2013) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 3
In order to examine the function of Vpu proteins from seven HIV group N strains, Invitrogen CD4 antibody (Invitrogen, MHCD0405) was used in flow cytometry on human samples (fig 3). PLoS Pathog (2012) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 2
In order to assess the functionality of virus-specific CD8+ T cells in older individuals acutely infected with West Nile virus and chronically infected with Epstein Barr virus and Cytomegalovirus, Invitrogen CD4 antibody (noca, S3.5) was used in flow cytometry on human samples (fig 2). PLoS Pathog (2012) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to identify integrin alpha2 as a novel stem cell marker, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 1). Stem Cells (2013) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to elucidate the influence of H. pylori on T(reg) function and proliferation, Invitrogen CD4 antibody (Caltag, clone S3.5) was used in flow cytometry on human samples (fig 1). Clin Exp Immunol (2012) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 2
In order to study the roles of the decidua-derived CCL2 in the Th2 predominance found at the maternal-fetal interface, Invitrogen CD4 antibody (CALTAG, MHCD0401) was used in flow cytometry on human samples (fig 2). Clin Immunol (2012) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to determine the function and phenotypes of antigen-specific CD4(+) T cells in adults compared to infants upon acellular pertussis vaccine administration, Invitrogen CD4 antibody (eBiosciences, RPA T4) was used in flow cytometry on human samples . Clin Exp Immunol (2012) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; 1:75; fig 1
In order to determine the localization of CD4 positive T cells subsets in the healthy intestine, Invitrogen CD4 antibody (Invitrogen, MHCD0417) was used in flow cytometry on human samples at 1:75 (fig 1). PLoS ONE (2012) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:100
  • immunohistochemistry; human; 1:100
In order to study the role of TORC1 in the fetal brain lesions observed in tuberous sclerosis complex, Invitrogen CD4 antibody (Neomarkers, 4B12) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in immunohistochemistry on human samples at 1:100. Brain Pathol (2013) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to characterize therapy-induced T cell reactivity using a panel of 145 melanoma-associated CD8(+) T cell epitopes, Invitrogen CD4 antibody (Invitrogen, MHCD0429) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2012) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to analyze the regulation of Amphiregulin expression in human T cell subsets, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to explore the multifunctional IL-17A responses against S. Typhi antigens in T memory subsets, Invitrogen CD4 antibody (Invitrogen, clone S3.5) was used in flow cytometry on human samples (fig 1). PLoS ONE (2012) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; rhesus macaque
In order to study alterations in mucosal immunity during SIV infection, Invitrogen CD4 antibody (eBioscience, OKT4) was used in flow cytometry on rhesus macaque samples . Mucosal Immunol (2012) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3e
In order to investigate promyelocytic leukemia zinc-finger expression in T-lymphoblastic lymphoma/acute lymphoblastic leukemia, Invitrogen CD4 antibody (Thermo Fisher, 4B12) was used in immunohistochemistry - paraffin section on human samples (fig 3e). Mod Pathol (2012) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to study influenza-specific CD4 T cells respond to vaccination using Ki67 as a marker, Invitrogen CD4 antibody (Invitrogen, clone S3.5) was used in flow cytometry on human samples (fig 1). Vaccine (2012) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to assess cell-mediated immune responses in Thai HIV phase III prime/boost vaccine trial patients, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 1). J Immunol (2012) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human
Invitrogen CD4 antibody (eBioscience, OKT-4) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to determine the role of HIV-1 Nef in dendritic cell-mediated viral transmission and HIV-1 infection, Invitrogen CD4 antibody (Caltag Laboratories, S3.5) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; tbl 3
In order to explore the importance of vitamin B6 in the recipients of allogeneic kidney graft, Invitrogen CD4 antibody (Caltag, clone S3.5) was used in flow cytometry on human samples (tbl 3). J Ren Nutr (2013) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig 2a
In order to investigate leukocyte-endothelial interactions at the blood brain barrier, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 2a). Sci Transl Med (2012) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry; human; 1:10
In order to evaluate the prognostic value of tumor-infiltrating lymphocytes in the anthracycline-based chemotherapy, Invitrogen CD4 antibody (Lab Vision, MS-1528) was used in immunohistochemistry on human samples at 1:10. Breast Cancer Res (2011) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; human; fig s1
Invitrogen CD4 antibody (eBioscience, OKT4) was used in flow cytometry on human samples (fig s1). PLoS Pathog (2011) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples . Nat Immunol (2011) ncbi
mouse monoclonal (RPA-T4, BC96)
  • flow cytometry; human
Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples . Nat Immunol (2011) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to study changes in T cell subsets during HBV infection, Invitrogen CD4 antibody (Invitrogen, MHCD0406) was used in flow cytometry on human samples (fig 1). Immunol Invest (2012) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 3
In order to demonstrate that transcriptional gene silencing reduces HIV transcription in primary human CD4(+) T cells, Invitrogen CD4 antibody (Life Technologies, MHCD0405) was used in flow cytometry on human samples (fig 3). Hum Gene Ther (2012) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; rhesus macaque; loading ...; fig 2a
In order to test if CCR5 signaling suppression reduces HIV-associated chronic immune activation, Invitrogen CD4 antibody (eBioscience, OKT4) was used in flow cytometry on rhesus macaque samples (fig 2a). J Med Primatol (2012) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig 1b
In order to elucidate relationships among MAPK pathway function, HIV-1-induced activation, and exhaustion markers in circulating CD8+ T cells, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 1b). J Virol (2011) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 2
In order to discuss the live attenuated yellow fever vaccines, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 2). J Infect Dis (2011) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to elucidate the link between Th17-cell homeostasis and B cells, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 1). PLoS ONE (2011) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig S2
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen CD4 antibody (Invitrogen, Q10007) was used in flow cytometry on human samples (fig S2). Proc Natl Acad Sci U S A (2012) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry; human; 1:20; fig S5B
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen CD4 antibody (Thermo Scientific, MS-1528-S1) was used in immunohistochemistry on human samples at 1:20 (fig S5B). Proc Natl Acad Sci U S A (2012) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to examine the relationship between T cells and antigen load in patients with chronic Mycobacterium tuberculosis infection, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 1). J Immunol (2011) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:10; tbl 2
In order to identify biomarkers to distinguish between true recurrence and new primary cases of ipsilateral breast tumor recurrence, Invitrogen CD4 antibody (Lab vision, MS-1528) was used in immunohistochemistry - paraffin section on human samples at 1:10 (tbl 2). Breast Cancer (Auckl) (2011) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 2
In order to test if anti-CD8 Abs induce effector function, Invitrogen CD4 antibody (Caltag, clone S3.5) was used in flow cytometry on human samples (fig 2). J Immunol (2011) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to test if rejection of AAV-transduced hepatocytes is due to AAV capsid-specific CD8 positive T cells that become reactivated upon gene transfer, Invitrogen CD4 antibody (Invitrogen, clone S3.5) was used in flow cytometry on human samples (fig 1). Mol Ther (2011) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to investigate the role of type I IFN and tetherin in HIV-1 infection of dendritic cells, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples . Retrovirology (2011) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1, 2
In order to examine the impact of Tregs on CAR-modified T cells in the SCID-Beige xenotransplant model, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 1, 2). Cancer Res (2011) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig s8
In order to track T cells after transplantation, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig s8). EMBO Mol Med (2011) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; rat; 12 ug/ml; tbl 2
In order to characterize bone marrow-derived mesenchymal stem cells from patients with ankylosing spondylitis, Invitrogen CD4 antibody (eBioscience, OKT4) was used in flow cytometry on rat samples at 12 ug/ml (tbl 2). Arthritis Res Ther (2011) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 7
In order to determine the role of cIAP1 and cIAP2 to B-cell physiology in vivo, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 7). Blood (2011) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; 1:10; fig 7
In order to develop a microfabricated biochip that counts the number CD4+ T lymphocytes in human blood samples, Invitrogen CD4 antibody (Invitrogen, MHCD0400) was used in flow cytometry on human samples at 1:10 (fig 7). Lab Chip (2011) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to identify immunological/virological biomarkers associated with sleep quality in patients with chronic hepatitis C, Invitrogen CD4 antibody (Caltag, MHCD0404) was used in flow cytometry on human samples (fig 1). Scand J Immunol (2011) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; tbl 3
In order to examine human cross-reactive T cells against a pandemic virus, Invitrogen CD4 antibody (Invitrogen, clone S3.5) was used in flow cytometry on human samples (tbl 3). Vaccine (2011) ncbi
mouse monoclonal (S3.5)
  • immunocytochemistry; human; fig 3
In order to discuss the use of internal antigens to provide better protection against multiple influenza subtypes, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in immunocytochemistry on human samples (fig 3). Clin Infect Dis (2011) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to identify immunologic correlates of immune reconstitution inflammatory syndrome in HIV patients, Invitrogen CD4 antibody (Caltag, clone S3.5) was used in flow cytometry on human samples (fig 1). Blood (2010) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to investigate the role of beta catenin signaling in regulating CD4 expression by CD4(dim)CD8(bright) T cells, Invitrogen CD4 antibody (Invitrogen, clone S3.5) was used in flow cytometry on human samples (fig 1). J Immunol (2010) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to report that HSP70 activates human NK cells to kill target cells expressing MICA in a natural killer group 2 member D-dependent manner, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 1). J Cell Mol Med (2010) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 3
In order to use flow cytometry to compare the composition of the human and rhesus macaques cellular immune system, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 3). Immunology (2010) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; mouse; fig 3
In order to compare the therapeutic efficacy of CD19-specific human primary T cells that constitutively express gamma(c)-cytokines, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on mouse samples (fig 3). Blood (2010) ncbi
mouse monoclonal (OKT4 (OKT-4))
  • flow cytometry; rhesus macaque
In order to examine the in vivo effect of CD8+ lymphocyte depletion on the lifespan of productively SIV-infected cells, Invitrogen CD4 antibody (eBioscience, OKT4) was used in flow cytometry on rhesus macaque samples . PLoS Pathog (2010) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to report that human Tregs promote the generation of myeloid dendritic cells which abrogate post transplant lethality, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . PLoS Biol (2010) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to report that human Tregs promote the generation of myeloid dendritic cells which abrogate post transplant lethality, Invitrogen CD4 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples . PLoS Biol (2010) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 2
In order to characterize a Sindbis virus envelope pseudotyped lentiviral vector that targets CD4, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 2). J Virol (2009) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to evaluate if attachment inhibitors have potent antientry activity and contribute to immune system homeostasis in individuals infected with HIV-1, Invitrogen CD4 antibody (Molecular Probes, S3.5) was used in flow cytometry on human samples . Antimicrob Agents Chemother (2009) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to determine the role of CD59 on human CD4+ T cells, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . J Immunol (2009) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to study the improvement of simultaneous phenotype-specific telomere length measurement by FISH-flow cytometry by quantum dots thermal stability, Invitrogen CD4 antibody (Invitrogen, noca) was used in flow cytometry on human samples . J Immunol Methods (2009) ncbi
mouse monoclonal (RPA-T4)
  • immunohistochemistry; human; 1:200; fig 3
In order to test if the frequency of CD83+ mature DCs correlates with caries invasion, Invitrogen CD4 antibody (Zymed, RPA-T4) was used in immunohistochemistry on human samples at 1:200 (fig 3). Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to develop a xenotransplantation system using human hematopoietic stem cells and mice, Invitrogen CD4 antibody (Caltag/Invitrogen, S3.5) was used in flow cytometry on human samples . Nat Protoc (2008) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 2
In order to characterize lymphocyte subgroups in peripheral blood of advanced stage lung cancer patients, Invitrogen CD4 antibody (Caltag, MHCD0401) was used in flow cytometry on human samples (fig 2). Med Oncol (2010) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; 1:100; fig 2
In order to show that suberoylanilide hydroxamic acid reactivates HIV from latency in chronically infected cell lines and primary cells, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples at 1:100 (fig 2). J Biol Chem (2009) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
Invitrogen CD4 antibody (eBioscience, clone RPA-T4) was used in flow cytometry on human samples . J Immunol Methods (2009) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry; human; 1:10; fig 1
In order to study autoantibodies and tumor-infiltrating T cells in epithelial ovarian cancer, Invitrogen CD4 antibody (Lab Vision, MS-1528) was used in immunohistochemistry on human samples at 1:10 (fig 1). PLoS ONE (2008) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to assess the effects of Sirolimus and Sorafenib on proliferation and survival of lymphoid cell subsets, Invitrogen CD4 antibody (Caltag, MHCD0412) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2009) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 3b
In order to correlate Notch receptor expression and the severity of systemic lupus erythematosus disease, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 3b). Lupus (2008) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 2
In order to study the effect of EBV load in patients with rheumatoid arthritis, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 2). J Immunol (2008) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig s2
In order to examine the frequency, phenotype, and function of T regulatory cells in patients with systemic lupus erythematosus and inactive disease, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig s2). Clin Exp Immunol (2008) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; loading ...; fig 2b
In order to demonstrate that aerosolized interferon-gamma results in the transient conversion of sputum smears in multidrug-resistant pulmonary tuberculosis, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples (fig 2b). Int J Tuberc Lung Dis (2008) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; 1:100; fig 1
In order to examine the changes in signaling pathways of human CD4(+) and CD8(+) T cells from HIV-infected patients, Invitrogen CD4 antibody (Invitrogen, S3.5) was used in flow cytometry on human samples at 1:100 (fig 1). J Immunol (2008) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to characterize cellular immunity in patients co-infected with HIV-1 and Mycobacterium leprae, Invitrogen CD4 antibody (Caltag Laboratories, S3.5) was used in flow cytometry on human samples . Immunology (2008) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 3
In order to assess the immunological status after Bz-treatment during early indeterminate Chagas disease, Invitrogen CD4 antibody (Caltag, RPA-T4) was used in flow cytometry on human samples (fig 3). Microbes Infect (2008) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1A
In order to quantify the prevalence of Th1 and Th17 cells in the joints of rheumatoid arthritis patients, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 1A). Ann Rheum Dis (2008) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to describe the relationship of the inhibitory effect of Nef with Hck-dependent down-regulation of macrophage-colony stimulating factor receptor Fms, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . Blood (2008) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; mouse; fig 8
In order to describe retinoids as positive regulatory factors for generating gut-homing FoxP3+ T cells in both humans and mice, Invitrogen CD4 antibody (Caltag Laboratories, S3.5) was used in flow cytometry on mouse samples (fig 8). J Immunol (2007) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; sooty mangabey
In order to find that generalized CD4+ T cell depletion from the blood and mucosal tissues is not sufficient to induce AIDS in Cercocebus atys, Invitrogen CD4 antibody (Caltag Laboratories, S3.5) was used in flow cytometry on sooty mangabey samples . J Immunol (2007) ncbi
mouse monoclonal (S3.5)
  • other; mouse
In order to determine the role of beta-arrestin 1 to T cell survival, Invitrogen CD4 antibody (Caltag, MHCD0400) was used in other on mouse samples . Nat Immunol (2007) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1A
In order to propose a model in which the gamma chain cytokines IL-2, IL-4, IL-7, and IL-15 maintain the optimal regulatory function of human CD4+ CD25+ T cells in a PI3K-dependent manner, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 1A). Int Immunol (2007) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to observe a female patient with a polyautoimmune autoimmune enteropathy syndrome resembling a mild form of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, Invitrogen CD4 antibody (Caltag Laboratories, S3.5) was used in flow cytometry on human samples . Gastroenterology (2007) ncbi
mouse monoclonal (S3.5)
  • blocking or activating experiments; human
In order to report that CD4 potentiates human iNKT cell activation by engaging CD1d molecules, Invitrogen CD4 antibody (Caltag Laboratory, S3.5) was used in blocking or activating experiments on human samples . Blood (2007) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 3
In order to characterize the kinetics of the adaptive immune response following primary 17DD vaccination in order to clarify how it elicits such broad protection, Invitrogen CD4 antibody (Caltag, RPA-T4) was used in flow cytometry on human samples (fig 3). Clin Exp Immunol (2007) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to characterize CD34+ cells from bone marrow of untreated patients with chronic myelogenous leukemia in chronic phase, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . Leukemia (2007) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to study GATA-3 and T-box expression in human T cells, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . Blood (2007) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to measure T cell responses to a tumor-associated antigen and test if T regulatory cells affect those anti-tumor immune responses in patients with colorectal cancer, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . PLoS ONE (2006) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; tbl 1
In order to characterize B cells in human tonsils, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (tbl 1). Blood (2007) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to investigate the role of galectin-1 in CD4+CD25+ T cells, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 1). Blood (2007) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; African green monkey; fig 6A
  • flow cytometry; human; fig 3A
In order to characterize filoviral glycoproteins and study their contribution to infection, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on African green monkey samples (fig 6A) and in flow cytometry on human samples (fig 3A). FASEB J (2006) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to study how the human VH4 immunoglobulin repertoire changes with age, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . Scand J Immunol (2006) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to report the expression of chemokine receptors on FOXP3+ T cells, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . J Immunol (2006) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to detect the JAK2 V617F mutation in hematopoietic stem cells and their progeny in patients with polycythemia vera, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2006) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to test if impaired neonatal CD4 T-cell immunity contributes to the low incidence of acute graft-versus-host disease after allogeneic transplantation of hematopoietic stem cells using cord blood, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 1). Biol Blood Marrow Transplant (2006) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to develop methods to establish long-term, antigen-specific T-cell lines and clones, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . Immunol Lett (2006) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 3
In order to test if delta-1 affects the formation of human plasmacytoid dendritic cells, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 3). Blood (2006) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to examine the immunogenicity of the ESAT-6-CFP-10 complex, Invitrogen CD4 antibody (Caltag, MHCD0406) was used in flow cytometry on human samples . Int Immunol (2005) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to elucidate the lineage of central memory T cells and effector memory T cells, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . J Immunol (2005) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 3
In order to study T cell homing in skin infected with Haemophilus ducreyi, Invitrogen CD4 antibody (CalTag, S3.5) was used in flow cytometry on human samples (fig 3). Infect Immun (2005) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to test if transfer of allogeneic material to T cells modifies human alloresponses, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . Am J Transplant (2005) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; tbl 2
In order to study human cytomegalovirus-specific CD4+ and CD8+ T cells, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (tbl 2). Eur J Immunol (2005) ncbi
mouse monoclonal (S3.5)
In order to study the microdomains involved in the incorporation of the CD4 into the envelope of vesicular stomatitis virus, Invitrogen CD4 antibody (Caltag, MHCD0400) was used . J Virol (2005) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; African green monkey; fig 1
In order to discuss available reagents for studying the neotropical primate squirrel monkey, Invitrogen CD4 antibody (Caltag Laboratories, S3.5) was used in flow cytometry on African green monkey samples (fig 1). J Immunol Methods (2005) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 3
In order to examine the expression of IL-16 after injury, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 3). J Trauma (2005) ncbi
mouse monoclonal (S3.5)
  • immunohistochemistry - frozen section; human; fig 1
In order to assess the capacity of human tonsil CD57+ germinal center T helper cells in inducing B cell Ig synthesis, Invitrogen CD4 antibody (Caltag, S3.5) was used in immunohistochemistry - frozen section on human samples (fig 1). BMC Immunol (2005) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to develop models to study HIV-1 infected eosinophilic cells, Invitrogen CD4 antibody (Caltag, MHCD0400) was used in flow cytometry on human samples . AIDS Res Hum Retroviruses (2004) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 2
In order to elucidate how Lck is recruited to the immunological synapse, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 2). J Immunol (2004) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to investigate T cell-mediated transfer of varicella-zoster virus to skin, Invitrogen CD4 antibody (Caltag, 3.5) was used in flow cytometry on human samples . J Exp Med (2004) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to assess if T regulatory cells modulate infiltrating T lymphocytes in human metastatic melanoma, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . J Immunol (2004) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to characterize CD28nullCD4+ T cells and study the function, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 1). Scand J Immunol (2004) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to develop a comprehensive catalogue of phenotypic and functional parameters of human CD4+ T cell differentiation stages, Invitrogen CD4 antibody (CALTAG, S3.5) was used in flow cytometry on human samples (fig 1). Int Immunol (2004) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 4
In order to study the interactions between CD4(+)CD25(+) T cells and human CD8(+) T cells, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 4). Eur J Immunol (2003) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 1
In order to demonstrate the expression of ICOSL by glioma cells in vitro and in vivo, Invitrogen CD4 antibody (Caltag, RPA-T4) was used in flow cytometry on human samples (fig 1). Glia (2003) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 5
In order to utilize systemic liposomes to increase the transfection and gene expression in circulating lymphocytes without activation, Invitrogen CD4 antibody (Caltag, MHCD0401) was used in flow cytometry on human samples (fig 5). Mol Ther (2003) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to test if CD103 has a regulatory role in the microenvironment of the epithelial cell layer, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to ask if flow cytometry can be used for the detection of bone marrow involvement in the different types of B-cell malignant neoplasms, Invitrogen CD4 antibody (Zymed, S3.5) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to investigate antigen specificity of CD4+CD25+ regulatory T cells, Invitrogen CD4 antibody (Caltag, clone S3.5) was used in flow cytometry on human samples (fig 1). Blood (2003) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to examine the role of CD4(+)CD25(+) cells in regulating alloresponses in human transplant recipients, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 1). J Am Soc Nephrol (2003) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to study gamma delta T cells in the synovial fluid of human Lyme arthritis, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 1). J Immunol (2003) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to report the unconventional expression of CD4 at the surface of peripheral blood neutrophils, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . Blood (2003) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to investigate the role of CCR4 and CCR10 for cutaneous homing of T cells, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . Blood (2003) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to identify and characterize immature CD2(-/low) T cells in peripheral blood, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 1). J Immunol (2002) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to investigate graft-versus-leukemia, Invitrogen CD4 antibody (Caltag Laboratories, clone S3.5) was used in flow cytometry on human samples (fig 1). Blood (2002) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to report how to isolate highly purified hematopoietic intermediates, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2002) ncbi
mouse monoclonal (RPA-T4)
  • immunocytochemistry; human; 1:1000; fig 6
In order to elucidate mechanisms that regulate synaptic targeting of N-type channels, Invitrogen CD4 antibody (Zymed, 070403) was used in immunocytochemistry on human samples at 1:1000 (fig 6). J Neurosci (2002) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to discuss methods to assess adenosine deaminase expression in hematopoietic cells, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . Hum Gene Ther (2002) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to determine how CCR5 expression is reduced in cells from ccr5Delta32 heterozygotes, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . J Biol Chem (2002) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to characterize CCR5 truncations, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . J Biol Chem (2001) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 3
In order to assess cryptomonad-derived phycobiliproteins for their applicability to flow cytometry, Invitrogen CD4 antibody (Caltag Laboratories, clone S3.5) was used in flow cytometry on human samples (fig 3). Cytometry (2001) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 1
In order to characterize the localization and function of STRL33/Bonzo, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 1). Blood (2000) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 2
In order to investigate the role Th1 cells and their relationship with Th2 cells in human systemic lupus erythematosus, Invitrogen CD4 antibody (Caltag, MHCD0406) was used in flow cytometry on human samples (fig 2). Haematologica (2000) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to characterize the cells present in the cutaneous blister fluid patients with toxic epidermal necrolysis, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . Clin Exp Immunol (2000) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to determine the number of CD4, CCR5, and CXCR4 antibody-binding sites on various T cells and macrophages, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (1999) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to study selective expression of cytokines by T cells, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . J Immunol (1999) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human
In order to study responses of peripheral blood T cells to malaria antigens, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples . Infect Immun (1998) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; fig 7
In order to report an in vitro assay for thymic T-cell development, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples (fig 7). Blood (1998) ncbi
mouse monoclonal (S3.5)
  • immunocytochemistry; human; fig 2
In order to describe the cellular composition and organization of lymphoid aggregates in the stratum basalis of uterine endometrium, Invitrogen CD4 antibody (Caltag, S3.5) was used in immunocytochemistry on human samples (fig 2). J Leukoc Biol (1997) ncbi
mouse monoclonal (S3.5)
  • flow cytometry; human; 2 ug
In order to examine the expression of several integrins on thymocyte subpopulations and correlate them with well known thymocyte markers, Invitrogen CD4 antibody (Caltag, S3.5) was used in flow cytometry on human samples at 2 ug. Blood (1995) ncbi
BioLegend
rat monoclonal (A161A1)
  • flow cytometry; human; loading ...
BioLegend CD4 antibody (Biolegend, A161A1) was used in flow cytometry on human samples . J Exp Med (2022) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:1000; loading ...
BioLegend CD4 antibody (Biolegend, 317416) was used in flow cytometry on human samples at 1:1000. J Hematol Oncol (2022) ncbi
mouse monoclonal (SK3)
  • flow cytometry; mouse; fig 2b
BioLegend CD4 antibody (BioLegend, SK3) was used in flow cytometry on mouse samples (fig 2b). Mol Ther Oncolytics (2022) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 2b, 3a
BioLegend CD4 antibody (BioLegend, SK3) was used in flow cytometry on human samples (fig 2b, 3a). Proc Natl Acad Sci U S A (2022) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s3c
BioLegend CD4 antibody (BioLegend, 300521) was used in flow cytometry on human samples (fig s3c). Sci Adv (2022) ncbi
rat monoclonal (A161A1)
  • flow cytometry; human; fig s5f
BioLegend CD4 antibody (BioLegend, 357404) was used in flow cytometry on human samples (fig s5f). Sci Adv (2022) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD4 antibody (Biolegend, SK3) was used in flow cytometry on human samples (fig 1b). Oncoimmunology (2022) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:100; loading ...; fig 6a
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples at 1:100 (fig 6a). J Neuroinflammation (2022) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 7a
BioLegend CD4 antibody (BioLegend, 317431) was used in flow cytometry on human samples (fig 7a). Cell Rep (2022) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 2e
BioLegend CD4 antibody (Biolegend, 317428) was used in flow cytometry on human samples (fig 2e). Biomark Res (2022) ncbi
mouse monoclonal (RPA-T4)
  • mass cytometry; human; loading ...; fig 2d
BioLegend CD4 antibody (Biolegend, 300541) was used in mass cytometry on human samples (fig 2d). Biomark Res (2022) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig s3b
BioLegend CD4 antibody (BioLegend, 344604) was used in flow cytometry on human samples (fig s3b). Mol Ther Nucleic Acids (2022) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:100; loading ...; fig 1b
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples at 1:100 (fig 1b). Signal Transduct Target Ther (2022) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 5a
BioLegend CD4 antibody (BioLegend, 300532) was used in flow cytometry on human samples (fig 5a). Front Mol Biosci (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:50; fig 5b
BioLegend CD4 antibody (BioLegend, 317442) was used in flow cytometry on human samples at 1:50 (fig 5b). Sci Transl Med (2021) ncbi
rat monoclonal (A161A1)
  • flow cytometry; human; 1:100; loading ...; fig 6b
BioLegend CD4 antibody (BioLegend, 357403) was used in flow cytometry on human samples at 1:100 (fig 6b). Nat Nanotechnol (2022) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD4 antibody (BioLegend, RPAT4) was used in flow cytometry on human samples (fig 1a). Sci Adv (2021) ncbi
mouse monoclonal (RPA-T4)
  • immunohistochemistry; human; fig 1a
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in immunohistochemistry on human samples (fig 1a). Front Immunol (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; fig 1b
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig 1b). Front Immunol (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...
BioLegend CD4 antibody (Biolegend, 317441) was used in flow cytometry on human samples . Cell Rep Med (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 5:100; loading ...; fig 3e
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples at 5:100 (fig 3e). Nat Commun (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 1:50; loading ...; fig s4
BioLegend CD4 antibody (BioLegend, 300558) was used in flow cytometry on human samples at 1:50 (fig s4). Nat Med (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:100; loading ...; fig 2h
BioLegend CD4 antibody (Biolegend, 317418) was used in flow cytometry on human samples at 1:100 (fig 2h). Nat Med (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD4 antibody (Biolegend, 2RPA-T4) was used in flow cytometry on human samples (fig 1a). Front Immunol (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; mouse; 1:1000; loading ...; fig 7l
BioLegend CD4 antibody (Biolegend, 317415) was used in flow cytometry on mouse samples at 1:1000 (fig 7l). Cell Rep Med (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse; fig 2c
BioLegend CD4 antibody (Biolegend, RPA-T4) was used in flow cytometry on mouse samples (fig 2c). Adv Sci (Weinh) (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 1:40; loading ...
BioLegend CD4 antibody (Biolegend, 300558) was used in flow cytometry on human samples at 1:40. elife (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:50; loading ...
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples at 1:50. Nature (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples . Arthritis Res Ther (2021) ncbi
rat monoclonal (A161A1)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD4 antibody (Biolegend, 357410) was used in flow cytometry on human samples (fig 1b). Mucosal Immunol (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples . Aging Cell (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CD4 antibody (Biolegend, 300538) was used in flow cytometry on human samples (fig s1b). BMC Biol (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3b
  • immunohistochemistry; human; 1:50; loading ...; fig 4d
BioLegend CD4 antibody (Biolegend, RPA-T4) was used in flow cytometry on human samples (fig 3b) and in immunohistochemistry on human samples at 1:50 (fig 4d). Acta Neuropathol (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples . Immunity (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BioLegend CD4 antibody (Biolegend, RPA-T4) was used in flow cytometry on human samples . Immunity (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s6e
BioLegend CD4 antibody (BioLegend, 300508) was used in flow cytometry on human samples (fig s6e). Sci Transl Med (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:200
BioLegend CD4 antibody (Biolegend, 317414) was used in flow cytometry on human samples at 1:200. Science (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse; 1:20; loading ...; fig s1j
BioLegend CD4 antibody (BioLegend, 300514) was used in flow cytometry on mouse samples at 1:20 (fig s1j). Nature (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:20; fig 5a
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples at 1:20 (fig 5a). Science (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD4 antibody (Biolegend, RPA-T4) was used in flow cytometry on human samples (fig 3a). elife (2020) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 2a, s2, 3a
BioLegend CD4 antibody (Biolegend, 300518) was used in flow cytometry on human samples (fig 2a, s2, 3a). Am J Respir Crit Care Med (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 3b
BioLegend CD4 antibody (BioLegend, 317440) was used in flow cytometry on human samples (fig 3b). Cell (2021) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig s3d
BioLegend CD4 antibody (BioLegend, 344646) was used in flow cytometry on human samples (fig s3d). Cell (2021) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:100; loading ...; fig 1s3a
BioLegend CD4 antibody (Biolegend, 317416) was used in flow cytometry on human samples at 1:100 (fig 1s3a). elife (2020) ncbi
rat monoclonal (A161A1)
  • flow cytometry; human; 1:200; loading ...; fig 2g
BioLegend CD4 antibody (BioLegend, 357408) was used in flow cytometry on human samples at 1:200 (fig 2g). elife (2020) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 1:400; loading ...; fig 1b
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples at 1:400 (fig 1b). J Clin Invest (2020) ncbi
rat monoclonal (A161A1)
  • flow cytometry; human; loading ...; fig 1a, 1b
BioLegend CD4 antibody (Biolegend, A161A1) was used in flow cytometry on human samples (fig 1a, 1b). elife (2020) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 3:50; loading ...; fig 3j
BioLegend CD4 antibody (Biolegend, RPA-T4) was used in flow cytometry on human samples at 3:50 (fig 3j). Science (2020) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig s1a). Sci Adv (2020) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig s12a
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig s12a). Nat Commun (2020) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; 2 ug/ml; loading ...; fig 1d
BioLegend CD4 antibody (Biolegend, SK3) was used in flow cytometry on human samples at 2 ug/ml (fig 1d). Science (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s20
BioLegend CD4 antibody (Biolegend, 300510) was used in flow cytometry on human samples (fig s20). Science (2019) ncbi
rat monoclonal (A161A1)
  • flow cytometry; human; 1:200; loading ...; fig 7b
BioLegend CD4 antibody (BioLegend, 357415) was used in flow cytometry on human samples at 1:200 (fig 7b). elife (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD4 antibody (Biolegend, 317442) was used in flow cytometry on human samples (fig 3c). Cell Rep (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig e1a, 3h
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig e1a, 3h). Nature (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD4 antibody (Biolegend, RPA-T4) was used in flow cytometry on human samples (fig 3c). elife (2019) ncbi
rat monoclonal (A161A1)
  • flow cytometry; human; 1:100; loading ...; fig 7a
BioLegend CD4 antibody (Biolegend, 357404) was used in flow cytometry on human samples at 1:100 (fig 7a). elife (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 7c, 7f
BioLegend CD4 antibody (Biolegend, clone OKT4) was used in flow cytometry on human samples (fig 7c, 7f). Sci Rep (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples (fig 1a). Arthritis Res Ther (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s6c
BioLegend CD4 antibody (Biolegend, RPA-T4) was used in flow cytometry on human samples (fig s6c). Science (2019) ncbi
mouse monoclonal (RPA-T4)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 7d, 7f
  • flow cytometry; human; loading ...; fig 7a, 7c, 7e
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 7d, 7f) and in flow cytometry on human samples (fig 7a, 7c, 7e). J Clin Invest (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD4 antibody (Biolegend, 317440) was used in flow cytometry on human samples (fig 1a). Cell Mol Gastroenterol Hepatol (2020) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD4 antibody (BioLegend, 300541) was used in flow cytometry on human samples (fig s1a). Cell (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 1:200; loading ...; fig 1a
BioLegend CD4 antibody (Biolegend, 300517) was used in flow cytometry on human samples at 1:200 (fig 1a). Nat Commun (2019) ncbi
mouse monoclonal (RPA-T4)
  • mass cytometry; human; loading ...
BioLegend CD4 antibody (Biolegend, RPA-T4) was used in mass cytometry on human samples . PLoS Pathog (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples (fig 1a). J Immunol (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse; loading ...; fig 6d
BioLegend CD4 antibody (Biolegend, RPA-T4) was used in flow cytometry on mouse samples (fig 6d). J Clin Invest (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3f, 3g
BioLegend CD4 antibody (Biolegend, RPA-T4) was used in flow cytometry on human samples (fig 3f, 3g). Brain Pathol (2020) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 6
BioLegend CD4 antibody (BioLegend, 300507) was used in flow cytometry on human samples (fig 6). Gastroenterol Res Pract (2019) ncbi
mouse monoclonal (RPA-T4)
  • other; human; loading ...; fig 4b
BioLegend CD4 antibody (BioLegend, 300563) was used in other on human samples (fig 4b). Cell (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:100; loading ...; fig 2s1b
BioLegend CD4 antibody (Biolegend, 317444) was used in flow cytometry on human samples at 1:100 (fig 2s1b). elife (2019) ncbi
mouse monoclonal (SK3)
  • mass cytometry; human; loading ...; fig s1
BioLegend CD4 antibody (BioLegend, SK3) was used in mass cytometry on human samples (fig s1). J Exp Med (2019) ncbi
mouse monoclonal (OKT4)
  • immunocytochemistry; rat; 1:400; loading ...; fig 4a
BioLegend CD4 antibody (BioLegend, 317402) was used in immunocytochemistry on rat samples at 1:400 (fig 4a). elife (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 3b
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig 3b). Front Immunol (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD4 antibody (Biolegend, RPA-T4) was used in flow cytometry on human samples (fig 3a). Front Immunol (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig s8
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig s8). Nat Commun (2019) ncbi
rat monoclonal (A161A1)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD4 antibody (BioLegend, 357416) was used in flow cytometry on human samples (fig 1a). Immunity (2019) ncbi
rat monoclonal (A161A1)
  • immunohistochemistry - frozen section; human; loading ...; fig 2a
BioLegend CD4 antibody (BioLegend, A16A1) was used in immunohistochemistry - frozen section on human samples (fig 2a). J Clin Invest (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 1 ug/ml; loading ...; fig s13
BioLegend CD4 antibody (BioLegend, 300511) was used in flow cytometry on human samples at 1 ug/ml (fig s13). Science (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 1s2
BioLegend CD4 antibody (BioLegend, 317434) was used in flow cytometry on human samples (fig 1s2). elife (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 7j
BioLegend CD4 antibody (BioLegend, 317434) was used in flow cytometry on human samples (fig 7j). Cell (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s10d
BioLegend CD4 antibody (Biolegend, RPA-T4) was used in flow cytometry on human samples (fig s10d). Nature (2019) ncbi
mouse monoclonal (OKT4)
BioLegend CD4 antibody (Biolegend, OKT4) was used . J Biol Chem (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples (fig 1a). Nat Immunol (2019) ncbi
rat monoclonal (A161A1)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD4 antibody (BioLegend, A161A1) was used in flow cytometry on human samples (fig s1a). Aging (Albany NY) (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s7a
BioLegend CD4 antibody (BioLegend, 300526) was used in flow cytometry on human samples (fig s7a). Proc Natl Acad Sci U S A (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 2a
BioLegend CD4 antibody (Biolegend, RPA-T4) was used in flow cytometry on human samples (fig 2a). Cell Stem Cell (2019) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD4 antibody (Biolegend, SK3) was used in flow cytometry on human samples (fig s1). Arthritis Res Ther (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig s1f
BioLegend CD4 antibody (Biolegend, 317434) was used in flow cytometry on human samples (fig s1f). Cell (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig s3c
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig s3c). Transl Oncol (2019) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; 1:100; loading ...; fig 2a
BioLegend CD4 antibody (Biolegend, 344608) was used in flow cytometry on human samples at 1:100 (fig 2a). Nat Med (2019) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; rhesus macaque; loading ...; fig 1c
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on rhesus macaque samples (fig 1c). J Virol (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples (fig 1a). Leukemia (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 5b
BioLegend CD4 antibody (BioLegend, 300518) was used in flow cytometry on human samples (fig 5b). Nat Immunol (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 1e
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig 1e). J Immunol (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig 1a). Bone Marrow Transplant (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples (fig 1a). J Immunol (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse; loading ...; fig 3e
BioLegend CD4 antibody (BioLegend, 300508) was used in flow cytometry on mouse samples (fig 3e). Immunity (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples (fig 1a). J Virol (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 3b
BioLegend CD4 antibody (Biolegend, 317407) was used in flow cytometry on human samples (fig 3b). Biosci Rep (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse; 1:60; loading ...; fig 7a
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on mouse samples at 1:60 (fig 7a). J Virol (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD4 antibody (BioLegend, OKT-4) was used in flow cytometry on human samples (fig 1). Am J Trop Med Hyg (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples (fig 1). Am J Trop Med Hyg (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig s2
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig s2). Nat Immunol (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig 1a). Int J Infect Dis (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 2d
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig 2d). J Exp Med (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:100; fig 1a
BioLegend CD4 antibody (BioLegend, 317408) was used in flow cytometry on human samples at 1:100 (fig 1a). Nat Commun (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; fig s2e
BioLegend CD4 antibody (BioLegend, 317408) was used in flow cytometry on human samples (fig s2e). Cell (2018) ncbi
rat monoclonal (A161A1)
  • flow cytometry; human; loading ...; fig 7g
BioLegend CD4 antibody (BioLegend, A161A1) was used in flow cytometry on human samples (fig 7g). J Immunol (2018) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 5c
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig 5c). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...
In order to study the involvement of RANKL in decidual M2 macrophage polarization, BioLegend CD4 antibody (Biolegend, 300506) was used in flow cytometry on human samples . Cell Death Dis (2017) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 4b
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig 4b). J Clin Invest (2017) ncbi
mouse monoclonal (SK3)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend CD4 antibody (BioLegend, SK3) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 6a
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig 6a). Oncoimmunology (2017) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; tbl 1
In order to assess the use of dried formats of the lymphocytosis screening tube and of the primary immune deficiency orientation tube, BioLegend CD4 antibody (BioLegend, SK3) was used in flow cytometry on human samples (tbl 1). J Immunol Methods (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; tbl 1
In order to assess the use of dried formats of the lymphocytosis screening tube and of the primary immune deficiency orientation tube, BioLegend CD4 antibody (BioLegend, 300521) was used in flow cytometry on human samples (tbl 1). J Immunol Methods (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD4 antibody (BioLegend, 300528) was used in flow cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; tbl s9
In order to optimize and assess potential malaria vaccine regimens, BioLegend CD4 antibody (BioLegend, 317441) was used in flow cytometry on human samples (tbl s9). Nature (2017) ncbi
mouse monoclonal (RPA-T4)
BioLegend CD4 antibody (Biolegend, 300528) was used . Sci Rep (2017) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; rhesus macaque; loading ...; fig s4e
In order to study CXCR5+ CD8 T cells in SIV-infected animals, BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on rhesus macaque samples (fig s4e). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to characterize activated T cells in joint tissue from patients with rheumatoid arthritis, BioLegend CD4 antibody (biolegend, RPA-T4) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3b
In order to assess whether human T-cell leukemia virus type 1 bZIP factor enhances the proliferation of expressing T cells after stimulation via the T-cell receptor, BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples (fig 3b). PLoS Pathog (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 1b
In order to report the proteome of CADA-treated SUP-T1 human CD4+ T lymphocytes, BioLegend CD4 antibody (BioLegend, SK3) was used in flow cytometry on human samples (fig 1b). Mol Cell Proteomics (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse; loading ...; fig s4
In order to study the impact of modulating IFN-I signaling during suppressive combined antiretroviral therapy, BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on mouse samples (fig s4). J Clin Invest (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples (fig 2a). Cell Death Dis (2016) ncbi
mouse monoclonal (UCHT1; 3G8; MEM-188)
  • flow cytometry; human; fig 3b
BioLegend CD4 antibody (BioLegend, 319101) was used in flow cytometry on human samples (fig 3b). J Appl Physiol (1985) (2017) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig 3c). J Virol (2017) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:25; loading ...; fig 2a
In order to measure CD11d expression on lymphocyte subsets using flow cytometry, BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples at 1:25 (fig 2a). J Leukoc Biol (2017) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BioLegend CD4 antibody (Biolegend, SK3) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples (fig s1). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; fig 4s1b
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig 4s1b). PLoS ONE (2016) ncbi
mouse monoclonal (OKT4)
BioLegend CD4 antibody (BioLegend, 317416) was used . Stem Cell Reports (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 2b
BioLegend CD4 antibody (BioLegend, 300508) was used in flow cytometry on human samples (fig 2b). Oncogene (2017) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 6f
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig 6f). Sci Rep (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 6e
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples (fig 6e). J Clin Invest (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3b
In order to suggest that the BRD4-p300 signaling cascade promotes antitumor T cell grafts that could be used adoptive immunotherapy, BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples (fig 3b). J Clin Invest (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples (fig 4a). J Exp Med (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD4 antibody (BioLegend, SK3) was used in flow cytometry on human samples (fig s1). J Clin Invest (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; fig s4a
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig s4a). J Immunol (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; fig s2a
BioLegend CD4 antibody (Biolegend, SK3) was used in flow cytometry on human samples (fig s2a). Eur J Immunol (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD4 antibody (Biolegend, RPA-T4) was used in flow cytometry on human samples (fig 1). J Immunol (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 3c
In order to generate a T-cell receptor-like monoclonal antibody (8F4) that binds the PR1/HLA-A2 complex and test it in preclinical models of acute myeloid leukemia, BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples (fig 3c). Cytotherapy (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig s3
BioLegend CD4 antibody (Biolegend, RPA-T4) was used in flow cytometry on human samples (fig s3). Sci Rep (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; rhesus macaque; loading ...; fig 1h
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BioLegend CD4 antibody (BioLegend, 317433) was used in flow cytometry on rhesus macaque samples (fig 1h). Nat Med (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig s3
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig s3). Nature (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 2
BioLegend CD4 antibody (BioLegend, 300508) was used in flow cytometry on human samples (fig 2). Traffic (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; rhesus macaque; loading ...; fig 8a
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on rhesus macaque samples (fig 8a). PLoS ONE (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 2a
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples (fig 2a). Am J Transplant (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1d
BioLegend CD4 antibody (Biolegend, 300521) was used in flow cytometry on human samples (fig 1d). Oncotarget (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 5a
In order to characterize B and T cells from patients with thrombocytopenia, BioLegend CD4 antibody (BioLegend, 317429) was used in flow cytometry on human samples (fig 5a). Haematologica (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; fig 1
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 6b
In order to discuss the impact of filaggrin mutations on the development of atopic dermatitis, BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples (fig 6b). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
In order to describe a method to expand antigen-specific regulatory T cells in vivo, BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples . Nature (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; tbl s1
In order to explore how junctional adhesion molecule family members differentially regulate CXCR4 function and CXCL12 secretion in the bone marrow niche, BioLegend CD4 antibody (Biolegend, 300510) was used in flow cytometry on human samples (tbl s1). Stem Cells (2016) ncbi
mouse monoclonal (OKT4)
  • immunohistochemistry - frozen section; rhesus macaque
BioLegend CD4 antibody (Biolegend, 317422) was used in immunohistochemistry - frozen section on rhesus macaque samples . Mucosal Immunol (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to evaluate the promotion of B cell activation and CXCR4 downregulation by CD161 and LLT1 expression in human germinal centers, BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples . J Immunol (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; rhesus macaque; fig 3
In order to assess the ability of HIV-1 envelope glycoprotein-specific broadly neutralizing monoclonal antibodies to suppress acute simian-human immunodeficiency virus replication in rhesus macaques, BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on rhesus macaque samples (fig 3). J Virol (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; mouse
In order to study immune escape from CD8+ T cell killing mediated by PD-L1 expression on retrovirus-infected cells, BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on mouse samples . PLoS Pathog (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; fig 1
In order to assess the CD4/CD8 ratio as a marker for CD4+ T cell dysfunction in chronic HIV infection, BioLegend CD4 antibody (Biolegend, Clone OKT4) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
In order to study the relationship between HIV infection and the innate immune system, BioLegend CD4 antibody (Biolegend, 317427) was used in flow cytometry on human samples . J Vis Exp (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; fig 2
In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig 2). PLoS Pathog (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; 1:200; fig 1
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples at 1:200 (fig 1). Nat Commun (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; rhesus macaque; fig 4
In order to elucidate how CD8 positive T cells suppress virus replication during simian immunodeficiency virus infection, BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on rhesus macaque samples (fig 4). J Virol (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BioLegend CD4 antibody (Biolegend, RPA-T4) was used in flow cytometry on human samples . Histochem Cell Biol (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; fig 6
In order to report the phase I trial results of CDX-301, BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples (fig 6). Bone Marrow Transplant (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
BioLegend CD4 antibody (Biolegend, 317427) was used in flow cytometry on human samples . Scand J Immunol (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD4 antibody (Biolegend, RPA-T4) was used in flow cytometry on human samples (fig 3a). J Immunol Res (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 4b
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples (fig 4b). J Immunol Res (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
BioLegend CD4 antibody (Biolegend, 317435) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; fig 1
BioLegend CD4 antibody (BioLegend, SK3) was used in flow cytometry on human samples (fig 1). J Autoimmun (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples . J Autoimmun (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples . Clin Immunol (2015) ncbi
mouse monoclonal (OKT4)
BioLegend CD4 antibody (Biolegend, 317428) was used . Cancer Res (2015) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples . PLoS Negl Trop Dis (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples . Eur J Immunol (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to examine the effect of lytic EBV antigen-specific CD8+ T cells on EBV infection in humanized mice, BioLegend CD4 antibody (Biolegend, RPA-T4) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (RPA-T4)
BioLegend CD4 antibody (Biolegend, 300514) was used . PLoS ONE (2014) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; rhesus macaque
In order to examine the effect of HMBPP-deficient Listeria mutant immunization, BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on rhesus macaque samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (OKT4)
BioLegend CD4 antibody (Biolegend, OKT4) was used . PLoS ONE (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 1
In order to study the role of plasmacytoid dendritic cells in human immunodeficiency virus type 1 infection and pathogenesis, BioLegend CD4 antibody (Biolegend, 300510) was used in flow cytometry on human samples (fig 1). PLoS Pathog (2014) ncbi
mouse monoclonal (RPA-T4)
BioLegend CD4 antibody (Biolegend, 300506) was used . J Biol Chem (2014) ncbi
mouse monoclonal (OKT4)
BioLegend CD4 antibody (Biolegend, 317417) was used . J Vis Exp (2014) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (OKT4)
BioLegend CD4 antibody (BioLegend, 317416) was used . J Immunol (2014) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend CD4 antibody (Biolegend, OKT-4) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (SK3)
  • blocking or activating experiments; human
BioLegend CD4 antibody (Biolegend, SK3) was used in blocking or activating experiments on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; rhesus macaque
BioLegend CD4 antibody (BioLegend, OKT4) was used in flow cytometry on rhesus macaque samples . J Immunol (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 5
In order to investigate how heme regulates Spic in macrophages, BioLegend CD4 antibody (BioLegend, 300514) was used in flow cytometry on human samples (fig 5). Cell (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BioLegend CD4 antibody (BioLegend, RPA-T4) was used in flow cytometry on human samples . J Immunol (2013) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human
BioLegend CD4 antibody (Biolegend, OKT4) was used in flow cytometry on human samples . Tuberculosis (Edinb) (2013) ncbi
Abcam
domestic rabbit monoclonal (EPR6855)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 6e
Abcam CD4 antibody (Abcam, ab133616) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 6e). Nat Commun (2022) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 1d
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry on mouse samples at 1:50 (fig 1d). Cell Death Dis (2022) ncbi
domestic rabbit monoclonal (BL-155-1C11)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 5e
Abcam CD4 antibody (Abcam, 243872) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5e). Mol Cancer Ther (2022) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry; mouse; 1:1000; fig s5b
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry on mouse samples at 1:1000 (fig s5b). Sci Transl Med (2022) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry; mouse; 1:1000; loading ...
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry on mouse samples at 1:1000. EMBO Mol Med (2022) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 1g
Abcam CD4 antibody (Abcam, 183685) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 1g). Front Med (Lausanne) (2022) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 4g
Abcam CD4 antibody (Abcam, 183685) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 4g). Front Pharmacol (2022) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry; mouse; fig 7a
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry on mouse samples (fig 7a). Nat Commun (2022) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3b, s7f
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry - paraffin section on mouse samples (fig 3b, s7f). Cell Rep (2022) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry; mouse; fig 4g
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry on mouse samples (fig 4g). J Exp Clin Cancer Res (2022) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 3b
Abcam CD4 antibody (Abcam, EPR19514) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 3b). Med Oncol (2022) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 8a
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry - frozen section on mouse samples (fig 8a). Front Oncol (2021) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3b
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry - paraffin section on mouse samples (fig 3b). Biomedicines (2021) ncbi
domestic rabbit monoclonal (EPR6855)
  • immunohistochemistry; human; loading ...; fig 4
Abcam CD4 antibody (Abcam, EPR6855) was used in immunohistochemistry on human samples (fig 4). Front Immunol (2021) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry; mouse; 1:100; fig 2e
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry on mouse samples at 1:100 (fig 2e). Cell Death Discov (2021) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 2a
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 2a). J Clin Invest (2021) ncbi
domestic rabbit monoclonal (EPR6855)
  • immunohistochemistry; human; loading ...; fig 2a
Abcam CD4 antibody (Abcam, ab133616) was used in immunohistochemistry on human samples (fig 2a). Am J Clin Exp Urol (2021) ncbi
domestic rabbit monoclonal (EPR6855)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; fig 7a
Abcam CD4 antibody (Abcam, ab133616) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig 7a). Immunity (2021) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig s6g
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6g). Nat Commun (2021) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry; mouse; loading ...; fig 8c
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry on mouse samples (fig 8c). Neoplasia (2021) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - paraffin section; mouse; fig s5
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry - paraffin section on mouse samples (fig s5). Cancer Sci (2021) ncbi
domestic rabbit monoclonal (EPR6855)
  • immunohistochemistry - paraffin section; human
Abcam CD4 antibody (Abcam, ab133616) was used in immunohistochemistry - paraffin section on human samples . Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (EPR6855)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2e
Abcam CD4 antibody (Abcam, ab133616) was used in immunohistochemistry - paraffin section on human samples (fig 2e). Aging Cell (2020) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 3
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry on mouse samples at 1:500 (fig 3). Sci Rep (2020) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry; mouse; loading ...
Abcam CD4 antibody (Abcam, EPR19514) was used in immunohistochemistry on mouse samples . Mucosal Immunol (2021) ncbi
domestic rabbit monoclonal (EPR6855)
  • immunohistochemistry - paraffin section; rhesus macaque; 1:200; loading ...; fig s6c
Abcam CD4 antibody (Abcam, ab133616) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:200 (fig s6c). Science (2020) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry; mouse; loading ...
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry on mouse samples . World J Gastroenterol (2020) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Oncoimmunology (2020) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 3s1a
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 3s1a). elife (2020) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunocytochemistry; mouse; loading ...; fig e5b
Abcam CD4 antibody (Abcam, ab183685) was used in immunocytochemistry on mouse samples (fig e5b). Nature (2020) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5b
Abcam CD4 antibody (Abcam, EPR19514) was used in immunohistochemistry - paraffin section on mouse samples (fig 5b). Cancers (Basel) (2020) ncbi
domestic rabbit monoclonal (EPR6855)
  • immunohistochemistry - paraffin section; human; 1.1 ug/ml; fig 3a
Abcam CD4 antibody (Abcam, ab133616) was used in immunohistochemistry - paraffin section on human samples at 1.1 ug/ml (fig 3a). Acta Neuropathol Commun (2020) ncbi
domestic rabbit monoclonal (EPR6855)
  • immunohistochemistry; human; loading ...; fig s5a
Abcam CD4 antibody (Abcam, ERP6855) was used in immunohistochemistry on human samples (fig s5a). Nature (2020) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 2b
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 2b). Nat Commun (2020) ncbi
domestic rabbit monoclonal (EPR6855)
  • immunohistochemistry - paraffin section; human; loading ...; fig s7d
Abcam CD4 antibody (Abcam, ab133616) was used in immunohistochemistry - paraffin section on human samples (fig s7d). Cell (2019) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig e3g
Abcam CD4 antibody (Abcam, EPR19514) was used in immunohistochemistry - paraffin section on mouse samples (fig e3g). Nature (2019) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig e8d
Abcam CD4 antibody (Abcam, 183685) was used in immunohistochemistry - paraffin section on mouse samples (fig e8d). Nature (2019) ncbi
domestic rabbit monoclonal (EPR19514)
  • flow cytometry; mouse; 1:500; loading ...; fig 3c
Abcam CD4 antibody (Abcam, ab183685) was used in flow cytometry on mouse samples at 1:500 (fig 3c). J Immunother Cancer (2019) ncbi
domestic rabbit monoclonal (EPR6855)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3e
Abcam CD4 antibody (Abcam, ab133616) was used in immunohistochemistry - paraffin section on human samples (fig 3e). Brain Pathol (2020) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - paraffin section; mouse; fig 3g
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry - paraffin section on mouse samples (fig 3g). J Clin Invest (2019) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig e5c
  • flow cytometry; mouse; loading ...; fig e5b
Abcam CD4 antibody (Abcam, 183685) was used in immunohistochemistry - paraffin section on mouse samples (fig e5c) and in flow cytometry on mouse samples (fig e5b). Nature (2019) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1d
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry - paraffin section on mouse samples (fig 1d). Cancer Cell (2019) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry; human; 1:100; loading ...
Abcam CD4 antibody (Abcam, EPR19514) was used in immunohistochemistry on human samples at 1:100. Nature (2019) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6d
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry - paraffin section on mouse samples (fig 6d). Nat Commun (2019) ncbi
domestic rabbit monoclonal (EPR19514)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 1k'
Abcam CD4 antibody (Abcam, ab183685) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 1k'). Cell Death Dis (2018) ncbi
domestic rabbit monoclonal
  • immunohistochemistry; mouse; 1:200; loading ...; fig s4a
Abcam CD4 antibody (Abcam, ab221775) was used in immunohistochemistry on mouse samples at 1:200 (fig s4a). Breast Cancer Res (2018) ncbi
domestic rabbit monoclonal (EPR6855)
  • immunohistochemistry - paraffin section; human; loading ...; fig s1a
Abcam CD4 antibody (Abcam, ab133616) was used in immunohistochemistry - paraffin section on human samples (fig s1a). Nat Commun (2018) ncbi
domestic rabbit monoclonal (EPR6855)
  • immunohistochemistry - paraffin section; human; fig 1a
Abcam CD4 antibody (Abcam, 133616) was used in immunohistochemistry - paraffin section on human samples (fig 1a). Sci Rep (2017) ncbi
domestic rabbit monoclonal (EPR6855)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2c
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, Abcam CD4 antibody (Abcam, EPR6855) was used in immunohistochemistry - paraffin section on human samples (fig 2c). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit monoclonal (EPR6855)
  • western blot; human; fig 2a
In order to analyze HIV-1 Vpu sequences isolated from patients, Abcam CD4 antibody (Abcam, ab133616) was used in western blot on human samples (fig 2a). Sci Rep (2017) ncbi
domestic rabbit monoclonal (EPR6855)
  • flow cytometry; mouse; 1:100; loading ...; fig 5
Abcam CD4 antibody (Abcam, ab133616) was used in flow cytometry on mouse samples at 1:100 (fig 5). Exp Ther Med (2016) ncbi
mouse monoclonal (MEM-241)
  • flow cytometry; human
Abcam CD4 antibody (Abcam, ab18282) was used in flow cytometry on human samples . Traffic (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (MT310)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 1e
Santa Cruz Biotechnology CD4 antibody (Santa Cruz, sc-19641) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 1e). iScience (2022) ncbi
mouse monoclonal (MT310)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2b
Santa Cruz Biotechnology CD4 antibody (Santa Cruz, SC-19641) was used in immunohistochemistry - paraffin section on mouse samples (fig 2b). Front Immunol (2021) ncbi
mouse monoclonal (MT310)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig s6c
Santa Cruz Biotechnology CD4 antibody (Santa, sc-19641) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig s6c). Theranostics (2021) ncbi
mouse monoclonal (MT310)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 9d
Santa Cruz Biotechnology CD4 antibody (Santa Cruz, sc-19641) was used in immunohistochemistry on mouse samples at 1:50 (fig 9d). J Neuroinflammation (2020) ncbi
rat monoclonal (GK1.5)
  • immunohistochemistry - frozen section; mouse; 1:500
  • immunohistochemistry; mouse; loading ...; fig 45
In order to outline the protocols for antibodies used for immunohistochemical studies, Santa Cruz Biotechnology CD4 antibody (Santa Cruz, sc-13573) was used in immunohistochemistry - frozen section on mouse samples at 1:500 and in immunohistochemistry on mouse samples (fig 45). J Toxicol Pathol (2017) ncbi
mouse monoclonal (MT310)
  • flow cytometry; human; loading ...; fig s1c
In order to demonstrate that neonatal CD8 positive T cells have a specific genetic program biased toward the innate immune response, Santa Cruz Biotechnology CD4 antibody (Santa Cruz, MT310) was used in flow cytometry on human samples (fig s1c). Cell Rep (2016) ncbi
mouse monoclonal (1F6)
  • immunohistochemistry - paraffin section; human; 1:100; fig s3
Santa Cruz Biotechnology CD4 antibody (Santa Cruz, sc-59032) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s3). Oncotarget (2016) ncbi
mouse monoclonal (RIV6)
  • immunoprecipitation; rat; fig s3
Santa Cruz Biotechnology CD4 antibody (Santa Cruz, sc-52385) was used in immunoprecipitation on rat samples (fig s3). PLoS ONE (2015) ncbi
rat monoclonal (GK1.5)
  • immunohistochemistry - frozen section; mouse; 1:100
Santa Cruz Biotechnology CD4 antibody (Santa Cruz, sc-13573) was used in immunohistochemistry - frozen section on mouse samples at 1:100. J Mol Cell Cardiol (2014) ncbi
rat monoclonal (GK1.5)
  • immunoprecipitation; rat
  • western blot; rat; 1:500
In order to identify the molecular mechanisms that regulate the enrichment of KCNQ channels at the neuronal axon, Santa Cruz Biotechnology CD4 antibody (Santa Cruz Biotech, sc-13573) was used in immunoprecipitation on rat samples and in western blot on rat samples at 1:500. PLoS ONE (2014) ncbi
mouse monoclonal (MT310)
  • immunocytochemistry; human
Santa Cruz Biotechnology CD4 antibody (Santa Cruz Biotechnology, MT310) was used in immunocytochemistry on human samples . J Cell Physiol (2014) ncbi
Miltenyi Biotec
mouse monoclonal (VIT4)
  • flow cytometry; human; 1:100; fig 2f
Miltenyi Biotec CD4 antibody (Miltenyi, 130-113-221) was used in flow cytometry on human samples at 1:100 (fig 2f). Nat Med (2021) ncbi
mouse monoclonal (VIT4)
  • flow cytometry; human; loading ...; fig 1
Miltenyi Biotec CD4 antibody (Miltenyi, VIT4) was used in flow cytometry on human samples (fig 1). Arthritis Res Ther (2021) ncbi
mouse monoclonal (VIT4)
  • flow cytometry; human; loading ...
Miltenyi Biotec CD4 antibody (Miltenyi Biotec, VIT4) was used in flow cytometry on human samples . EMBO Mol Med (2021) ncbi
mouse monoclonal (M-T466)
  • flow cytometry; rhesus macaque; loading ...; fig s8
Miltenyi Biotec CD4 antibody (Miltenyi, 130-113-250) was used in flow cytometry on rhesus macaque samples (fig s8). Nat Commun (2020) ncbi
mouse monoclonal (VIT4)
  • flow cytometry; human; loading ...; fig 6a
Miltenyi Biotec CD4 antibody (Miltenyi Biotec, 130-113-219) was used in flow cytometry on human samples (fig 6a). Cell (2019) ncbi
mouse monoclonal (M-T466)
  • flow cytometry; human; loading ...; fig 7d
Miltenyi Biotec CD4 antibody (Miltenyi Biotec, 130-113-251) was used in flow cytometry on human samples (fig 7d). Cell (2019) ncbi
human monoclonal (REA623)
  • flow cytometry; human; loading ...; fig 4a
Miltenyi Biotec CD4 antibody (Miltenyi, REA623) was used in flow cytometry on human samples (fig 4a). Front Immunol (2018) ncbi
mouse monoclonal (M-T466)
  • flow cytometry; human; fig 1
Miltenyi Biotec CD4 antibody (Miltenyi Biotec, M-T466) was used in flow cytometry on human samples (fig 1). Biosci Rep (2017) ncbi
Bio-Rad
mouse monoclonal (CVS4)
  • flow cytometry; horses; 1:10; loading ...; fig 1
Bio-Rad CD4 antibody (BioRad, CVS4) was used in flow cytometry on horses samples at 1:10 (fig 1). Antioxidants (Basel) (2020) ncbi
mouse monoclonal (CVS4)
  • flow cytometry; horses; loading ...; fig 4c
Bio-Rad CD4 antibody (Bio-Rad, CVS4) was used in flow cytometry on horses samples (fig 4c). Proc Natl Acad Sci U S A (2017) ncbi
Bio X Cell
mouse monoclonal (OKT-4)
  • blocking or activating experiments; human; ; fig 3s2b
Bio X Cell CD4 antibody (BioXCell, BE0003-2) was used in blocking or activating experiments on human samples at (fig 3s2b). elife (2020) ncbi
OriGene
mouse monoclonal (OTI10B5)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig st3
  • immunohistochemistry - paraffin section; rat; 1:50; loading ...; fig st3
  • immunohistochemistry - paraffin section; dogs; 1:50; loading ...; fig st3
In order to outline the protocols for antibodies used for immunohistochemical studies, OriGene CD4 antibody (OriGene, TA500477) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig st3), in immunohistochemistry - paraffin section on rat samples at 1:50 (fig st3) and in immunohistochemistry - paraffin section on dogs samples at 1:50 (fig st3). J Toxicol Pathol (2017) ncbi
mouse monoclonal (OTI6E10)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1c
OriGene CD4 antibody (Zhongshan Golden Bridge, OTI6E10) was used in immunohistochemistry - paraffin section on human samples (fig 1c). Cancer Immunol Immunother (2017) ncbi
Novus Biologicals
domestic rabbit polyclonal (SP107)
Novus Biologicals CD4 antibody (Novus Biologicals, NBP1-19371) was used . Sci Rep (2015) ncbi
Dako
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 4d
Dako CD4 antibody (Dako, 4B12) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 4d). Front Oncol (2021) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 2d
Dako CD4 antibody (Dako, M7310) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2d). J Pers Med (2021) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry; human; loading ...; fig 2a
Dako CD4 antibody (Dako, 4B12) was used in immunohistochemistry on human samples (fig 2a). PLoS ONE (2020) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4h
Dako CD4 antibody (DAKO, 4B12) was used in immunohistochemistry - paraffin section on human samples (fig 4h). PLoS ONE (2020) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; loading ...
Dako CD4 antibody (DAKO, M7310) was used in immunohistochemistry - paraffin section on human samples . elife (2020) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 2b-b
Dako CD4 antibody (Dako, 4B12) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2b-b). Ann Clin Transl Neurol (2020) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - frozen section; human; 1:200; loading ...; fig 1b
Dako CD4 antibody (Dako, M7310) was used in immunohistochemistry - frozen section on human samples at 1:200 (fig 1b). elife (2019) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 6a
Dako CD4 antibody (Dako, M7310) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 6a). Nat Commun (2019) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:2000; loading ...; fig 2i
In order to look for C3d+ microglial clusters in patients with multiple sclerosis, Dako CD4 antibody (Dako, 4B12) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 2i). Glia (2017) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:80; loading ...; fig 2a
Dako CD4 antibody (Dako, M7310) was used in immunohistochemistry - paraffin section on human samples at 1:80 (fig 2a). J Immunol Res (2016) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry; human; fig 4
In order to study IFN responses from dendritic cells isolated from patients with Sjogren's syndrome, Dako CD4 antibody (Dako, 4B12) was used in immunohistochemistry on human samples (fig 4). Ann Rheum Dis (2017) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:400; loading ...
Dako CD4 antibody (Dako, M7310) was used in immunohistochemistry - paraffin section on human samples at 1:400. Oncol Lett (2016) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry; human; loading ...; fig 5
Dako CD4 antibody (Dako, M731001-2) was used in immunohistochemistry on human samples (fig 5). Part Fibre Toxicol (2016) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human
In order to examine the histopathological patterns and their associations with clinical characteristics in Chinese patients with nasal inverted papilloma, Dako CD4 antibody (Dako, 4B12) was used in immunohistochemistry - paraffin section on human samples . Laryngoscope (2016) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; fig 2
In order to characterize Chinese nasal polyp, Dako CD4 antibody (Dako, 4B12) was used in immunohistochemistry - paraffin section on human samples (fig 2). Int Forum Allergy Rhinol (2016) ncbi
mouse monoclonal (4B12)
  • immunocytochemistry; human; 1:20; fig 2
In order to examine Cx43 channels in reactive follicular dendritic cell development and follicular lymphomas, Dako CD4 antibody (Dako, clone: 4B12) was used in immunocytochemistry on human samples at 1:20 (fig 2). J Immunol Res (2015) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; fig 1g
  • flow cytometry; human; fig 2b
Dako CD4 antibody (Dako, 4B12) was used in immunohistochemistry - paraffin section on human samples (fig 1g) and in flow cytometry on human samples (fig 2b). J Immunol (2015) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry; human; 1:40
Dako CD4 antibody (DAKO, M7310 (4B12)) was used in immunohistochemistry on human samples at 1:40. Muscle Nerve (2015) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:80; fig 1
Dako CD4 antibody (Dako, M7310) was used in immunohistochemistry - paraffin section on human samples at 1:80 (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:40
Dako CD4 antibody (DAKO, 4B12) was used in immunohistochemistry - paraffin section on human samples at 1:40. Eur J Cancer (2015) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; mouse
Dako CD4 antibody (Dako, M7310) was used in immunohistochemistry - paraffin section on mouse samples . Arthritis Rheumatol (2015) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; ready-to-use
In order to determine if the presence of the DUSP22-IRF4 translocation is a distinctive histological features in patients with cutaneous anaplastic large cell lymphoma, Dako CD4 antibody (Dako, 4B12) was used in immunohistochemistry - paraffin section on human samples at ready-to-use. Histopathology (2015) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:200
Dako CD4 antibody (Dako, M7310) was used in immunohistochemistry - paraffin section on human samples at 1:200. Br J Dermatol (2014) ncbi
mouse monoclonal (4B12)
  • immunocytochemistry; human; 1:40
Dako CD4 antibody (Dako, 4B12) was used in immunocytochemistry on human samples at 1:40. Nephrology (Carlton) (2014) ncbi
Beckman Coulter
mouse monoclonal (SFCI12T4D11)
  • flow cytometry; human; loading ...; fig s1
Beckman Coulter CD4 antibody (Beckman Coulter, SFCI12T4D11) was used in flow cytometry on human samples (fig s1). EBioMedicine (2020) ncbi
mouse monoclonal (13B8.2)
  • flow cytometry; human; loading ...; fig 2a
Beckman Coulter CD4 antibody (Beckman Coulter, 13B8.2) was used in flow cytometry on human samples (fig 2a). Arthritis Res Ther (2020) ncbi
mouse monoclonal (13B8.2)
  • flow cytometry; human; loading ...; fig s4a, s8a
Beckman Coulter CD4 antibody (Beckman Coulter, 13B8.2) was used in flow cytometry on human samples (fig s4a, s8a). Nat Commun (2020) ncbi
mouse monoclonal (13B8.2)
  • flow cytometry; human; loading ...; fig 2a
Beckman Coulter CD4 antibody (Beckman Coulter Immunotech, IM2636U) was used in flow cytometry on human samples (fig 2a). Nature (2018) ncbi
mouse monoclonal (13B8.2)
  • flow cytometry; human; loading ...; fig s8e
Beckman Coulter CD4 antibody (Coulter, 13B8.2) was used in flow cytometry on human samples (fig s8e). Nature (2017) ncbi
mouse monoclonal (13B8.2)
  • flow cytometry; human; loading ...; fig 1
Beckman Coulter CD4 antibody (Beckman Coulter, IM2636U) was used in flow cytometry on human samples (fig 1). Exp Ther Med (2017) ncbi
mouse monoclonal (13B8.2)
  • flow cytometry; human; loading ...; fig 6d
Beckman Coulter CD4 antibody (Beckman Coulter, A96417) was used in flow cytometry on human samples (fig 6d). Oncoimmunology (2016) ncbi
mouse monoclonal (SFCI12T4D11)
  • flow cytometry; human; 1:500; loading ...; fig s2
Beckman Coulter CD4 antibody (Beckman Coulter, RPA-T4) was used in flow cytometry on human samples at 1:500 (fig s2). JCI Insight (2017) ncbi
mouse monoclonal (13B8.2)
  • flow cytometry; human; loading ...; fig 4a
In order to report that patients with PTEN mutations experience autoimmunity and lymphoid hyperplasia, Beckman Coulter CD4 antibody (Immunotec, 13B8.2) was used in flow cytometry on human samples (fig 4a). J Allergy Clin Immunol (2017) ncbi
mouse monoclonal (13B8.2)
  • flow cytometry; human; loading ...; fig s1
Beckman Coulter CD4 antibody (Beckman Coulter, 13B8.2) was used in flow cytometry on human samples (fig s1). J Immunol (2016) ncbi
mouse monoclonal (13B8.2)
  • flow cytometry; human; 1:100; fig 1
Beckman Coulter CD4 antibody (Beckman Coulter, IM2636U) was used in flow cytometry on human samples at 1:100 (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (SFCI12T4D11)
  • flow cytometry; human; fig S1
Beckman Coulter CD4 antibody (Beckman Coulter, SFCI12T4D11) was used in flow cytometry on human samples (fig S1). J Neuroinflammation (2015) ncbi
mouse monoclonal (SFCI12T4D11)
  • flow cytometry; human
Beckman Coulter CD4 antibody (Beckman Coulter, SFCI12T4D11) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (SFCI12T4D11)
  • flow cytometry; human
Beckman Coulter CD4 antibody (Beckman Coulter, SFCI12t4D11) was used in flow cytometry on human samples . Clin Exp Immunol (2015) ncbi
mouse monoclonal (13B8.2)
  • flow cytometry; human
Beckman Coulter CD4 antibody (Beckman Coulter, PN IM0448U) was used in flow cytometry on human samples . Curr Protoc Cytom (2015) ncbi
mouse monoclonal (SFCI12T4D11)
  • flow cytometry; human; 0.5:100
In order to compared leukocyte proportions and absolute counts using reference real-time methods with a novel assay that allows long-term cryopreservation of fixed leukocytes for later counting, Beckman Coulter CD4 antibody (Beckman Coulter, 6604727) was used in flow cytometry on human samples at 0.5:100. Cytometry A (2015) ncbi
mouse monoclonal (13B8.2)
  • flow cytometry; human
Beckman Coulter CD4 antibody (Beckman-Coulter, 13B8.2) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (13B8.2)
  • chromatin immunoprecipitation; human
In order to characterize the coincidence detection with cell differentiation using a microfluidic impedance biochip, Beckman Coulter CD4 antibody (Beckman Coulter, IM0398) was used in chromatin immunoprecipitation on human samples . Lab Chip (2014) ncbi
mouse monoclonal (SFCI12T4D11)
  • flow cytometry; human
Beckman Coulter CD4 antibody (Beckman Coulter, SFCI12T4D11) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2014) ncbi
mouse monoclonal (13B8.2)
  • flow cytometry; human; fig 1
In order to characterize VLA-4 blockade and promotion of differential routes into human CNS involving MCAM-adhesion of TH17 cells and PSGL-1 rolling of T cells, Beckman Coulter CD4 antibody (Beckman Coulter, 13B8.2) was used in flow cytometry on human samples (fig 1). J Exp Med (2014) ncbi
mouse monoclonal (SFCI12T4D11)
  • flow cytometry; human
Beckman Coulter CD4 antibody (Beckman Coulter, SFCI12T4D11) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (SFCI12T4D11)
  • flow cytometry; human
Beckman Coulter CD4 antibody (Beckman-Coulter, SFCI12T4D11) was used in flow cytometry on human samples . FASEB J (2014) ncbi
mouse monoclonal (13B8.2)
  • flow cytometry; human
Beckman Coulter CD4 antibody (Beckman Coulter, 13 B8.2) was used in flow cytometry on human samples . Clin Exp Immunol (2014) ncbi
mouse monoclonal (13B8.2)
  • flow cytometry; human
Beckman Coulter CD4 antibody (Beckman Coulter, 13B8.2) was used in flow cytometry on human samples . J Immunol Res (2014) ncbi
mouse monoclonal (SFCI12T4D11)
  • flow cytometry; human; fig 2A
In order to investigate human T lymphotropic virus type 1 bZIP factor-specific CD4 T cell responses, Beckman Coulter CD4 antibody (Beckman Coulter, SFCI12T4D11) was used in flow cytometry on human samples (fig 2A). J Immunol (2014) ncbi
Tonbo Biosciences
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 4h
Tonbo Biosciences CD4 antibody (TONBO, OKT4) was used in flow cytometry on human samples (fig 4h). Oncoimmunology (2022) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse; loading ...; fig 3f
Tonbo Biosciences CD4 antibody (Tonbo Biosciences, 20-0049-T100) was used in flow cytometry on mouse samples (fig 3f). Nat Commun (2020) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; mouse; loading ...; fig 1d
Tonbo Biosciences CD4 antibody (Tonbo Biosciences, OKT4) was used in flow cytometry on mouse samples (fig 1d). J Virol (2020) ncbi
mouse monoclonal (RPA-T4)
  • immunohistochemistry - frozen section; human; loading ...; fig 5a
Tonbo Biosciences CD4 antibody (TonboBiosciences, RPA-T4) was used in immunohistochemistry - frozen section on human samples (fig 5a). Science (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3c
Tonbo Biosciences CD4 antibody (Tonbo, RPA-T4) was used in flow cytometry on human samples (fig 3c). Front Immunol (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1a
Tonbo Biosciences CD4 antibody (Tonbo Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (OKT4)
  • flow cytometry; human; loading ...; fig 7
In order to assess how ABCG1 loss in T cells affects atherosclerosis, Tonbo Biosciences CD4 antibody (Tonbo Biosciences, OKT4) was used in flow cytometry on human samples (fig 7). J Clin Invest (2016) ncbi
Cell Marque
domestic rabbit monoclonal (SP35)
  • immunohistochemistry; human; 1:100; fig s1e
Cell Marque CD4 antibody (Cell Marque, EP204, 104R-25) was used in immunohistochemistry on human samples at 1:100 (fig s1e). Nature (2021) ncbi
domestic rabbit monoclonal (SP35)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
In order to analyze differentially expressed granzyme inhibitors in pediatric primitive neuroectodermal tumors of the central nervous system, Cell Marque CD4 antibody (Cell Marque, SP35) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (SP35)
  • immunohistochemistry - paraffin section; human; 1:25
Cell Marque CD4 antibody (Cell Marque, 104R-15) was used in immunohistochemistry - paraffin section on human samples at 1:25. Prostate (2015) ncbi
domestic rabbit monoclonal (SP35)
  • immunohistochemistry - paraffin section; human; fig 5
Cell Marque CD4 antibody (Cell Marque, SP35) was used in immunohistochemistry - paraffin section on human samples (fig 5). PLoS ONE (2014) ncbi
Cell Signaling Technology
mouse monoclonal (Edu-2)
  • flow cytometry; human; 1:1000; loading ...; tbl 1
Cell Signaling Technology CD4 antibody (Cell signaling, 3563) was used in flow cytometry on human samples at 1:1000 (tbl 1). Exp Ther Med (2016) ncbi
National Institutes of Health AIDS Research and Reference Reagent Program
mouse monoclonal (SIM4)
  • flow cytometry; human; 1:20; fig s5d
National Institutes of Health AIDS Research and Reference Reagent Program CD4 antibody (AIDS Reagent Program, SIM.4) was used in flow cytometry on human samples at 1:20 (fig s5d). Proc Natl Acad Sci U S A (2017) ncbi
BD Biosciences
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 1:50; loading ...; fig 2h
BD Biosciences CD4 antibody (BD, 557871) was used in flow cytometry on human samples at 1:50 (fig 2h). Nat Commun (2022) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 1:100; fig s1b
BD Biosciences CD4 antibody (BD Pharmingen, 555346) was used in flow cytometry on human samples at 1:100 (fig s1b). Nat Commun (2022) ncbi
mouse monoclonal (L200)
  • flow cytometry; rhesus macaque; ; fig 9a
BD Biosciences CD4 antibody (BD Pharmingen, L200) was used in flow cytometry on rhesus macaque samples at (fig 9a). Front Immunol (2022) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 8a
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig 8a). J Clin Invest (2022) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s2a, s2b
BD Biosciences CD4 antibody (BD Pharmingen, 562424) was used in flow cytometry on human samples (fig s2a, s2b). Oncoimmunology (2022) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Biosciences, 550369) was used in flow cytometry on human samples . J Clin Invest (2022) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s2b
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig s2b). Front Immunol (2021) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; fig 3g
BD Biosciences CD4 antibody (BD Bioscience, SK3) was used in flow cytometry on human samples (fig 3g). J Immunother Cancer (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 3g
BD Biosciences CD4 antibody (BD Bioscience, RPA-T4) was used in flow cytometry on human samples (fig 3g). J Immunother Cancer (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse; 1:1000; loading ...; fig 7l
BD Biosciences CD4 antibody (BD Biosciences, 560158) was used in flow cytometry on mouse samples at 1:1000 (fig 7l). Cell Rep Med (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...
BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples . Adv Sci (Weinh) (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD4 antibody (BD Biosciences, 560649) was used in flow cytometry on human samples (fig 5a). J Clin Invest (2021) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; 1:50; loading ...; fig 4a
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples at 1:50 (fig 4a). Nat Commun (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; ; loading ...; fig 3a
BD Biosciences CD4 antibody (BD Bioscience, RPA-T4) was used in flow cytometry on human samples at (fig 3a). J Immunother Cancer (2021) ncbi
mouse monoclonal (L200)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD4 antibody (BD Biosciences, L200) was used in flow cytometry on human samples (fig 2a). Int J Mol Sci (2021) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig s9c
BD Biosciences CD4 antibody (BD, 563550) was used in flow cytometry on human samples (fig s9c). Science (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s2d
BD Biosciences CD4 antibody (BD, 555347) was used in flow cytometry on human samples (fig s2d). Signal Transduct Target Ther (2021) ncbi
mouse monoclonal (SK3)
  • flow cytometry; mouse; loading ...; fig 2d
BD Biosciences CD4 antibody (BD Biosciences, 563550) was used in flow cytometry on mouse samples (fig 2d). J Autoimmun (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1
BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples (fig 1). Arthritis Res Ther (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...
BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples . EMBO Mol Med (2021) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse; loading ...; fig 4a
BD Biosciences CD4 antibody (BD biosciences, 560246) was used in flow cytometry on mouse samples (fig 4a). Biomedicines (2020) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD4 antibody (BD, RPAT4) was used in flow cytometry on human samples (fig 3a). BMC Cancer (2020) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 5a, 5c
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig 5a, 5c). J Clin Invest (2021) ncbi
mouse monoclonal (RPA-T4)
  • western blot; human; 1:25; loading ...; fig s8a
BD Biosciences CD4 antibody (BD, 562658) was used in western blot on human samples at 1:25 (fig s8a). Science (2020) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...
BD Biosciences CD4 antibody (BD Biosciences, 347324) was used in flow cytometry on human samples . J Clin Invest (2020) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s3a
BD Biosciences CD4 antibody (Becton Dickinson, RPA-T4) was used in flow cytometry on human samples (fig s3a). EBioMedicine (2020) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s3a
BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples (fig s3a). Aging (Albany NY) (2020) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD4 antibody (BD Biosciences, SK 3) was used in flow cytometry on human samples (fig 1a). Arch Immunol Ther Exp (Warsz) (2020) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 2s5a
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig 2s5a). elife (2020) ncbi
mouse monoclonal (L200)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD4 antibody (BD Biosciences, 552838) was used in flow cytometry on human samples (fig 2a). elife (2020) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 7k
BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples (fig 7k). J Exp Med (2020) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 1:100; loading ...; fig 1f
BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples at 1:100 (fig 1f). elife (2020) ncbi
mouse monoclonal (L200)
  • flow cytometry; African green monkey; loading ...; fig 2a
BD Biosciences CD4 antibody (BD Pharmingen, 551980) was used in flow cytometry on African green monkey samples (fig 2a). PLoS Pathog (2020) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences CD4 antibody (BD Bioscience, SK3) was used in flow cytometry on human samples (fig s1a). Oncoimmunology (2020) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse; loading ...; fig s2a
  • flow cytometry; human; loading ...; fig s2a
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on mouse samples (fig s2a) and in flow cytometry on human samples (fig s2a). Nature (2020) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 5c
BD Biosciences CD4 antibody (BD Bioscience, 560650) was used in flow cytometry on human samples (fig 5c). Stem Cell Res Ther (2020) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig e1a, 3h
BD Biosciences CD4 antibody (BD, SK3) was used in flow cytometry on human samples (fig e1a, 3h). Nature (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 10a, 12a
BD Biosciences CD4 antibody (BD Biosciences, 555349) was used in flow cytometry on human samples (fig 10a, 12a). Hum Vaccin Immunother (2020) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 15b
BD Biosciences CD4 antibody (BD Biosciences, 347324) was used in flow cytometry on human samples (fig 15b). Hum Vaccin Immunother (2020) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 4d
BD Biosciences CD4 antibody (BD Bioscience, 561843) was used in flow cytometry on human samples (fig 4d). Cell Mol Gastroenterol Hepatol (2020) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD4 antibody (BD Biosciences, 557922) was used in flow cytometry on human samples (fig 1a). Nat Commun (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples (fig 1c). PLoS Pathog (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig s1). Eur J Immunol (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD4 antibody (BD, 558116) was used in flow cytometry on human samples (fig 1b). J Immunol (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig ex1
BD Biosciences CD4 antibody (BD Bioscience, RPA-T4) was used in flow cytometry on human samples (fig ex1). Nature (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s2
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig s2). JCI Insight (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; tbl 1
BD Biosciences CD4 antibody (BD, 558116) was used in flow cytometry on human samples (tbl 1). J Exp Med (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig ex5e
BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples (fig ex5e). Nat Med (2019) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 7a
BD Biosciences CD4 antibody (BD Biosciences, 340133) was used in flow cytometry on human samples (fig 7a). elife (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 5
BD Biosciences CD4 antibody (BD, RPAT4) was used in flow cytometry on human samples (fig 5). Front Immunol (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences CD4 antibody (BD Biosciences, 562658) was used in flow cytometry on human samples (fig s1a). J Clin Invest (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD4 antibody (BD, 561843) was used in flow cytometry on human samples (fig 1c). elife (2019) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 2d
BD Biosciences CD4 antibody (BD, 563877) was used in flow cytometry on human samples (fig 2d). Cell (2019) ncbi
mouse monoclonal (L200)
  • flow cytometry; human; 1:12.5; loading ...; fig 2s1a
BD Biosciences CD4 antibody (BD, 550631) was used in flow cytometry on human samples at 1:12.5 (fig 2s1a). elife (2019) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 4b
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig 4b). J Immunol (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3c
BD Biosciences CD4 antibody (BD Pharmingen, 555349) was used in flow cytometry on human samples (fig 3c). BMC Immunol (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 2b
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 2b). J Immunol (2019) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 1
BD Biosciences CD4 antibody (BD Pharmingen, SK3) was used in flow cytometry on human samples (fig 1). Am J Transplant (2019) ncbi
mouse monoclonal (RPA-T4)
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used . Am J Transplant (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples (fig 1a). J Virol (2019) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD4 antibody (BD Horizon, SK3) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2019) ncbi
mouse monoclonal (L200)
  • flow cytometry; rhesus macaque; loading ...; fig 2a
BD Biosciences CD4 antibody (BD Biosciences, L200) was used in flow cytometry on rhesus macaque samples (fig 2a). J Virol (2019) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 5d
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 5d). J Immunol (2018) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig s6d
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig s6d). Cell (2018) ncbi
mouse monoclonal (SK3)
  • immunohistochemistry - frozen section; human; loading ...; fig 2c
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in immunohistochemistry - frozen section on human samples (fig 2c). J Infect Dis (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 2a). J Infect Dis (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1d
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 1d). Int J Hematol (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s6c
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig s6c). Leukemia (2019) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 5b
BD Biosciences CD4 antibody (BD Biosciences, 563028) was used in flow cytometry on human samples (fig 5b). Nat Immunol (2018) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; fig 2a
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig 2a). J Autoimmun (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 2a). J Clin Invest (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3b
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 3b). Front Immunol (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s4b
BD Biosciences CD4 antibody (BD Pharmingen, RPA-T4) was used in flow cytometry on human samples (fig s4b). Sci Immunol (2018) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig s5a
BD Biosciences CD4 antibody (BD Pharmingen, SK3) was used in flow cytometry on human samples (fig s5a). Sci Immunol (2018) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 1e
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig 1e). Nat Med (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD4 antibody (BD Bioscience, 560158) was used in flow cytometry on human samples (fig 1b). J Clin Invest (2018) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig s1). J Clin Invest (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1
BD Biosciences CD4 antibody (BD Biosciences, 555346) was used in flow cytometry on human samples (fig 1). Oncotarget (2018) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 2c
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig 2c). Sci Rep (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse; loading ...; fig s13
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on mouse samples (fig s13). J Clin Invest (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 4e
BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples (fig 4e). J Clin Invest (2018) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 3e
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig 3e). J Clin Invest (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD4 antibody (BD Pharmingen, RPA-T4) was used in flow cytometry on human samples (fig 5a). Obes Facts (2017) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD4 antibody (BD, SK3) was used in flow cytometry on human samples (fig 3a). J Virol (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 2c
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 2c). Sci Rep (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s2a
BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples (fig s2a). Nature (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1a
In order to study the expression of CCR10 and CXCR3 in circulating CD8 T cells specific for human herpes simplex virus, BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples (fig 1a). J Virol (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to investigate the role of dopamine in B cell maturation in germinal centres, BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s3c
In order to report that autosomal recessive, partial Go-Ichi-Ni-San 1 deficiency impairs DNA replication and underlies intra-uterine and postnatal growth retardation, chronic neutropenia, and natural killer cell deficiency, BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples (fig s3c). J Clin Invest (2017) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 4a
In order to determine the role of PD-1 in regulating anti-tumor T cell reactivities, BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig 4a). Science (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 1a
In order to generate T cells from cord blood hematopoietic progenitor cells transduced to express an antigen receptor as assess their ability to limit malignant cells and graft versus host disease, BD Biosciences CD4 antibody (BD Biosciences, 557922) was used in flow cytometry on human samples (fig 1a). Oncoimmunology (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 2a
In order to examine the effect of glucose-6-phosphate transporter mutation on immune cell homeostasis and CD4+ T cell functions, BD Biosciences CD4 antibody (BD Pharmingen, RPA-T4) was used in flow cytometry on human samples (fig 2a). J Immunol (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD4 antibody (BD Pharmingen, 560158) was used in flow cytometry on human samples (fig 1b). Sci Rep (2017) ncbi
mouse monoclonal (SK3)
  • flow cytometry; rhesus macaque; loading ...; fig s16b
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on rhesus macaque samples (fig s16b). JCI Insight (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; tbl 2
In order to assess the use of dried formats of the lymphocytosis screening tube and of the primary immune deficiency orientation tube, BD Biosciences CD4 antibody (BDB, RPA-T4) was used in flow cytometry on human samples (tbl 2). J Immunol Methods (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...
In order to examine AnxA1 in peripheral blood mononuclear cells from patients with coronary artery disease, BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples . PLoS ONE (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s2
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig s2). Nature (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3a
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, BD Biosciences CD4 antibody (BD Pharmingen, 560650) was used in flow cytometry on human samples (fig 3a). Cell Res (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; tbl 1
In order to compare methods of isolating skin mononuclear phagocytes, BD Biosciences CD4 antibody (Becton Dickinson, RPA-T4) was used in flow cytometry on human samples (tbl 1). J Leukoc Biol (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse; loading ...; fig s3
BD Biosciences CD4 antibody (BD Biosciences, 560650) was used in flow cytometry on mouse samples (fig s3). Nat Commun (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig s1a). Immun Ageing (2017) ncbi
mouse monoclonal (SK3)
  • flow cytometry; mouse; loading ...
In order to assess the effects of targeting the chimeric antigen receptors to the TRAC locus, BD Biosciences CD4 antibody (BD biosciences, 563552) was used in flow cytometry on mouse samples . Nature (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 1c
In order to investigate lactam-specific T-cell response in the skin and blood of humans, BD Biosciences CD4 antibody (BD Biosciences, RPA T4) was used in flow cytometry on human samples (fig 1c). J Allergy Clin Immunol (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s2
BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples (fig s2). Oncoimmunology (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 5a). Blood (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples (fig s1a). JCI Insight (2017) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 1d
BD Biosciences CD4 antibody (BD Biosciences, 340672) was used in flow cytometry on human samples (fig 1d). Oncoimmunology (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...
BD Biosciences CD4 antibody (Pharmingen, SK3) was used in flow cytometry on human samples . Oncol Lett (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 2
BD Biosciences CD4 antibody (BD Pharmingen, 555346) was used in flow cytometry on human samples (fig 2). Mol Med Rep (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BD Biosciences CD4 antibody (BD Bioscience, RPA-T4) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 2a
In order to investigate the role of CA9 in the tumorigenicity of cells derived from human adult T-cell leukemia/lymphoma, BD Biosciences CD4 antibody (BD Pharmingen, RPA-T4) was used in flow cytometry on human samples (fig 2a). Cancer Sci (2017) ncbi
mouse monoclonal (L200)
  • flow cytometry; crab eating macaque; loading ...; fig 3a
In order to ask if small particle aerosols of virus would penetrate the lower respiratory tract and blanket alveoli where target cells reside, BD Biosciences CD4 antibody (BD Biosciences, L200) was used in flow cytometry on crab eating macaque samples (fig 3a). J Immunol (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 5b
In order to propose that decidual stromal cells are a cellular source of BAFF for B cells present in decidua during pregnancy, BD Biosciences CD4 antibody (BD Bioscience, 561842) was used in flow cytometry on human samples (fig 5b). Sci Rep (2017) ncbi
mouse monoclonal (L120)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD4 antibody (BD Bioscience, L120) was used in flow cytometry on human samples (fig s1). Haematologica (2017) ncbi
mouse monoclonal (L200)
  • flow cytometry; rhesus macaque; loading ...; fig 4a
In order to establish the ability of the herpes simplex virus-1 VC2 vaccine to elicit immune responses in rhesus macaques, BD Biosciences CD4 antibody (BD Biosciences, L200) was used in flow cytometry on rhesus macaque samples (fig 4a). Vaccine (2017) ncbi
mouse monoclonal (L200)
  • flow cytometry; rhesus macaque; loading ...; fig s9
BD Biosciences CD4 antibody (BD Horizon, L200) was used in flow cytometry on rhesus macaque samples (fig s9). PLoS Pathog (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s1a
In order to describe complete autosomal recessive IL-17RA deficiency in patients with chronic mucocutaneous candidiasis, BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig s1a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 4a
In order to investigate the roles of CD16+ monocytes in T-cell activation and B-cell responses in systemic lupus erythematosus, BD Biosciences CD4 antibody (BD Biosciences, 562281) was used in flow cytometry on human samples (fig 4a). Front Immunol (2016) ncbi
mouse monoclonal (L200)
  • flow cytometry; human; loading ...; fig 3a
  • flow cytometry; African green monkey; loading ...; fig 1a
In order to suggest that persistent immune activation causes impairment of lymphocytes to respond to chemotactic stimuli, preventing their trafficking from the blood stream to peripheral organs, BD Biosciences CD4 antibody (BD Pharmingen, L200) was used in flow cytometry on human samples (fig 3a) and in flow cytometry on African green monkey samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (L200)
  • flow cytometry; human; loading ...; tbl s2
BD Biosciences CD4 antibody (BD Biosciences, 550628) was used in flow cytometry on human samples (tbl s2). Science (2016) ncbi
mouse monoclonal (M-T477)
  • flow cytometry; human; loading ...; fig 6b
In order to generate cell line to examine the molecular events controlling HIV expression in the microglia, BD Biosciences CD4 antibody (BD, 556615) was used in flow cytometry on human samples (fig 6b). J Neurovirol (2017) ncbi
mouse monoclonal (SK3)
  • flow cytometry; rhesus macaque; loading ...; fig 3f
In order to discuss the assessment of species cross-reactive human agents in large animal graft-versus-host disease models, BD Biosciences CD4 antibody (BD Pharmingen, 341105) was used in flow cytometry on rhesus macaque samples (fig 3f). Transplantation (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1
In order to study the role of PD-1 and Tim-3 crosstalk in the regulation of antitumor T cell responses, BD Biosciences CD4 antibody (BD, 560650) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s12c
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig s12c). J Clin Invest (2016) ncbi
mouse monoclonal (L200)
  • flow cytometry; human; loading ...; fig 5a
In order to determine which cells express CD83, BD Biosciences CD4 antibody (BD Biosciences, L200) was used in flow cytometry on human samples (fig 5a). J Immunol (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1a
In order to study the contribution of T follicular helper cells to islet autoimmunity, BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (L200)
  • flow cytometry; African green monkey; 1:20; fig 4b
BD Biosciences CD4 antibody (BD Biosciences, 560836) was used in flow cytometry on African green monkey samples at 1:20 (fig 4b). Nat Commun (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 1:20; loading ...; fig 1c
BD Biosciences CD4 antibody (BD Biosciences, 560345) was used in flow cytometry on human samples at 1:20 (fig 1c). Nat Commun (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1a
In order to establish the T Cell receptor-inducible costimulator as a promising target for direct T regulatory cell-targeting therapeutic agents for gastric cancer, BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 1a). Int J Cancer (2017) ncbi
mouse monoclonal (L200)
  • flow cytometry; rhesus macaque; loading ...; fig s7c
In order to assess the efficacy of targeting alpha4 beta7 integrin to treat SIV, BD Biosciences CD4 antibody (BD Horizon, 562402) was used in flow cytometry on rhesus macaque samples (fig s7c). Science (2016) ncbi
mouse monoclonal (L200)
  • flow cytometry; rhesus macaque; loading ...; fig 8a
BD Biosciences CD4 antibody (BD, 562402) was used in flow cytometry on rhesus macaque samples (fig 8a). Sci Rep (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1a, s2h
In order to discuss targeting CD123 to treat systemic lupus erythematosus, BD Biosciences CD4 antibody (BD Biosciences, 555346) was used in flow cytometry on human samples (fig 1a, s2h). JCI Insight (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1d
BD Biosciences CD4 antibody (BD Biosciences, 557707) was used in flow cytometry on human samples (fig 1d). Cell (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 1d
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 1d). J Virol (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3h
In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples (fig 3h). J Exp Med (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 3h
In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, BD Biosciences CD4 antibody (BD, SK3) was used in flow cytometry on human samples (fig 3h). J Exp Med (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3a
In order to investigate the basis for T regulatory cell accumulation in melanoma, BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 3a). Cancer Res (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 1a
In order to determine the S. Typhi, S. Paratyphi A, and S. Paratyphi B cross-reactive CD4 positive T cell responses elicited by immunization with Ty21a, BD Biosciences CD4 antibody (BD, SK3) was used in flow cytometry on human samples (fig 1a). Clin Immunol (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 5a
In order to determine the S. Typhi, S. Paratyphi A, and S. Paratyphi B cross-reactive CD4 positive T cell responses elicited by immunization with Ty21a, BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples (fig 5a). Clin Immunol (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 6a
BD Biosciences CD4 antibody (Becton Dickinson, RPA-T4) was used in flow cytometry on human samples (fig 6a). J Virol (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3b
In order to assess dextran-based nanoparticles as a drug delivery system to target myeloid cells of the liver, BD Biosciences CD4 antibody (BD Biosciences, 555348) was used in flow cytometry on human samples (fig 3b). Nanomedicine (Lond) (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 4b
In order to analyze the capacity of monocytes, neutrophils, and CD4 T cells to serve as accessory cells for gamma delta T cell activation, BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig 4b). J Immunol (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s1a
In order to compare expression and function of the CD300 family of receptors between neonatal and adult immune cells, BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig s1a). Sci Rep (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 1
BD Biosciences CD4 antibody (BD Biosciences, 561844) was used in flow cytometry on human samples (fig 1). Mol Med Rep (2016) ncbi
mouse monoclonal (L200)
  • flow cytometry; common marmoset; loading ...; fig 5a
BD Biosciences CD4 antibody (BD Biosciences, L-200) was used in flow cytometry on common marmoset samples (fig 5a). J Virol (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 5c
BD Biosciences CD4 antibody (BD Biosciences, RTA-T4) was used in flow cytometry on human samples (fig 5c). J Immunol (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to assess the contribution of cytomorphology and flow cytometry to histopathological studies of brain biopsies, BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2018) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3a
In order to utilize humanized major histocompatibility class I- and class II-deficient NOG mice to assess the antitumor effect of an anti-programmed death-1 antibody, BD Biosciences CD4 antibody (BD Pharmingen, RPA-T4) was used in flow cytometry on human samples (fig 3a). Clin Cancer Res (2017) ncbi
mouse monoclonal (L200)
  • flow cytometry; rhesus macaque; loading ...; fig 5a
In order to report the effect of IL-15 inhibition on T and natural killer cell dynamics in rhesus macaques, BD Biosciences CD4 antibody (BD Biosciences, L200) was used in flow cytometry on rhesus macaque samples (fig 5a). J Immunol (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig s2
  • flow cytometry; mouse; loading ...; fig s5
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, BD Biosciences CD4 antibody (BD Bioscience, RPA-T4) was used in flow cytometry on human samples (fig s2) and in flow cytometry on mouse samples (fig s5). J Clin Invest (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig s2c
BD Biosciences CD4 antibody (BD, SK3) was used in flow cytometry on human samples (fig s2c). J Clin Invest (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 2
In order to study activation of myeloid dendritic cells, regulatory T cells and effector cells in lichen planus, BD Biosciences CD4 antibody (BD Biosciences, RPA T4) was used in flow cytometry on human samples (fig 2). J Transl Med (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 3b
  • flow cytometry; mouse; loading ...; fig st1
BD Biosciences CD4 antibody (BD Pharmingen, SK3) was used in flow cytometry on human samples (fig 3b) and in flow cytometry on mouse samples (fig st1). J Clin Invest (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 2a
In order to monitor T cells expressing a CD19-specific chimeric antigen receptor in vivo non-invasively, BD Biosciences CD4 antibody (Biosciences, 347327) was used in flow cytometry on human samples (fig 2a). Mol Imaging Biol (2016) ncbi
mouse monoclonal (L200)
  • flow cytometry; rhesus macaque; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BD Biosciences CD4 antibody (BD Biosciences, 552838) was used in flow cytometry on rhesus macaque samples . Nat Med (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 5d
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig 5d). J Immunol (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 1:40; fig 3
BD Biosciences CD4 antibody (BD PharMingen, 560158) was used in flow cytometry on human samples at 1:40 (fig 3). Oncoimmunology (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 3c
In order to investigate if ectopic expression of CX3CR1 enhances the homing of adoptively transferred T cells towards CX3CL1-producing tumors, resulting in increased T cell infiltration in tumor tissues, BD Biosciences CD4 antibody (BD Biosciences, 557852) was used in flow cytometry on human samples (fig 3c). J Immunother Cancer (2016) ncbi
mouse monoclonal (L200)
  • flow cytometry; human; 1:100; loading ...; fig 2b
In order to define the underlying mechanism of Runt-related transcription factor 3's involvement in the differentiation of T-helper 17 and T-helper 22 cells in psoriasis, BD Biosciences CD4 antibody (BD Biosciences, 550628) was used in flow cytometry on human samples at 1:100 (fig 2b). Mol Med Rep (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig s1a
In order to discover that T follicular helper cells preferentially express the transcriptional coactivator Bob1, BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig s1a). Eur J Immunol (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 1d
In order to explore the role of the JAK/STAT pathway in controlling Foxp3 in regulatory T cells, BD Biosciences CD4 antibody (BD, SK3) was used in flow cytometry on human samples (fig 1d). PLoS ONE (2016) ncbi
mouse monoclonal (L200)
  • flow cytometry; baboons; fig 5
In order to analyze how chimeric 2C10R4 anti-CD40 antibody therapy is essential for long-term survival of pig-to-primate cardiac xenograft (GTKO.hCD46.hTBM), BD Biosciences CD4 antibody (Pharmingen, 560811) was used in flow cytometry on baboons samples (fig 5). Nat Commun (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 2d
In order to demonstrate that effector T-cell accumulation and TCR repertoire diversity reduction precede the development of foot ulcers in diabetic patients, BD Biosciences CD4 antibody (BD, SK3) was used in flow cytometry on human samples (fig 2d). Cell Mol Immunol (2017) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD4 antibody (BD, 555347) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (L200)
  • flow cytometry; human; tbl 2
In order to determine the contribution of Leukocyte Ig Like Receptors to Mycobacterium tuberculosis infection, BD Biosciences CD4 antibody (BD Pharmingen, 560836) was used in flow cytometry on human samples (tbl 2). Sci Rep (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 1
BD Biosciences CD4 antibody (BD, 555349) was used in flow cytometry on human samples (fig 1). Nat Biotechnol (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD PharMingen, 555346) was used in flow cytometry on human samples . Immunity (2016) ncbi
mouse monoclonal (L200)
  • flow cytometry; African green monkey; loading ...; fig 4a
In order to report that B cells modulate the local granulomatous response in Mycobacterium tuberculosis-infected macaques during acute infection, BD Biosciences CD4 antibody (BD Biosciences, L200) was used in flow cytometry on African green monkey samples (fig 4a). Infect Immun (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig st1
BD Biosciences CD4 antibody (BD Horizon, RPA-T4) was used in flow cytometry on human samples (fig st1). J Autoimmun (2016) ncbi
mouse monoclonal (L200)
  • flow cytometry; rhesus macaque; fig s1
BD Biosciences CD4 antibody (BD Biosciences Pharmingen, L200) was used in flow cytometry on rhesus macaque samples (fig s1). Mucosal Immunol (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 5
BD Biosciences CD4 antibody (BD Bioscience, RPA-T4) was used in flow cytometry on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 8a
BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples (fig 8a). PLoS Pathog (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD4 antibody (BD Pharmingen, RPA-T4) was used in flow cytometry on human samples (fig 2a). PLoS ONE (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; fig 2b
In order to Targeting CD8(+) T cells prevents psoriasis development, BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig 2b). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; fig 7.45.3
In order to validate a single-cell measurement, simultaneously, for cell surface proteins, messenger RNA, and intracellular proteins, BD Biosciences CD4 antibody (BD Biosciences, 562970) was used in flow cytometry on human samples (fig 7.45.3). Curr Protoc Cytom (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1
In order to characterize the gut-associated lymphoid tissue of HIV-controllers, BD Biosciences CD4 antibody (Becton-Dickinson, RPA-T4) was used in flow cytometry on human samples (fig 1). Immunol Res (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Biosciences, 555347) was used in flow cytometry on human samples . Mediators Inflamm (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Biosciences, RPAT4) was used in flow cytometry on human samples . PLoS Pathog (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig s1
BD Biosciences CD4 antibody (BD Biosciences, 555349) was used in flow cytometry on human samples (fig s1). Sci Rep (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 4b
In order to study heat-shock protein 70 in non-small cell lung cancer cells, BD Biosciences CD4 antibody (BD, 555346) was used in flow cytometry on human samples (fig 4b). Front Immunol (2015) ncbi
mouse monoclonal (SK3)
  • flow cytometry; rhesus macaque; loading ...; fig 5
In order to describe a selective CD28 antagonist for treatment of rheumatoid arthritis, BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on rhesus macaque samples (fig 5). Clin Exp Immunol (2016) ncbi
mouse monoclonal (L200)
  • other; human; fig 1
  • flow cytometry; human; fig 1
In order to study the use of bispecific T cell engager, BD Biosciences CD4 antibody (BD, L200) was used in other on human samples (fig 1) and in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 1:25; tbl 1
BD Biosciences CD4 antibody (BD Pharmingen, 557695) was used in flow cytometry on human samples at 1:25 (tbl 1). PLoS ONE (2015) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; fig 2a
In order to develop an antigen presenting cell/T-cell platform to study intrathecal CD4 positive and CD8 positive T-cell responses to candidate MS-associated autoantigens, BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig 2a). Eur J Immunol (2016) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 2
BD Biosciences CD4 antibody (BD Biosciences, 560158) was used in flow cytometry on human samples (fig 2). Retrovirology (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 1
BD Biosciences CD4 antibody (BD Biosciences, # 560650) was used in flow cytometry on human samples (fig 1). Immunol Res (2015) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...
In order to discuss the importance of IL-5 positive Th2 cells to allergies, BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples . J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (L200)
  • flow cytometry; human; fig 2
BD Biosciences CD4 antibody (BD Biosciences, L-200) was used in flow cytometry on human samples (fig 2). J Clin Invest (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD4 antibody (BD PharMingen, 555346) was used in flow cytometry on human samples (fig 2a). PLoS ONE (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3a
In order to assess the efficacy of a single vaccination of the Yellow Fever vaccine, BD Biosciences CD4 antibody (BD PharMingen, RPA-T4) was used in flow cytometry on human samples (fig 3a). Hum Vaccin Immunother (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; fig 1
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; fig 1
In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig 1). PLoS Pathog (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 1a
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 1a). PLoS Negl Trop Dis (2015) ncbi
mouse monoclonal (L200)
  • flow cytometry; marmosets; loading ...; fig 1a
In order to test a therapeutic antibody against CD127 in a mouse model of experimental autoimmune encephalomyelitis, BD Biosciences CD4 antibody (BD Biosciences, L200) was used in flow cytometry on marmosets samples (fig 1a). J Neuroimmune Pharmacol (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig 3b
In order to examine the effects of immunosuppressive agents on Polyomavirus BKV-specific T cells, BD Biosciences CD4 antibody (BD Bioscience, SK3) was used in flow cytometry on human samples (fig 3b). Kidney Int (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 6
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 6). J Hematol Oncol (2015) ncbi
mouse monoclonal (L120)
  • flow cytometry; human; 1:100; fig 6
BD Biosciences CD4 antibody (BD Bioscience, 340419) was used in flow cytometry on human samples at 1:100 (fig 6). Stem Cells Int (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 1a
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 1a). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; tbl 1
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; 1:25
BD Biosciences CD4 antibody (BD Biosciences, 563550) was used in flow cytometry on human samples at 1:25. Nat Commun (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to report that alefacept depletes both memory T cells and NK cells, BD Biosciences CD4 antibody (Becton Dickinson, RPA-T4) was used in flow cytometry on human samples . Biol Blood Marrow Transplant (2015) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; fig 1
In order to discuss using the infiltrate to diagnosis B-cell lymphomas, BD Biosciences CD4 antibody (BD, SK3) was used in flow cytometry on human samples (fig 1). Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; fig S1
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig S1). J Neuroinflammation (2015) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; fig 2
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples (fig 2). J Immunol (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1, 5a
In order to look at patterns of S. Typhi-specific modulation of the homing potential of circulating Treg in patients with typhoid compared to healthy individuals, BD Biosciences CD4 antibody (BD, 560158) was used in flow cytometry on human samples (fig 1, 5a). PLoS Pathog (2015) ncbi
mouse monoclonal (L200)
  • flow cytometry; human; fig 3,4,5
BD Biosciences CD4 antibody (BD, 550628) was used in flow cytometry on human samples (fig 3,4,5). Nucleic Acids Res (2015) ncbi
mouse monoclonal (L200)
In order to analyze the expression of alpha4beta7-integrin in primate lymphocites., BD Biosciences CD4 antibody (BD bioscience, 560811) was used . J Immunol (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 1
  • immunocytochemistry; human; fig 4
BD Biosciences CD4 antibody (BD Bioscience, RPA-T4) was used in flow cytometry on human samples (fig 1) and in immunocytochemistry on human samples (fig 4). Nat Immunol (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 2
In order to elucidate Th17 cell polarization, depletion, and restoration in response to HIV infection and antiretroviral therapy, BD Biosciences CD4 antibody (BD Pharmingen, RPA-T4) was used in flow cytometry on human samples (fig 2). Retrovirology (2015) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; tbl 4
In order to discuss how to diagnosis hematolymphoid neoplasms using flow cytometry, BD Biosciences CD4 antibody (BD Bioscience, SK3) was used in flow cytometry on human samples (tbl 4). Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; 1:100; fig 5
BD Biosciences CD4 antibody (BD Biosciences, 558116) was used in flow cytometry on human samples at 1:100 (fig 5). Nat Commun (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 2a
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 2a). J Immunol (2015) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...
In order to assess intrahepatic delivery of anti-CEA chimeric antigen receptor-modified T cells through percutaneous hepatic artery infusions, BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples . Clin Cancer Res (2015) ncbi
mouse monoclonal (L200)
  • flow cytometry; human
In order to study dysregulation of CD62L expression during HIV infection, BD Biosciences CD4 antibody (BD, L200) was used in flow cytometry on human samples . J Virol (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to study the behavior of the HIV-1 Vpu alleles in the plasma of elite controller patients, BD Biosciences CD4 antibody (BD Bioscience, RPA-T4) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (SK3)
  • flow cytometry; rhesus macaque; fig 1
  • flow cytometry; human; fig 1
In order to examine the role of lymphocyte activation gene-3 during HIV infection, BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on rhesus macaque samples (fig 1) and in flow cytometry on human samples (fig 1). J Immunol (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse; 1:800; fig s9
BD Biosciences CD4 antibody (BD, 557871) was used in flow cytometry on mouse samples at 1:800 (fig s9). Nat Commun (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to examine the effects of pantethine on membrane lipid rafts, BD Biosciences CD4 antibody (BD PharMingen, RPA-T4) was used in flow cytometry on human samples . J Cell Physiol (2015) ncbi
mouse monoclonal (L120)
  • flow cytometry; human
In order to show that intermediate DNA methylation is a conserved signature of gene regulation and exon usage, BD Biosciences CD4 antibody (BD Biosciences, 340419) was used in flow cytometry on human samples . Nat Commun (2015) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; fig 1
  • immunocytochemistry; human; fig 1
BD Biosciences CD4 antibody (BD Bioscience, SK3) was used in flow cytometry on human samples (fig 1) and in immunocytochemistry on human samples (fig 1). J Neuroimmunol (2015) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; tbl 2
BD Biosciences CD4 antibody (BD Bioscience, SK3 + SK5) was used in flow cytometry on human samples (tbl 2). Clin Transplant (2015) ncbi
mouse monoclonal (L200)
  • flow cytometry; African green monkey; loading ...; fig s2a
In order to describe the functional characteristics and dynamics of T cells in individual granulomas, BD Biosciences CD4 antibody (BD Horizon, L200) was used in flow cytometry on African green monkey samples (fig s2a). PLoS Pathog (2015) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; fig 2
BD Biosciences CD4 antibody (BD Bioscience, SK3) was used in flow cytometry on human samples (fig 2). Cell Res (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Pharmingen, 555346) was used in flow cytometry on human samples . Alcohol (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to discuss methods to measure cytokine production by Th1 and Th17 cells, BD Biosciences CD4 antibody (BD, 562424) was used in flow cytometry on human samples . Curr Protoc Cytom (2015) ncbi
mouse monoclonal (L200)
  • flow cytometry; mouse
BD Biosciences CD4 antibody (BD Pharmingen, L200) was used in flow cytometry on mouse samples . Vaccines (Basel) (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 4
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 4). Nat Immunol (2015) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human
In order to assess the effects of long-term cryopreservation of fixed cells on the measurement of mycobacteria induced CD4 T cell immunity, BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples . J Immunol Methods (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Bioscience, RPA-T4) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (L200)
  • flow cytometry; rhesus macaque
BD Biosciences CD4 antibody (BD Biosciences, L-200) was used in flow cytometry on rhesus macaque samples . J Infect Dis (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples . Eur J Cancer (2015) ncbi
mouse monoclonal (L200)
  • flow cytometry; crab eating macaque; fig s2
BD Biosciences CD4 antibody (BD Biosciences, L200) was used in flow cytometry on crab eating macaque samples (fig s2). J Autoimmun (2015) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human
In order to assess the efficacy of using flow cytometry immunophenotyping with fine-needle aspiration cytology for the diagnosis of thyroid lymphoma, BD Biosciences CD4 antibody (BD, SK3) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 13.2
BD Biosciences CD4 antibody (BD Pharmingen, 555347) was used in flow cytometry on human samples (fig 13.2). Methods Enzymol (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (SK3)
  • flow cytometry; crab eating macaque
In order to describe a prime-boost regimen for the HIV vaccination of Macaca fascicularis, BD Biosciences CD4 antibody (BD, SK-3) was used in flow cytometry on crab eating macaque samples . PLoS ONE (2014) ncbi
mouse monoclonal (L200)
  • flow cytometry; rhesus macaque
BD Biosciences CD4 antibody (BD Biosciences, L200) was used in flow cytometry on rhesus macaque samples . J Immunol (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 5
In order to study the immune effects of tadalafil in patients with head and neck squamous cell carcinoma., BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples (fig 5). Clin Cancer Res (2015) ncbi
mouse monoclonal (L200)
  • flow cytometry; mouse; fig s3
BD Biosciences CD4 antibody (Pharmingen, 550630) was used in flow cytometry on mouse samples (fig s3). Stem Cell Res (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (SK3)
  • immunocytochemistry; human
In order to study the role of dendritic cells in relation to T cells, BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in immunocytochemistry on human samples . J Immunol (2014) ncbi
mouse monoclonal (L200)
  • flow cytometry; rhesus macaque
BD Biosciences CD4 antibody (BD Biosciences, L200) was used in flow cytometry on rhesus macaque samples . J Immunol (2014) ncbi
mouse monoclonal (L200)
  • flow cytometry; baboons; fig 1
In order to study the effect of age, gender, social status and peer group on T cells in baboons, BD Biosciences CD4 antibody (Becton-Dickinson, clone L200) was used in flow cytometry on baboons samples (fig 1). PLoS ONE (2014) ncbi
mouse monoclonal (L200)
  • flow cytometry; human; fig 2
In order to compare five SIV vaccine platforms, BD Biosciences CD4 antibody (BD Pharmingen, clone L200) was used in flow cytometry on human samples (fig 2). Clin Immunol (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse
BD Biosciences CD4 antibody (BD Pharmingen, 555347) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples . J Allergy Clin Immunol (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to test the safety and immunogenicity of an adenovirus 35-vectored tuberculosis vaccine candidate AERAS-402 in infants, BD Biosciences CD4 antibody (BD Biosciences, Clone RPA-T4) was used in flow cytometry on human samples . Vaccine (2014) ncbi
mouse monoclonal (RPA-T4)
  • immunocytochemistry; mouse
BD Biosciences CD4 antibody (PharMingen, RPA-T4) was used in immunocytochemistry on mouse samples . Hum Pathol (2014) ncbi
mouse monoclonal (L200)
  • flow cytometry; rhesus macaque
BD Biosciences CD4 antibody (BD Biosciences, L200) was used in flow cytometry on rhesus macaque samples . Antimicrob Agents Chemother (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human
In order to study the role of CD93 molecule in mature dendritic cells and T cells, BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on human samples . Immunobiology (2015) ncbi
mouse monoclonal (L200)
  • flow cytometry; human
  • immunocytochemistry; human
In order to study the effect of atorvastatin on telomerase activity in peripheral blood mononuclear cells and T-lymphocytes, BD Biosciences CD4 antibody (BD, 7560644) was used in flow cytometry on human samples and in immunocytochemistry on human samples . Atherosclerosis (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Horizon, RPA-T4) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (L200)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Biosciences, 550630) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples . Am J Transplant (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Bioscience, SK3) was used in flow cytometry on human samples . Med Microbiol Immunol (2014) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; fig 3
In order to characterize two cases of anaplastic large cell lymphoma using flow cytometry, BD Biosciences CD4 antibody (Becton Dickinson, SK3) was used in flow cytometry on human samples (fig 3). Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (L200)
  • flow cytometry; African green monkey; fig 1
BD Biosciences CD4 antibody (BD Biosciences, L200) was used in flow cytometry on African green monkey samples (fig 1). PLoS Pathog (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 3b
In order to show that latency-associated peptide and glycoprotein A repetitions predominant identify human antigen-specific T regulatory cells, BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples (fig 3b). Eur J Immunol (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD4 antibody (BD Biosciences, 555346) was used in flow cytometry on human samples (fig 2a). Oncotarget (2014) ncbi
mouse monoclonal (SK3)
  • immunocytochemistry; human
In order to analyze HIV-specific naive and memory CD4(+) T cells through two methods, BD Biosciences CD4 antibody (BD, SK3) was used in immunocytochemistry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (L200)
  • flow cytometry; rhesus macaque; fig s1a
In order to explore germinal center-related hyperimmune responses and disease severity during viral infection, BD Biosciences CD4 antibody (BD Pharmingen, L200) was used in flow cytometry on rhesus macaque samples (fig s1a). J Immunol (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Horizon, RPA-T4) was used in flow cytometry on human samples . J Virol (2014) ncbi
mouse monoclonal (SK3)
  • flow cytometry; mouse; fig 1
BD Biosciences CD4 antibody (BD Biosciences, SK3) was used in flow cytometry on mouse samples (fig 1). Leukemia (2015) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BD Biosciences CD4 antibody (BD Bioscience, RPA-T4) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Pharmingen, RPA-T4) was used in flow cytometry on human samples . Immunol Cell Biol (2014) ncbi
mouse monoclonal (L200)
  • flow cytometry; mouse
In order to study the role of human endogenous retrovirus (HERV) envelope proteins in the uptake of exosomes, BD Biosciences CD4 antibody (BD Pharmingen, L200) was used in flow cytometry on mouse samples . FASEB J (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 4
BD Biosciences CD4 antibody (BD Bioscience, RPA-T4) was used in flow cytometry on human samples (fig 4). J Immunol (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples . J Clin Immunol (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Bioscience, clone RPA-T4) was used in flow cytometry on human samples . Mol Ther (2014) ncbi
mouse monoclonal (L200)
  • flow cytometry; chimpanzee
In order to study the in vitro response of gammadelta T-cell subsets from HIV1-infected and control chimpanzees to T-cell activators, BD Biosciences CD4 antibody (BD Biosciences, L200) was used in flow cytometry on chimpanzee samples . J Med Primatol (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Pharmingen, RPA-T4) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (RPA-T4)
  • immunocytochemistry; mouse; fig 2
In order to investigate how phosphorylation controls IFITM3 trafficking and degradation, BD Biosciences CD4 antibody (BD, 557695) was used in immunocytochemistry on mouse samples (fig 2). J Biol Chem (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the effects of lymphopenia and chronic exposure to IFN on T cell homeostasis, BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples (fig 1a). PLoS Pathog (2014) ncbi
mouse monoclonal (SK3)
  • immunohistochemistry; human
BD Biosciences CD4 antibody (Becton Dickinson, SK3) was used in immunohistochemistry on human samples . Arthritis Rheumatol (2014) ncbi
mouse monoclonal (L200)
  • immunohistochemistry; human
BD Biosciences CD4 antibody (BD, 550628) was used in immunohistochemistry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD, SK3) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (L200)
  • flow cytometry; rhesus macaque
In order to compare vaccination with highly conserved gag elements verses full-length gag DNA, BD Biosciences CD4 antibody (BD, L200) was used in flow cytometry on rhesus macaque samples . PLoS ONE (2014) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; tbl 1
In order to examine the changes in erythrocytes and T-lymphocytes and to explore the mechanisms involved in stress-induced depression using a rat depression model, BD Biosciences CD4 antibody (BD Bio-sciences, clone SK3) was used in flow cytometry on human samples (tbl 1). Environ Toxicol Pharmacol (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on human samples . Clin Exp Immunol (2014) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; loading ...; fig s3
In order to correlate biomarkers associated with coagulation, monocyte activation, and inflammation in elite controllers of HIV infection, BD Biosciences CD4 antibody (BD Bioscience, SK3) was used in flow cytometry on human samples (fig s3). J Infect Dis (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to use zinc-finger nucleases to simultaneous modify ccr5 and cxcr4 in primary human CD4(+) T cells and introduce these cells into a humanized mouse model of HIV-1 infection, BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (SK3)
  • flow cytometry; human; tbl 1
In order to compare fine needle aspiration cytology with flow cytometry immunophenotyping for the diagnosis of lymphoproliferative processes in the salivary glands, BD Biosciences CD4 antibody (BD, clone SK3) was used in flow cytometry on human samples (tbl 1). Cytopathology (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human; fig 2
BD Biosciences CD4 antibody (Becton-Dickinson, 558116) was used in flow cytometry on human samples (fig 2). Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; human
In order to study the use of DEC-205 targeting in vaccination against Epstein-Barr virus, BD Biosciences CD4 antibody (BD, RPA-T4) was used in flow cytometry on human samples . Blood (2008) ncbi
mouse monoclonal (RPA-T4)
  • flow cytometry; mouse; fig 1
In order to determine the expression of CD39 in mouse and human T cells, BD Biosciences CD4 antibody (BD Biosciences, RPA-T4) was used in flow cytometry on mouse samples (fig 1). Blood (2007) ncbi
mouse monoclonal (SK3)
  • flow cytometry; South American squirrel monkey
In order to discuss available reagents for studying the neotropical primate squirrel monkey, BD Biosciences CD4 antibody (BDIS, SK3) was used in flow cytometry on South American squirrel monkey samples . J Immunol Methods (2005) ncbi
Leica Biosystems
mouse monoclonal
  • immunohistochemistry; human; 1:20; fig 4b
Leica Biosystems CD4 antibody (Novocastra, NCL-L-CD4-368) was used in immunohistochemistry on human samples at 1:20 (fig 4b). Cancers (Basel) (2022) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig s5e
Leica Biosystems CD4 antibody (Leica, 4B12) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig s5e). Acta Neuropathol (2021) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:20; loading ...; fig 4
Leica Biosystems CD4 antibody (Leica, 4B12) was used in immunohistochemistry - paraffin section on human samples at 1:20 (fig 4). Exp Eye Res (2020) ncbi
mouse monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; fig s2a
Leica Biosystems CD4 antibody (Leica Biosystems, CD4-368-L-CE-H) was used in immunohistochemistry - paraffin section on human samples (fig s2a). Cell (2018) ncbi
mouse monoclonal
  • immunohistochemistry; African green monkey; loading ...
In order to perform an enhanced embryo-fetal development investigation using pateclizumab in cynomolgus monkeys, Leica Biosystems CD4 antibody (Novocastra, NCL-L-CD4-368) was used in immunohistochemistry on African green monkey samples . Reprod Toxicol (2016) ncbi
monoclonal (4B12)
  • immunohistochemistry; human; 1:100; loading ...; fig 1a
In order to explore the relationship between tumor-infiltrating lymphocytes and the clinical outcomes of triple-negative breast cancers, Leica Biosystems CD4 antibody (Leica biosystems, 4B12) was used in immunohistochemistry on human samples at 1:100 (fig 1a). Breast Cancer Res Treat (2016) ncbi
monoclonal (1F6)
  • immunocytochemistry; African green monkey; fig 3
In order to study lymph node-resident simian immunodeficiency virus env-specific T follicular helper cells due to vaccine induction in Rhesus Macaques, Leica Biosystems CD4 antibody (Leica Microsystems, 1F6) was used in immunocytochemistry on African green monkey samples (fig 3). J Immunol (2016) ncbi
monoclonal (4B12)
  • immunohistochemistry; human; 1:100
Leica Biosystems CD4 antibody (Novocastra, 4B12) was used in immunohistochemistry on human samples at 1:100. Scand J Immunol (2015) ncbi
monoclonal (4B12)
  • immunohistochemistry - paraffin section; human; 1:80
Leica Biosystems CD4 antibody (Novocastra, 4B12) was used in immunohistochemistry - paraffin section on human samples at 1:80. J Dermatol Sci (2015) ncbi
monoclonal (4B12)
  • immunohistochemistry; human; 1:150
Leica Biosystems CD4 antibody (NOVOCASTRA, 4B12) was used in immunohistochemistry on human samples at 1:150. BMC Clin Pathol (2014) ncbi
monoclonal (4B12)
  • immunohistochemistry - paraffin section; human
In order to characterize stroma cells and ductal epithelium comparing chronic pancreatitis and pancreatic ductal adenocarcinoma, Leica Biosystems CD4 antibody (Leica Novocastra, 4B12) was used in immunohistochemistry - paraffin section on human samples . PLoS ONE (2014) ncbi
monoclonal (4B12)
  • immunohistochemistry - paraffin section; human
Leica Biosystems CD4 antibody (Leica, 4B12) was used in immunohistochemistry - paraffin section on human samples . Int J Gynecol Pathol (2014) ncbi
monoclonal (4B12)
  • immunohistochemistry - paraffin section; human
In order to investigate the clinical and pathological features in a girl with common variable immunodeficiency, Leica Biosystems CD4 antibody (Novocastra, 4B12) was used in immunohistochemistry - paraffin section on human samples . Int J Surg Pathol (2014) ncbi
Articles Reviewed
  1. Ravindranathan S, Passang T, Li J, Wang S, Dhamsania R, Ware M, et al. Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma. Nat Commun. 2022;13:6418 pubmed publisher
  2. Kemper K, Gielen E, Boross P, Houtkamp M, Plantinga T, de Poot S, et al. Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor models. Life Sci Alliance. 2022;5: pubmed publisher
  3. Chen Y, Lian N, Chen S, Xiao T, Ke Y, Zhang Y, et al. GSDME deficiency leads to the aggravation of UVB-induced skin inflammation through enhancing recruitment and activation of neutrophils. Cell Death Dis. 2022;13:841 pubmed publisher
  4. Ni H, Zhang H, Li L, Huang H, Guo H, Zhang L, et al. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer. J Immunother Cancer. 2022;10: pubmed publisher
  5. Amaral E, Foreman T, Namasivayam S, Hilligan K, Kauffman K, Barbosa Bomfim C, et al. GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection. J Exp Med. 2022;219: pubmed publisher
  6. Zhang T, Xia W, Song X, Mao Q, Huang X, Chen B, et al. Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway. J Hematol Oncol. 2022;15:114 pubmed publisher
  7. Coy S, Wang S, Stopka S, Lin J, Yapp C, Ritch C, et al. Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma. Nat Commun. 2022;13:4814 pubmed publisher
  8. Secchiari F, Nu xf1 ez S, Sierra J, Ziblat A, Regge M, Raffo Iraolagoitia X, et al. The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology. Oncoimmunology. 2022;11:2104991 pubmed publisher
  9. Sullivan P, Kumar R, Li W, Hoglund V, Wang L, Zhang Y, et al. FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma. Mol Cancer Ther. 2022;21:1608-1621 pubmed publisher
  10. Yong L, Yu Y, Li B, Ge H, Zhen Q, Mao Y, et al. Calcium/calmodulin-dependent protein kinase IV promotes imiquimod-induced psoriatic inflammation via macrophages and keratinocytes in mice. Nat Commun. 2022;13:4255 pubmed publisher
  11. Jin Y, Lorvik K, Jin Y, Beck C, Sike A, Persiconi I, et al. Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer. Mol Ther Oncolytics. 2022;26:189-206 pubmed publisher
  12. Dinnon K, Leist S, Okuda K, Dang H, Fritch E, Gully K, et al. SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice. Sci Transl Med. 2022;14:eabo5070 pubmed publisher
  13. Paldor M, Levkovitch Siany O, Eidelshtein D, Adar R, Enk C, Marmary Y, et al. Single-cell transcriptomics reveals a senescence-associated IL-6/CCR6 axis driving radiodermatitis. EMBO Mol Med. 2022;14:e15653 pubmed publisher
  14. Laffey K, Stiles R, Ludescher M, Davis T, Khwaja S, Bram R, et al. Early expression of mature αβ TCR in CD4-CD8- T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations. Proc Natl Acad Sci U S A. 2022;119:e2118529119 pubmed publisher
  15. Tan H, Yong Y, Xue Y, Liu H, Furihata T, Shankar E, et al. cGAS and DDX41-STING mediated intrinsic immunity spreads intercellularly to promote neuroinflammation in SOD1 ALS model. iScience. 2022;25:104404 pubmed publisher
  16. Chen P, Katsuyama E, Satyam A, Li H, Rubio J, Jung S, et al. CD38 reduces mitochondrial fitness and cytotoxic T cell response against viral infection in lupus patients by suppressing mitophagy. Sci Adv. 2022;8:eabo4271 pubmed publisher
  17. Wang Y, Feng R, Cheng G, Huang B, Tian J, Gan Y, et al. Low Dose Interleukin-2 Ameliorates Sjögren's Syndrome in a Murine Model. Front Med (Lausanne). 2022;9:887354 pubmed publisher
  18. Shankar S, Stolp J, Juvet S, Beckett J, Macklin P, Issa F, et al. Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis. Nat Commun. 2022;13:3121 pubmed publisher
  19. Qin L, Wang L, Zhang J, Zhou H, Yang Z, Wang Y, et al. Therapeutic strategies targeting uPAR potentiate anti-PD-1 efficacy in diffuse-type gastric cancer. Sci Adv. 2022;8:eabn3774 pubmed publisher
  20. Zhang R, Wang Y, Liu D, Luo Q, Du P, Zhang H, et al. Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice. Front Pharmacol. 2022;13:870848 pubmed publisher
  21. Pan C, Wu Q, Wang S, Mei Z, Zhang L, Gao X, et al. Combination with Toll-like receptor 4 (TLR4) agonist reverses GITR agonism mediated M2 polarization of macrophage in Hepatocellular carcinoma. Oncoimmunology. 2022;11:2073010 pubmed publisher
  22. Benkhoucha M, Tran N, Breville G, Senoner I, Bradfield P, Papayannopoulou T, et al. CD4+c-Met+Itgα4+ T cell subset promotes murine neuroinflammation. J Neuroinflammation. 2022;19:103 pubmed publisher
  23. Piao W, Li L, Saxena V, Iyyathurai J, Lakhan R, Zhang Y, et al. PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration. Nat Commun. 2022;13:2176 pubmed publisher
  24. Saxena V, Piao W, Li L, Paluskievicz C, Xiong Y, Simon T, et al. Treg tissue stability depends on lymphotoxin beta-receptor- and adenosine-receptor-driven lymphatic endothelial cell responses. Cell Rep. 2022;39:110727 pubmed publisher
  25. Cortes J, Filip I, Albero R, Patiño Galindo J, Quinn S, Lin W, et al. Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma. Cell Rep. 2022;39:110695 pubmed publisher
  26. Jiang Z, Qin L, Tang Y, Liao R, Shi J, He B, et al. Human induced-T-to-natural killer cells have potent anti-tumour activities. Biomark Res. 2022;10:13 pubmed publisher
  27. Tu J, Han D, Fang Y, Jiang H, Tan X, Xu Z, et al. MicroRNA-10b promotes arthritis development by disrupting CD4+ T cell subtypes. Mol Ther Nucleic Acids. 2022;27:733-750 pubmed publisher
  28. Boby N, Cao X, Williams K, Gadila S, Shroyer M, Didier P, et al. Simian Immunodeficiency Virus Infection Mediated Changes in Jejunum and Peripheral SARS-CoV-2 Receptor ACE2 and Associated Proteins or Genes in Rhesus Macaques. Front Immunol. 2022;13:835686 pubmed publisher
  29. Shen X, Geng R, Li Q, Chen Y, Li S, Wang Q, et al. ACE2-independent infection of T lymphocytes by SARS-CoV-2. Signal Transduct Target Ther. 2022;7:83 pubmed publisher
  30. Ploeger C, Schreck J, Huth T, Fraas A, Albrecht T, Charbel A, et al. STAT1 and STAT3 Exhibit a Crosstalk and Are Associated with Increased Inflammation in Hepatocellular Carcinoma. Cancers (Basel). 2022;14: pubmed publisher
  31. Salaroglio I, Belisario D, Bironzo P, Ananthanarayanan P, Ricci L, Digiovanni S, et al. SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma. J Exp Clin Cancer Res. 2022;41:75 pubmed publisher
  32. Besnard M, S xe9 razin C, Ossart J, Moreau A, Vimond N, Flippe L, et al. Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. J Clin Invest. 2022;132: pubmed publisher
  33. Yokomizo K, Waki K, Ozawa M, Yamamoto K, Ogasawara S, Yano H, et al. Knockout of high-mobility group box 1 in B16F10 melanoma cells induced host immunity-mediated suppression of in vivo tumor growth. Med Oncol. 2022;39:58 pubmed publisher
  34. Pinkert J, Boehm H, Trautwein M, Doecke W, Wessel F, Ge Y, et al. T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction. Oncoimmunology. 2022;11:2008110 pubmed publisher
  35. Yang B, Zhang Z, Chen X, Wang X, Qin S, Du L, et al. An Asia-specific variant of human IgG1 represses colorectal tumorigenesis by shaping the tumor microenvironment. J Clin Invest. 2022;132: pubmed publisher
  36. Almishri W, Swain L, D Mello C, Le T, Urbanski S, Nguyen H. ADAM Metalloproteinase Domain 17 Regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development in Mice. Front Immunol. 2021;12:779119 pubmed publisher
  37. Chen Y, Feng R, He B, Wang J, Xian N, Huang G, et al. PD-1H Expression Associated With CD68 Macrophage Marker Confers an Immune-Activated Microenvironment and Favorable Overall Survival in Human Esophageal Squamous Cell Carcinoma. Front Mol Biosci. 2021;8:777370 pubmed publisher
  38. Zhang Q, Hresko M, Picton L, Su L, Hollander M, Nunez Cruz S, et al. A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia. Sci Transl Med. 2021;13:eabg6986 pubmed publisher
  39. Liu Y, Wang L, Song Q, Ali M, Crowe W, Kucera G, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17:206-216 pubmed publisher
  40. Bristow C, Reeves M, Winston R. Alphataxin, a Small-Molecule Drug That Elevates Tumor-Infiltrating CD4+ T Cells, in Combination With Anti-PD-1 Therapy, Suppresses Murine Renal Cancer and Metastasis. Front Oncol. 2021;11:739080 pubmed publisher
  41. Fahy N, Palomares Cabeza V, Lolli A, Witte Bouma J, Merino A, Ridwan Y, et al. Chondrogenically Primed Human Mesenchymal Stem Cells Persist and Undergo Early Stages of Endochondral Ossification in an Immunocompetent Xenogeneic Model. Front Immunol. 2021;12:715267 pubmed publisher
  42. Hua X, Ge S, Zhang M, Mo F, Zhang L, Zhang J, et al. Pathogenic Roles of CXCL10 in Experimental Autoimmune Prostatitis by Modulating Macrophage Chemotaxis and Cytokine Secretion. Front Immunol. 2021;12:706027 pubmed publisher
  43. Ni Y, Hu B, Wu G, Shao Z, Zheng Y, Zhang R, et al. Interruption of neutrophil extracellular traps formation dictates host defense and tubular HOXA5 stability to augment efficacy of anti-Fn14 therapy against septic AKI. Theranostics. 2021;11:9431-9451 pubmed publisher
  44. Horiuchi S, Wu H, Liu W, Schmitt N, Provot J, Liu Y, et al. Tox2 is required for the maintenance of GC TFH cells and the generation of memory TFH cells. Sci Adv. 2021;7:eabj1249 pubmed publisher
  45. Ming S, Yin H, Li X, Gong S, Zhang G, Wu Y. GITR Promotes the Polarization of TFH-Like Cells in Helicobacter pylori-Positive Gastritis. Front Immunol. 2021;12:736269 pubmed publisher
  46. Lee Y, Kim T, Kim Y, Kim S, Lee S, Seo S, et al. Microbiota-derived lactate promotes hematopoiesis and erythropoiesis by inducing stem cell factor production from leptin receptor+ niche cells. Exp Mol Med. 2021;53:1319-1331 pubmed publisher
  47. Wang Z, He L, Li W, Xu C, Zhang J, Wang D, et al. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma. J Immunother Cancer. 2021;9: pubmed publisher
  48. Fierle J, Brioschi M, de Tiani M, Wetterwald L, Atsaves V, Abram Saliba J, et al. Soluble trivalent engagers redirect cytolytic T cell activity toward tumor endothelial marker 1. Cell Rep Med. 2021;2:100362 pubmed publisher
  49. Yamagishi M, Kubokawa M, Kuze Y, Suzuki A, Yokomizo A, Kobayashi S, et al. Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma. Nat Commun. 2021;12:4821 pubmed publisher
  50. Zhao Q, Koyama S, Yoshihara N, Takagi A, Komiyama E, Wada A, et al. The Alopecia Areata Phenotype Is Induced by the Water Avoidance Stress Test In cchcr1-Deficient Mice. Biomedicines. 2021;9: pubmed publisher
  51. Spiegel J, Patel S, Muffly L, Hossain N, Oak J, Baird J, et al. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nat Med. 2021;27:1419-1431 pubmed publisher
  52. Kim G, Kim W, Lim S, Lee H, Koo J, Nam K, et al. In Vivo Induction of Regulatory T Cells Via CTLA-4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse. Adv Sci (Weinh). 2021;8:2004973 pubmed publisher
  53. Dalla Pietà A, Cappuzzello E, Palmerini P, Ventura A, Visentin A, Astori G, et al. Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. J Immunother Cancer. 2021;9: pubmed publisher
  54. Yue X, Petersen F, Shu Y, Kasper B, Magatsin J, Ahmadi M, et al. Transfer of PBMC From SSc Patients Induces Autoantibodies and Systemic Inflammation in Rag2-/-/IL2rg-/- Mice. Front Immunol. 2021;12:677970 pubmed publisher
  55. Lu J, Wang W, Li P, Wang X, Gao C, Zhang B, et al. MiR-146a regulates regulatory T cells to suppress heart transplant rejection in mice. Cell Death Discov. 2021;7:165 pubmed publisher
  56. Li N, Torres M, Spetz M, Wang R, Peng L, Tian M, et al. CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice. Cell Rep Med. 2021;2:100297 pubmed publisher
  57. Bohannon C, Ende Z, Cao W, Mboko W, Ranjan P, Kumar A, et al. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders. Adv Sci (Weinh). 2021;8:e2100693 pubmed publisher
  58. Ramos M, Tian L, de Ruiter E, Song C, Paucarmayta A, Singh A, et al. Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction. elife. 2021;10: pubmed publisher
  59. Zhang X, Liu X, Zhou W, Du Q, Yang M, Ding Y, et al. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance. Cell Mol Gastroenterol Hepatol. 2021;12:1179-1199 pubmed publisher
  60. Barker K, Etesami N, Shenoy A, Arafa E, Lyon de Ana C, Smith N, et al. Lung-resident memory B cells protect against bacterial pneumonia. J Clin Invest. 2021;131: pubmed publisher
  61. Turner J, Kim W, Kalaidina E, Goss C, Rauseo A, Schmitz A, et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. 2021;595:421-425 pubmed publisher
  62. Hawerkamp H, Domdey A, Radau L, Sewerin P, Oláh P, Homey B, et al. Tofacitinib downregulates antiviral immune defence in keratinocytes and reduces T cell activation. Arthritis Res Ther. 2021;23:144 pubmed publisher
  63. Roca C, Burton O, Gergelits V, Prezzemolo T, Whyte C, Halpert R, et al. AutoSpill is a principled framework that simplifies the analysis of multichromatic flow cytometry data. Nat Commun. 2021;12:2890 pubmed publisher
  64. Zhou S, Meng F, Du S, Qian H, Ding N, Sha H, et al. Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation. J Immunother Cancer. 2021;9: pubmed publisher
  65. Egedal J, Xie G, Packard T, Laustsen A, Neidleman J, Georgiou K, et al. Hyaluronic acid is a negative regulator of mucosal fibroblast-mediated enhancement of HIV infection. Mucosal Immunol. 2021;: pubmed publisher
  66. Martínez Zamudio R, Dewald H, Vasilopoulos T, Gittens Williams L, Fitzgerald Bocarsly P, Herbig U. Senescence-associated β-galactosidase reveals the abundance of senescent CD8+ T cells in aging humans. Aging Cell. 2021;20:e13344 pubmed publisher
  67. Zong D, Huang B, LI Y, Lu Y, Xiang N, Guo C, et al. Chromatin accessibility landscapes of immune cells in rheumatoid arthritis nominate monocytes in disease pathogenesis. BMC Biol. 2021;19:79 pubmed publisher
  68. Laurent E, Sieber A, Salzer B, Wachernig A, Seigner J, Lehner M, et al. Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell Patients. ACS Synth Biol. 2021;10:1184-1198 pubmed publisher
  69. Mandolesi M, Sheward D, Hanke L, Ma J, Pushparaj P, Perez Vidakovics L, et al. SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses. Cell Rep Med. 2021;2:100252 pubmed publisher
  70. Pezzuto F, Lunardi F, Vedovelli L, Fortarezza F, Urso L, Grosso F, et al. P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment. Front Oncol. 2021;11:653497 pubmed publisher
  71. Pascal L, Dhir R, Balasubramani G, Chen W, Hudson C, Srivastava P, et al. E-cadherin expression is inversely correlated with aging and inflammation in the prostate. Am J Clin Exp Urol. 2021;9:140-149 pubmed
  72. Gómez Ferrer M, Villanueva Badenas E, Sánchez Sánchez R, Sánchez López C, Baquero M, Sepulveda P, et al. HIF-1α and Pro-Inflammatory Signaling Improves the Immunomodulatory Activity of MSC-Derived Extracellular Vesicles. Int J Mol Sci. 2021;22: pubmed publisher
  73. Weber E, Parker K, Sotillo E, Lynn R, Anbunathan H, Lattin J, et al. Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling. Science. 2021;372: pubmed publisher
  74. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed publisher
  75. Azzimonti B, Raimondo L, Squarzanti D, Rosso T, Zanetta P, Aluffi Valletti P, et al. Macrophages expressing TREM-1 are involved in the progression of HPV16-related oropharyngeal squamous cell carcinoma. Ann Med. 2021;53:541-550 pubmed publisher
  76. Szabo P, Dogra P, Gray J, Wells S, Connors T, Weisberg S, et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021;54:797-814.e6 pubmed publisher
  77. Chiou S, Tseng D, Reuben A, Mallajosyula V, Molina I, Conley S, et al. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity. 2021;54:586-602.e8 pubmed publisher
  78. Yin H, Zhang X, Yang P, Zhang X, Peng Y, Li D, et al. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming. Nat Commun. 2021;12:1394 pubmed publisher
  79. Paul S, Pearlman A, Douglass J, Mog B, Hsiue E, Hwang M, et al. TCR β chain-directed bispecific antibodies for the treatment of T cell cancers. Sci Transl Med. 2021;13: pubmed publisher
  80. Sivasubramaniyam T, Yang J, Cheng H, Zyla A, Li A, Besla R, et al. Dj1 deficiency protects against atherosclerosis with anti-inflammatory response in macrophages. Sci Rep. 2021;11:4723 pubmed publisher
  81. Minns D, Smith K, Alessandrini V, Hardisty G, Melrose L, Jackson Jones L, et al. The neutrophil antimicrobial peptide cathelicidin promotes Th17 differentiation. Nat Commun. 2021;12:1285 pubmed publisher
  82. Mo F, Duan S, Jiang X, Yang X, Hou X, Shi W, et al. Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy. Signal Transduct Target Ther. 2021;6:80 pubmed publisher
  83. Khosravi Maharlooei M, Li H, Hoelzl M, Zhao G, Ruiz A, Misra A, et al. Role of the thymus in spontaneous development of a multi-organ autoimmune disease in human immune system mice. J Autoimmun. 2021;119:102612 pubmed publisher
  84. Jaworek C, Verel Yilmaz Y, Driesch S, Ostgathe S, Cook L, Wagner S, et al. Cohort Analysis of ADAM8 Expression in the PDAC Tumor Stroma. J Pers Med. 2021;11: pubmed publisher
  85. Yao C, Lou G, Sun H, Zhu Z, Sun Y, Chen Z, et al. BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells. Nat Immunol. 2021;22:370-380 pubmed publisher
  86. Wang Q, Gao H, Clark K, Mugisha C, Davis K, Tang J, et al. CARD8 is an inflammasome sensor for HIV-1 protease activity. Science. 2021;371: pubmed publisher
  87. Bielecki P, Riesenfeld S, Hütter J, Torlai Triglia E, Kowalczyk M, Ricardo Gonzalez R, et al. Skin-resident innate lymphoid cells converge on a pathogenic effector state. Nature. 2021;592:128-132 pubmed publisher
  88. Biswas S, Mandal G, Payne K, Anadon C, Gatenbee C, Chaurio R, et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature. 2021;591:464-470 pubmed publisher
  89. Wang F, Ye W, Wang S, He Y, Zhong H, Wang Y, et al. Discovery of a new inhibitor targeting PD-L1 for cancer immunotherapy. Neoplasia. 2021;23:281-293 pubmed publisher
  90. Rosshirt N, Trauth R, Platzer H, Tripel E, Nees T, Lorenz H, et al. Proinflammatory T cell polarization is already present in patients with early knee osteoarthritis. Arthritis Res Ther. 2021;23:37 pubmed publisher
  91. Vavassori V, Mercuri E, Marcovecchio G, Castiello M, Schiroli G, Albano L, et al. Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome. EMBO Mol Med. 2021;13:e13545 pubmed publisher
  92. Break T, Oikonomou V, Dutzan N, Desai J, Swidergall M, Freiwald T, et al. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science. 2021;371: pubmed publisher
  93. Webb L, Fra Bido S, Innocentin S, Matheson L, Attaf N, Bignon A, et al. Ageing promotes early T follicular helper cell differentiation by modulating expression of RBPJ. Aging Cell. 2021;20:e13295 pubmed publisher
  94. Ebelt N, Zuniga E, Marzagalli M, Zamloot V, Blazar B, Salgia R, et al. Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Restructures the Immune Contexture to Improve Checkpoint Blockade Efficacy. Biomedicines. 2020;8: pubmed publisher
  95. Gregorova M, Morse D, Brignoli T, Steventon J, Hamilton F, Albur M, et al. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. elife. 2020;9: pubmed publisher
  96. Snyder M, Sembrat J, Noda K, MYERBURG M, Craig A, Mitash N, et al. Human Lung-Resident Macrophages Colocalize with and Provide Costimulation to PD1hi Tissue-Resident Memory T Cells. Am J Respir Crit Care Med. 2021;203:1230-1244 pubmed publisher
  97. Lund M, Howard C, Thurecht K, Campbell D, Mahler S, Walsh B. A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells. BMC Cancer. 2020;20:1214 pubmed publisher
  98. Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed publisher
  99. Kasatskaya S, Ladell K, Egorov E, Miners K, Davydov A, Metsger M, et al. Functionally specialized human CD4+ T-cell subsets express physicochemically distinct TCRs. elife. 2020;9: pubmed publisher
  100. Harro C, Perez Sanz J, Costich T, Payne K, Anadon C, Chaurio R, et al. Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice. J Clin Invest. 2021;131: pubmed publisher
  101. Witkowska Piłaszewicz O, Pingwara R, Winnicka A. The Effect of Physical Training on Peripheral Blood Mononuclear Cell Ex Vivo Proliferation, Differentiation, Activity, and Reactive Oxygen Species Production in Racehorses. Antioxidants (Basel). 2020;9: pubmed publisher
  102. Luo B, Zhan Y, Luo M, Dong H, Liu J, Lin Y, et al. Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration. Cell Death Dis. 2020;11:973 pubmed publisher
  103. Kasuga A, Semba T, Sato R, Nobusue H, Sugihara E, Takaishi H, et al. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice. Cancer Sci. 2021;112:1822-1838 pubmed publisher
  104. Zahedi K, Brooks M, Barone S, Rahmati N, Murray Stewart T, Dunworth M, et al. Ablation of polyamine catabolic enzymes provokes Purkinje cell damage, neuroinflammation, and severe ataxia. J Neuroinflammation. 2020;17:301 pubmed publisher
  105. Moreno Valladares M, Silva T, Garcés J, Sáenz Antoñanzas A, Moreno Cugnon L, Álvarez Satta M, et al. CD8+ T cells are present at low levels in the white matter with physiological and pathological aging. Aging (Albany NY). 2020;12:18928-18941 pubmed publisher
  106. Mateus J, Grifoni A, Tarke A, Sidney J, Ramirez S, Dan J, et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. 2020;370:89-94 pubmed publisher
  107. Tan E, Hopkins R, Lim C, Jamuar S, Ong C, Thoon K, et al. Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency. J Clin Invest. 2020;130:5817-5832 pubmed publisher
  108. Moreno Valladares M, Moreno Cugnon L, Silva T, Garcés J, Sáenz Antoñanzas A, Álvarez Satta M, et al. CD8+ T cells are increased in the subventricular zone with physiological and pathological aging. Aging Cell. 2020;:e13198 pubmed publisher
  109. Li Z, Zhang H, Huang Y, Huang J, Sun P, Zhou N, et al. Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation. Nat Commun. 2020;11:3806 pubmed publisher
  110. Bennstein S, Weinhold S, Manser A, Scherenschlich N, Noll A, Raba K, et al. Umbilical cord blood-derived ILC1-like cells constitute a novel precursor for mature KIR+NKG2A- NK cells. elife. 2020;9: pubmed publisher
  111. Camu W, Mickunas M, Veyrune J, Payan C, Garlanda C, Locati M, et al. Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial. EBioMedicine. 2020;59:102844 pubmed publisher
  112. Danzer H, Glaesner J, Baerenwaldt A, Reitinger C, Lux A, Heger L, et al. Human Fcγ-receptor IIb modulates pathogen-specific versus self-reactive antibody responses in lyme arthritis. elife. 2020;9: pubmed publisher
  113. Fischer M, Ruhnau J, Schulze J, Obst D, Floel A, Vogelgesang A. Spermine and spermidine modulate T-cell function in older adults with and without cognitive decline ex vivo. Aging (Albany NY). 2020;12:13716-13739 pubmed publisher
  114. Seitz V, Kleo K, Dröge A, Schaper S, Elezkurtaj S, Bedjaoui N, et al. Evidence for a role of RUNX1 as recombinase cofactor for TCRβ rearrangements and pathological deletions in ETV6-RUNX1 ALL. Sci Rep. 2020;10:10024 pubmed publisher
  115. Brouwer P, Caniels T, van der Straten K, Snitselaar J, Aldon Y, Bangaru S, et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science. 2020;369:643-650 pubmed publisher
  116. Janyst M, Kaleta B, Janyst K, Zagozdzon R, Kozlowska E, Lasek W. Comparative Study of Immunomodulatory Agents to Induce Human T Regulatory (Treg) Cells: Preferential Treg-Stimulatory Effect of Prednisolone and Rapamycin. Arch Immunol Ther Exp (Warsz). 2020;68:20 pubmed publisher
  117. Maisel K, Hrusch C, Medellin J, Potin L, Chapel D, Nurmi H, et al. Pro-lymphangiogenic VEGFR-3 signaling modulates memory T cell responses in allergic airway inflammation. Mucosal Immunol. 2021;14:144-151 pubmed publisher
  118. Cao W, Fang F, Gould T, Li X, Kim C, Gustafson C, et al. Ecto-NTPDase CD39 is a negative checkpoint that inhibits follicular helper cell generation. J Clin Invest. 2020;130:3422-3436 pubmed publisher
  119. Ma T, Luo X, George A, Mukherjee G, Sen N, Spitzer T, et al. HIV efficiently infects T cells from the endometrium and remodels them to promote systemic viral spread. elife. 2020;9: pubmed publisher
  120. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed publisher
  121. Liu X, Kong W, Peterson C, McGrail D, Hoang A, Zhang X, et al. PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma. Nat Commun. 2020;11:2135 pubmed publisher
  122. Pallikkuth S, Chaudhury S, Lu P, Pan L, Jongert E, Wille Reece U, et al. A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses. elife. 2020;9: pubmed publisher
  123. Hanaoka H, Nishimoto T, Okazaki Y, Takeuchi T, Kuwana M. A unique thymus-derived regulatory T cell subset associated with systemic lupus erythematosus. Arthritis Res Ther. 2020;22:88 pubmed publisher
  124. Beziat V, Tavernier S, Chen Y, Ma C, Materna M, Laurence A, et al. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med. 2020;217: pubmed publisher
  125. Tashita C, Hoshi M, Hirata A, Nakamoto K, Ando T, Hattori T, et al. Kynurenine plays an immunosuppressive role in 2,4,6-trinitrobenzene sulfate-induced colitis in mice. World J Gastroenterol. 2020;26:918-932 pubmed publisher
  126. Stebegg M, Bignon A, Hill D, Silva Cayetano A, Krueger C, Vanderleyden I, et al. Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination. elife. 2020;9: pubmed publisher
  127. Chaurasiya S, Yang A, Kang S, Lu J, Kim S, Park A, et al. Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model. Oncoimmunology. 2020;9:1729300 pubmed publisher
  128. He T, Yost S, Frankel P, Dagis A, Cao Y, Wang R, et al. Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis. PLoS ONE. 2020;15:e0229955 pubmed publisher
  129. Hajaj E, Eisenberg G, Klein S, Frankenburg S, Merims S, Ben David I, et al. SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint. elife. 2020;9: pubmed publisher
  130. Raehtz K, Barrenas F, Xu C, Busman Sahay K, Valentine A, Law L, et al. African green monkeys avoid SIV disease progression by preventing intestinal dysfunction and maintaining mucosal barrier integrity. PLoS Pathog. 2020;16:e1008333 pubmed publisher
  131. Lubow J, Virgilio M, Merlino M, Collins D, Mashiba M, Peterson B, et al. Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages. elife. 2020;9: pubmed publisher
  132. Maestre L, García García J, Jiménez S, Reyes García A, García González Á, Montes Moreno S, et al. High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations. PLoS ONE. 2020;15:e0229743 pubmed publisher
  133. Lu Z, Zou J, Li S, Topper M, Tao Y, Zhang H, et al. Epigenetic therapy inhibits metastases by disrupting premetastatic niches. Nature. 2020;579:284-290 pubmed publisher
  134. Tezera L, Bielecka M, Ogongo P, Walker N, Ellis M, Garay Baquero D, et al. Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α. elife. 2020;9: pubmed publisher
  135. Park J, Botting R, Domínguez Conde C, Popescu D, Lavaert M, Kunz D, et al. A cell atlas of human thymic development defines T cell repertoire formation. Science. 2020;367: pubmed publisher
  136. Chen H, Cong X, Wu C, Wu X, Wang J, Mao K, et al. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells. Sci Adv. 2020;6:eaax4690 pubmed publisher
  137. Cohen G, Chandran P, Lorsung R, Tomlinson L, Sundby M, Burks S, et al. The Impact of Focused Ultrasound in Two Tumor Models: Temporal Alterations in the Natural History on Tumor Microenvironment and Immune Cell Response. Cancers (Basel). 2020;12: pubmed publisher
  138. Rodríguez Lorenzo S, Konings J, van der Pol S, Kamermans A, Amor S, van Horssen J, et al. Inflammation of the choroid plexus in progressive multiple sclerosis: accumulation of granulocytes and T cells. Acta Neuropathol Commun. 2020;8:9 pubmed publisher
  139. Seitz C, Schroeder S, Knopf P, Krahl A, Hau J, Schleicher S, et al. GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells. Oncoimmunology. 2020;9:1683345 pubmed publisher
  140. Nixon C, Mavigner M, Sampey G, Brooks A, Spagnuolo R, Irlbeck D, et al. Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo. Nature. 2020;578:160-165 pubmed publisher
  141. Bracher A, Alcalá C, Ferrer J, Melzer N, Hohlfeld R, Casanova B, et al. An expanded parenchymal CD8+ T cell clone in GABAA receptor encephalitis. Ann Clin Transl Neurol. 2020;7:239-244 pubmed publisher
  142. Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-555 pubmed publisher
  143. Schafflick D, Xu C, Hartlehnert M, Cole M, Schulte Mecklenbeck A, Lautwein T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247 pubmed publisher
  144. Wang G, Xu J, Zhao J, Yin W, Liu D, Chen W, et al. Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice. Nat Commun. 2020;11:220 pubmed publisher
  145. Shapiro M, Cheever T, Malherbe D, Pandey S, Reed J, Yang E, et al. Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity. Nat Commun. 2020;11:70 pubmed publisher
  146. Queckborner S, Syk Lundberg E, Gemzell Danielsson K, Davies L. Endometrial stromal cells exhibit a distinct phenotypic and immunomodulatory profile. Stem Cell Res Ther. 2020;11:15 pubmed publisher
  147. Epps S, Coplin N, Luthert P, Dick A, Coupland S, Nicholson L. Features of ectopic lymphoid-like structures in human uveitis. Exp Eye Res. 2020;191:107901 pubmed publisher
  148. Le Nours J, Gherardin N, Ramarathinam S, Awad W, Wiede F, Gully B, et al. A class of γδ T cell receptors recognize the underside of the antigen-presenting molecule MR1. Science. 2019;366:1522-1527 pubmed publisher
  149. Uhlen M, Karlsson M, Zhong W, Tebani A, Pou C, Mikes J, et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366: pubmed publisher
  150. Wang B, Saito Y, Nishimura M, Ren Z, Tjan L, Refaat A, et al. An Animal Model That Mimics Human Herpesvirus 6B Pathogenesis. J Virol. 2020;94: pubmed publisher
  151. Jimeno R, Lebrusant Fernandez M, Margreitter C, LUCAS B, Veerapen N, Kelly G, et al. Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells. elife. 2019;8: pubmed publisher
  152. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  153. Lynn R, Weber E, Sotillo E, Gennert D, Xu P, Good Z, et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 2019;576:293-300 pubmed publisher
  154. Park C, Kehrl J. An integrin/MFG-E8 shuttle loads HIV-1 viral-like particles onto follicular dendritic cells in mouse lymph node. elife. 2019;8: pubmed publisher
  155. Calvanese V, Nguyen A, Bolan T, Vavilina A, Su T, Lee L, et al. MLLT3 governs human haematopoietic stem-cell self-renewal and engraftment. Nature. 2019;576:281-286 pubmed publisher
  156. Martínez Fábregas J, Wilmes S, Wang L, Hafer M, Pohler E, Lokau J, et al. Kinetics of cytokine receptor trafficking determine signaling and functional selectivity. elife. 2019;8: pubmed publisher
  157. Li Z, Wang H, Zeng Q, Yan J, Hu Y, Li H, et al. p65/miR-23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma. Cancer Med. 2020;9:711-723 pubmed publisher
  158. Muhammad F, Wang D, Montieth A, Lee S, Preble J, Foster C, et al. PD-1+ melanocortin receptor dependent-Treg cells prevent autoimmune disease. Sci Rep. 2019;9:16941 pubmed publisher
  159. Ma A, Motyka B, Gutfreund K, Shi Y, George R. A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B. Hum Vaccin Immunother. 2020;16:756-778 pubmed publisher
  160. Zhang Q, He Y, Luo N, Patel S, Han Y, Gao R, et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179:829-845.e20 pubmed publisher
  161. Strickley J, Messerschmidt J, Awad M, Li T, Hasegawa T, Ha D, et al. Immunity to commensal papillomaviruses protects against skin cancer. Nature. 2019;: pubmed publisher
  162. Ladinsky M, Khamaikawin W, Jung Y, Lin S, Lam J, An D, et al. Mechanisms of virus dissemination in bone marrow of HIV-1-infected humanized BLT mice. elife. 2019;8: pubmed publisher
  163. Pecher A, Kettemann F, Asteriti E, Schmid H, Duerr Stoerzer S, Keppeler H, et al. Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis. Arthritis Res Ther. 2019;21:212 pubmed publisher
  164. Stewart B, Ferdinand J, Young M, Mitchell T, Loudon K, Riding A, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365:1461-1466 pubmed publisher
  165. Griss J, Bauer W, Wagner C, Simon M, Chen M, Grabmeier Pfistershammer K, et al. B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. Nat Commun. 2019;10:4186 pubmed publisher
  166. Aghajanian H, Kimura T, Rurik J, Hancock A, Leibowitz M, Li L, et al. Targeting cardiac fibrosis with engineered T cells. Nature. 2019;573:430-433 pubmed publisher
  167. Rasoulouniriana D, Santana Magal N, Gutwillig A, Farhat Younis L, Wine Y, Saperia C, et al. A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity. J Clin Invest. 2019;129:4151-4164 pubmed publisher
  168. Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed publisher
  169. Jordan S, Tung N, Casanova Acebes M, Chang C, Cantoni C, Zhang D, et al. Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool. Cell. 2019;178:1102-1114.e17 pubmed publisher
  170. Choi J, Lee E, Kim S, Park S, Oh S, Kang J, et al. Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer. BMC Cancer. 2019;19:817 pubmed publisher
  171. Serra Peinado C, Grau Expósito J, Luque Ballesteros L, Astorga Gamaza A, Navarro J, Gallego Rodriguez J, et al. Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab. Nat Commun. 2019;10:3705 pubmed publisher
  172. Lou Q, Liu R, Yang X, Li W, Huang L, Wei L, et al. miR-448 targets IDO1 and regulates CD8+ T cell response in human colon cancer. J Immunother Cancer. 2019;7:210 pubmed publisher
  173. Gowthaman U, Chen J, Zhang B, Flynn W, Lu Y, Song W, et al. Identification of a T follicular helper cell subset that drives anaphylactic IgE. Science. 2019;365: pubmed publisher
  174. Leclerc M, Voilin E, Gros G, Corgnac S, de Montpreville V, Validire P, et al. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1. Nat Commun. 2019;10:3345 pubmed publisher
  175. Banga R, Rebecchini C, Procopio F, Noto A, Munoz O, Ioannidou K, et al. Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement. PLoS Pathog. 2019;15:e1007918 pubmed publisher
  176. Meckiff B, Ladell K, McLaren J, Ryan G, Leese A, James E, et al. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells. J Immunol. 2019;203:1276-1287 pubmed publisher
  177. Inagaki Katashiba N, Ito T, Inaba M, Azuma Y, Tanaka A, Phan V, et al. Statins can suppress DC-mediated Th2 responses through the repression of OX40-ligand and CCL17 expression. Eur J Immunol. 2019;49:2051-2062 pubmed publisher
  178. Papaioannou E, Yanez D, Ross S, Lau C, Solanki A, Chawda M, et al. Sonic Hedgehog signaling limits atopic dermatitis via Gli2-driven immune regulation. J Clin Invest. 2019;129:3153-3170 pubmed publisher
  179. Burel J, Pomaznoy M, Lindestam Arlehamn C, Weiskopf D, da Silva Antunes R, Jung Y, et al. Circulating T cell-monocyte complexes are markers of immune perturbations. elife. 2019;8: pubmed publisher
  180. Fransen N, Crusius J, Smolders J, Mizee M, Van Eden C, Luchetti S, et al. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms. Brain Pathol. 2020;30:106-119 pubmed publisher
  181. Xia Y, Gao Y, Wang B, Zhang H, Zhang Q. Optimizing the Method of Cell Separation from Bile of Patients with Cholangiocarcinoma for Flow Cytometry. Gastroenterol Res Pract. 2019;2019:5436961 pubmed publisher
  182. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
  183. Gu C, Wang L, Zurawski S, Oh S. Signaling Cascade through DC-ASGPR Induces Transcriptionally Active CREB for IL-10 Induction and Immune Regulation. J Immunol. 2019;: pubmed publisher
  184. Ardain A, Domingo Gonzalez R, Das S, Kazer S, Howard N, Singh A, et al. Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis. Nature. 2019;: pubmed publisher
  185. Fenwick C, Loredo Varela J, Joo V, Pellaton C, Farina A, Rajah N, et al. Tumor suppression of novel anti-PD-1 antibodies mediated through CD28 costimulatory pathway. J Exp Med. 2019;: pubmed publisher
  186. Sivaram N, McLaughlin P, Han H, Petrenko O, Jiang Y, Ballou L, et al. Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer. J Clin Invest. 2019;130: pubmed publisher
  187. Swaims Kohlmeier A, Haddad L, Li Z, Brookmeyer K, Baker J, Widom C, et al. Chronic immune barrier dysregulation among women with a history of violence victimization. JCI Insight. 2019;4: pubmed publisher
  188. Zumaquero E, Stone S, Scharer C, Jenks S, Nellore A, Mousseau B, et al. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. elife. 2019;8: pubmed publisher
  189. Fernandez I, Baxter R, Garcia Perez J, Vendrame E, Ranganath T, Kong D, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216:1255-1267 pubmed publisher
  190. Fletcher Jones A, Hildick K, Evans A, Nakamura Y, Wilkinson K, Henley J. The C-terminal helix 9 motif in rat cannabinoid receptor type 1 regulates axonal trafficking and surface expression. elife. 2019;8: pubmed publisher
  191. Thauland T, Pellerin L, Ohgami R, Bacchetta R, Butte M. Case Study: Mechanism for Increased Follicular Helper T Cell Development in Activated PI3K Delta Syndrome. Front Immunol. 2019;10:753 pubmed publisher
  192. Pavel Dinu M, Wiebking V, Dejene B, Srifa W, Mantri S, Nicolas C, et al. Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nat Commun. 2019;10:1634 pubmed publisher
  193. Hammerich L, Marron T, Upadhyay R, Svensson Arvelund J, Dhainaut M, Hussein S, et al. Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination. Nat Med. 2019;25:814-824 pubmed publisher
  194. Wu J, Ma S, Sandhoff R, Ming Y, Hotz Wagenblatt A, Timmerman V, et al. Loss of Neurological Disease HSAN-I-Associated Gene SPTLC2 Impairs CD8+ T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness. Immunity. 2019;50:1218-1231.e5 pubmed publisher
  195. Talreja J, Talwar H, Bauerfeld C, Grossman L, Zhang K, Tranchida P, et al. HIF-1α regulates IL-1β and IL-17 in sarcoidosis. elife. 2019;8: pubmed publisher
  196. Dang A, Teles R, Weiss D, Parvatiyar K, Sarno E, Ochoa M, et al. IL-26 contributes to host defense against intracellular bacteria. J Clin Invest. 2019;129:1926-1939 pubmed publisher
  197. Oda H, Beck D, Kuehn H, Sampaio Moura N, Hoffmann P, Ibarra M, et al. Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBAC. Front Immunol. 2019;10:479 pubmed publisher
  198. Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed publisher
  199. Yao W, Rose J, Wang W, Seth S, Jiang H, Taguchi A, et al. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Nature. 2019;: pubmed publisher
  200. Liao W, Overman M, Boutin A, Shang X, Zhao D, Dey P, et al. KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer. Cancer Cell. 2019;35:559-572.e7 pubmed publisher
  201. Finney O, Brakke H, Rawlings Rhea S, Hicks R, Doolittle D, López M, et al. CD19 CAR T cell product and disease attributes predict leukemia remission durability. J Clin Invest. 2019;129:2123-2132 pubmed publisher
  202. Naamati A, Williamson J, Greenwood E, Marelli S, Lehner P, Matheson N. Functional proteomic atlas of HIV infection in primary human CD4+ T cells. elife. 2019;8: pubmed publisher
  203. Lee J, Stone M, Porrett P, Thomas S, Komar C, Li J, et al. Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019;567:249-252 pubmed publisher
  204. Bacher P, Hohnstein T, Beerbaum E, Röcker M, Blango M, Kaufmann S, et al. Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans. Cell. 2019;: pubmed publisher
  205. Lodygin D, Hermann M, Schweingruber N, Flügel Koch C, Watanabe T, Schlosser C, et al. β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature. 2019;566:503-508 pubmed publisher
  206. Sueyoshi K, Ledderose C, Shen Y, Lee A, Shapiro N, Junger W. Lipopolysaccharide suppresses T cells by generating extracellular ATP that impairs their mitochondrial function via P2Y11 receptors. J Biol Chem. 2019;294:6283-6293 pubmed publisher
  207. Mayassi T, Ladell K, Gudjonson H, McLaren J, Shaw D, Tran M, et al. Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease. Cell. 2019;176:967-981.e19 pubmed publisher
  208. Haikala H, Anttila J, Marques E, Raatikainen T, Ilander M, Hakanen H, et al. Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy. Nat Commun. 2019;10:620 pubmed publisher
  209. Wen Z, Jin K, Shen Y, Yang Z, Li Y, Wu B, et al. N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation. Nat Immunol. 2019;20:313-325 pubmed publisher
  210. Langer S, Hammer C, Hopfensperger K, Klein L, Hotter D, De Jesus P, et al. HIV-1 Vpu is a potent transcriptional suppressor of NF-κB-elicited antiviral immune responses. elife. 2019;8: pubmed publisher
  211. Crivello P, Ahci M, Maaßen F, Wossidlo N, Arrieta Bolaños E, Heinold A, et al. Multiple Knockout of Classical HLA Class II β-Chains by CRISPR/Cas9 Genome Editing Driven by a Single Guide RNA. J Immunol. 2019;202:1895-1903 pubmed publisher
  212. Muller Durovic B, Grählert J, Devine O, Akbar A, Hess C. CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age. Aging (Albany NY). 2019;11:724-740 pubmed publisher
  213. Yu J, Liang C, Liu S. CD4-Dependent Modulation of HIV-1 Entry by LY6E. J Virol. 2019;93: pubmed publisher
  214. Taura M, Song E, Ho Y, Iwasaki A. Apobec3A maintains HIV-1 latency through recruitment of epigenetic silencing machinery to the long terminal repeat. Proc Natl Acad Sci U S A. 2019;116:2282-2289 pubmed publisher
  215. Montel Hagen A, Seet C, Li S, Chick B, Zhu Y, Chang P, et al. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells. Cell Stem Cell. 2019;24:376-389.e8 pubmed publisher
  216. Alam M, Yang D, Trivett A, Meyer T, Oppenheim J. HMGN1 and R848 Synergistically Activate Dendritic Cells Using Multiple Signaling Pathways. Front Immunol. 2018;9:2982 pubmed publisher
  217. Dagur R, Branch Woods A, Mathews S, Joshi P, Quadros R, Harms D, et al. Human-like NSG mouse glycoproteins sialylation pattern changes the phenotype of human lymphocytes and sensitivity to HIV-1 infection. BMC Immunol. 2019;20:2 pubmed publisher
  218. Koppejan H, Jansen D, Hameetman M, Thomas R, Toes R, van Gaalen F. Altered composition and phenotype of mucosal-associated invariant T cells in early untreated rheumatoid arthritis. Arthritis Res Ther. 2019;21:3 pubmed publisher
  219. Li H, van der Leun A, Yofe I, Lubling Y, Gelbard Solodkin D, van Akkooi A, et al. Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma. Cell. 2019;176:775-789.e18 pubmed publisher
  220. Gorth D, Shapiro I, Risbud M. Transgenic mice overexpressing human TNF-α experience early onset spontaneous intervertebral disc herniation in the absence of overt degeneration. Cell Death Dis. 2018;10:7 pubmed publisher
  221. Kumar A, Lee J, Suknuntha K, D Souza S, Thakur A, Slukvin I. NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells. J Immunol. 2019;202:770-776 pubmed publisher
  222. Richardson J, Armbruster N, Günter M, Henes J, Autenrieth S. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells. Front Immunol. 2018;9:2603 pubmed publisher
  223. Harper I, Gjorgjimajkoska O, Siu J, Parmar J, Mulder A, Claas F, et al. Prolongation of allograft survival by passenger donor regulatory T cells. Am J Transplant. 2019;19:1371-1379 pubmed publisher
  224. Amelio P, Portevin D, Hella J, Reither K, Kamwela L, Lweno O, et al. HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses. J Virol. 2019;93: pubmed publisher
  225. Perciani C, Farah B, Kaul R, Ostrowski M, Mahmud S, Anzala O, et al. Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation. J Clin Invest. 2019;129:875-886 pubmed publisher
  226. Wiedemann G, Aithal C, Kraechan A, Heise C, Cadilha B, Zhang J, et al. Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma. Transl Oncol. 2019;12:350-360 pubmed publisher
  227. Helmold Hait S, Vargas Inchaustegui D, Musich T, Mohanram V, Tuero I, Venzon D, et al. Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques. J Virol. 2019;93: pubmed publisher
  228. Wagner D, Amini L, Wendering D, Burkhardt L, Akyüz L, Reinke P, et al. High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat Med. 2019;25:242-248 pubmed publisher
  229. Deng M, Gui X, Kim J, Xie L, Chen W, Li Z, et al. LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. Nature. 2018;562:605-609 pubmed publisher
  230. Otsuka Y, Watanabe E, Shinya E, Okura S, Saeki H, Geijtenbeek T, et al. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells. J Immunol. 2018;201:3006-3016 pubmed publisher
  231. Hoang T, Harper J, Pino M, Wang H, Micci L, King C, et al. Bone Marrow-Derived CD4+ T Cells Are Depleted in Simian Immunodeficiency Virus-Infected Macaques and Contribute to the Size of the Replication-Competent Reservoir. J Virol. 2019;93: pubmed publisher
  232. Bradley T, Peppa D, Pedroza Pacheco I, Li D, Cain D, Henao R, et al. RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses. Cell. 2018;175:387-399.e17 pubmed publisher
  233. Patel N, Vukmanovic Stejic M, Suárez Fariñas M, Chambers E, Sandhu D, Fuentes Duculan J, et al. Impact of Zostavax Vaccination on T-Cell Accumulation and Cutaneous Gene Expression in the Skin of Older Humans After Varicella Zoster Virus Antigen-Specific Challenge. J Infect Dis. 2018;218:S88-S98 pubmed publisher
  234. Watanabe N, Takaku T, Takeda K, Shirane S, Toyota T, Koike M, et al. Dasatinib-induced anti-leukemia cellular immunity through a novel subset of CD57 positive helper/cytotoxic CD4 T cells in chronic myelogenous leukemia patients. Int J Hematol. 2018;108:588-597 pubmed publisher
  235. Tai Y, Lin L, Xing L, Cho S, Yu T, Acharya C, et al. APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications. Leukemia. 2019;33:426-438 pubmed publisher
  236. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed publisher
  237. Walwyn Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald A, et al. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. J Immunol. 2018;201:2028-2041 pubmed publisher
  238. Inoue Y, Endo S, Matsuno N, Kikukawa Y, Shichijo T, Koga K, et al. Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2018;: pubmed publisher
  239. Nguyen X, Dauvilliers Y, Quériault C, Pérals C, Romieu Mourez R, Paulet P, et al. Circulating follicular helper T cells exhibit reduced ICOS expression and impaired function in narcolepsy type 1 patients. J Autoimmun. 2018;94:134-142 pubmed publisher
  240. Zhu L, Xie X, Zhang L, Wang H, Jie Z, Zhou X, et al. TBK-binding protein 1 regulates IL-15-induced autophagy and NKT cell survival. Nat Commun. 2018;9:2812 pubmed publisher
  241. Yang T, St John L, Garber H, Kerros C, Ruisaard K, Clise Dwyer K, et al. Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation. J Immunol. 2018;201:1389-1399 pubmed publisher
  242. Nadjsombati M, McGinty J, Lyons Cohen M, Jaffe J, DiPeso L, Schneider C, et al. Detection of Succinate by Intestinal Tuft Cells Triggers a Type 2 Innate Immune Circuit. Immunity. 2018;49:33-41.e7 pubmed publisher
  243. Noto A, Procopio F, Banga R, Suffiotti M, Corpataux J, Cavassini M, et al. CD32+ and PD-1+ Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals. J Virol. 2018;92: pubmed publisher
  244. Heusinger E, Deppe K, Sette P, Krapp C, Kmiec D, Kluge S, et al. Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2. J Virol. 2018;92: pubmed publisher
  245. Chute C, Yang X, Meyer K, Yang N, O Neil K, Kasza I, et al. Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases. Breast Cancer Res. 2018;20:66 pubmed publisher
  246. Moysi E, Pallikkuth S, de Armas L, Gonzalez L, Ambrozak D, George V, et al. Altered immune cell follicular dynamics in HIV infection following influenza vaccination. J Clin Invest. 2018;128:3171-3185 pubmed publisher
  247. Boutboul D, Kuehn H, Van de Wyngaert Z, Niemela J, Callebaut I, Stoddard J, et al. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. J Clin Invest. 2018;128:3071-3087 pubmed publisher
  248. Frascaroli G, Lecher C, Varani S, Setz C, van der Merwe J, Brune W, et al. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4+ and CD8+ T Cells. Front Immunol. 2018;9:1129 pubmed publisher
  249. Galperin M, Farenc C, Mukhopadhyay M, Jayasinghe D, Decroos A, Benati D, et al. CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers. Sci Immunol. 2018;3: pubmed publisher
  250. Zacharakis N, Chinnasamy H, Black M, Xu H, Lu Y, Zheng Z, et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med. 2018;24:724-730 pubmed publisher
  251. Honeycutt J, Liao B, Nixon C, Cleary R, Thayer W, Birath S, et al. T cells establish and maintain CNS viral infection in HIV-infected humanized mice. J Clin Invest. 2018;128:2862-2876 pubmed publisher
  252. Yeo L, Woodwyk A, Sood S, Lorenc A, Eichmann M, Pujol Autonell I, et al. Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes. J Clin Invest. 2018;128:3460-3474 pubmed publisher
  253. Ng S, Yoshida N, Christie A, Ghandi M, Dharia N, Dempster J, et al. Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models. Nat Commun. 2018;9:2024 pubmed publisher
  254. Zhao S, Ding J, Wang S, Li C, Guo P, Zhang M, et al. Decreased expression of circulating Aire and increased Tfh/Tfr cells in myasthenia gravis patients. Biosci Rep. 2018;38: pubmed publisher
  255. Kiener R, Fleischmann M, Wiegand M, Lemmermann N, Schwegler C, Kaufmann C, et al. Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors. J Virol. 2018;92: pubmed publisher
  256. Hu X, Majchrzak K, Liu X, Wyatt M, Spooner C, Moisan J, et al. In Vitro Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness In Vivo. Cancer Res. 2018;78:3888-3898 pubmed publisher
  257. Risnes L, Christophersen A, Dahal Koirala S, Neumann R, Sandve G, Sarna V, et al. Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease. J Clin Invest. 2018;128:2642-2650 pubmed publisher
  258. Ondigo B, Ndombi E, Nicholson S, Oguso J, Carter J, Kittur N, et al. Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya. Am J Trop Med Hyg. 2018;98:1770-1781 pubmed publisher
  259. Clayton K, Collins D, Lengieza J, Ghebremichael M, Dotiwala F, Lieberman J, et al. Resistance of HIV-infected macrophages to CD8+ T lymphocyte-mediated killing drives activation of the immune system. Nat Immunol. 2018;19:475-486 pubmed publisher
  260. Ferrando Martinez S, Moysi E, Pegu A, Andrews S, Nganou Makamdop K, Ambrozak D, et al. Accumulation of follicular CD8+ T cells in pathogenic SIV infection. J Clin Invest. 2018;128:2089-2103 pubmed publisher
  261. Shi Y, Zhang P, Wang G, Liu X, Sun X, Zhang X, et al. Description of organ-specific phenotype, and functional characteristics of tissue resident lymphocytes from liver transplantation donor and research on immune tolerance mechanism of liver. Oncotarget. 2018;9:15552-15565 pubmed publisher
  262. Zhang C, Peng Y, Hublitz P, Zhang H, Dong T. Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy. Sci Rep. 2018;8:5549 pubmed publisher
  263. Panda S, Facchinetti V, Voynova E, Hanabuchi S, Karnell J, Hanna R, et al. Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. J Clin Invest. 2018;128:1873-1887 pubmed publisher
  264. Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed publisher
  265. Seki A, Rutz S. Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells. J Exp Med. 2018;215:985-997 pubmed publisher
  266. Hsieh W, Hsu T, Chang Y, Lai M. IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells. Nat Commun. 2018;9:463 pubmed publisher
  267. Huang S, Ren Y, Thomas A, Chan D, Mueller S, Ward A, et al. Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells. J Clin Invest. 2018;128:876-889 pubmed publisher
  268. Vo L, Kinney M, Liu X, Zhang Y, Barragan J, Sousa P, et al. Regulation of embryonic haematopoietic multipotency by EZH1. Nature. 2018;553:506-510 pubmed publisher
  269. Rivino L, Le Bert N, Gill U, Kunasegaran K, Cheng Y, Tan D, et al. Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation. J Clin Invest. 2018;128:668-681 pubmed publisher
  270. Pizzolla A, Nguyen T, Sant S, Jaffar J, Loudovaris T, Mannering S, et al. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018;128:721-733 pubmed publisher
  271. Gee M, Han A, Lofgren S, Beausang J, Mendoza J, Birnbaum M, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. 2018;172:549-563.e16 pubmed publisher
  272. Pugh J, Nemat Gorgani N, Norman P, Guethlein L, Parham P. Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage. J Immunol. 2018;200:1146-1158 pubmed publisher
  273. Amodio D, Cotugno N, Macchiarulo G, Rocca S, Dimopoulos Y, Castrucci M, et al. Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination. J Immunol. 2018;200:538-550 pubmed publisher
  274. Jasinski Bergner S, Büttner M, Quandt D, Seliger B, Kielstein H. Adiponectin and Its Receptors Are Differentially Expressed in Human Tissues and Cell Lines of Distinct Origin. Obes Facts. 2017;10:569-583 pubmed publisher
  275. Blom S, Paavolainen L, Bychkov D, Turkki R, Mäki Teeri P, Hemmes A, et al. Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis. Sci Rep. 2017;7:15580 pubmed publisher
  276. Moreno Cubero E, Subira D, Sanz de Villalobos E, Parra Cid T, Madejon A, Miquel J, et al. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity. J Virol. 2018;92: pubmed publisher
  277. Herndler Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M, et al. Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc Natl Acad Sci U S A. 2017;114:E9626-E9634 pubmed publisher
  278. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  279. Matos T, O Malley J, Lowry E, Hamm D, Kirsch I, Robins H, et al. Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing ?? T cell clones. J Clin Invest. 2017;127:4031-4041 pubmed publisher
  280. Liaskou E, Jeffery L, Chanouzas D, Soskic B, Seldin M, Harper L, et al. Genetic variation at the CD28 locus and its impact on expansion of pro-inflammatory CD28 negative T cells in healthy individuals. Sci Rep. 2017;7:7652 pubmed publisher
  281. Patel S, Sanjana N, Kishton R, Eidizadeh A, Vodnala S, Cam M, et al. Identification of essential genes for cancer immunotherapy. Nature. 2017;548:537-542 pubmed publisher
  282. Jiang X, Björkström N, Melum E. Intact CD100-CD72 Interaction Necessary for TCR-Induced T Cell Proliferation. Front Immunol. 2017;8:765 pubmed publisher
  283. Hensel M, Peng T, Cheng A, De Rosa S, Wald A, Laing K, et al. Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells. J Virol. 2017;91: pubmed publisher
  284. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed publisher
  285. Liszt K, Ley J, Lieder B, Behrens M, Stöger V, Reiner A, et al. Caffeine induces gastric acid secretion via bitter taste signaling in gastric parietal cells. Proc Natl Acad Sci U S A. 2017;114:E6260-E6269 pubmed publisher
  286. Ott P, Hu Z, Keskin D, Shukla S, Sun J, Bozym D, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547:217-221 pubmed publisher
  287. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  288. Meniailo M, Malashchenko V, Shmarov V, Gazatova N, Melashchenko O, Goncharov A, et al. Direct effects of interleukin-8 on growth and functional activity of T lymphocytes. Int Immunopharmacol. 2017;50:178-185 pubmed publisher
  289. Wu W, Grotefend C, Tsai M, Wang Y, Radic V, Eoh H, et al. ?20 IFITM2 differentially restricts X4 and R5 HIV-1. Proc Natl Acad Sci U S A. 2017;114:7112-7117 pubmed publisher
  290. Zheng C, Zheng L, Yoo J, Guo H, Zhang Y, Guo X, et al. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing. Cell. 2017;169:1342-1356.e16 pubmed publisher
  291. Sugimura R, Jha D, Han A, Soria Valles C, da Rocha E, Lu Y, et al. Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature. 2017;545:432-438 pubmed publisher
  292. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed publisher
  293. Chen C, Sun W, Chen J, Huang J. Dynamic variations of the peripheral blood immune cell subpopulation in patients with critical H7N9 swine-origin influenza A virus infection: A retrospective small-scale study. Exp Ther Med. 2017;13:1490-1494 pubmed publisher
  294. Stevanović S, Pasetto A, Helman S, Gartner J, Prickett T, Howie B, et al. Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer. Science. 2017;356:200-205 pubmed publisher
  295. Van Caeneghem Y, De Munter S, Tieppo P, Goetgeluk G, Weening K, Verstichel G, et al. Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities. Oncoimmunology. 2017;6:e1283460 pubmed publisher
  296. Dong P, Wen X, Liu J, Yan C, Yuan J, Luo L, et al. Simultaneous detection of decidual Th1/Th2 and NK1/NK2 immunophenotyping in unknown recurrent miscarriage using 8-color flow cytometry with FSC/Vt extended strategy. Biosci Rep. 2017;37: pubmed publisher
  297. Zanin Zhorov A, Weiss J, Trzeciak A, Chen W, Zhang J, Nyuydzefe M, et al. Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10. J Immunol. 2017;198:3809-3814 pubmed publisher
  298. Melis D, Carbone F, Minopoli G, La Rocca C, Perna F, De Rosa V, et al. Cutting Edge: Increased Autoimmunity Risk in Glycogen Storage Disease Type 1b Is Associated with a Reduced Engagement of Glycolysis in T Cells and an Impaired Regulatory T Cell Function. J Immunol. 2017;198:3803-3808 pubmed publisher
  299. Singh A, Subhi Y, Krogh Nielsen M, Falk M, Matzen S, Sellebjerg F, et al. Systemic frequencies of T helper 1 and T helper 17 cells in patients with age-related macular degeneration: A case-control study. Sci Rep. 2017;7:605 pubmed publisher
  300. Dowling D, van Haren S, Scheid A, Bergelson I, Kim D, Mancuso C, et al. TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth. JCI Insight. 2017;2:e91020 pubmed publisher
  301. Zhang J, Xu X, Shi M, Chen Y, Yu D, Zhao C, et al. CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. Oncoimmunology. 2017;6:e1258504 pubmed publisher
  302. van der Velden V, Flores Montero J, Perez Andres M, Martin Ayuso M, Crespo O, Blanco E, et al. Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples. J Immunol Methods. 2017;: pubmed publisher
  303. Bergström I, Lundberg A, Jonsson S, Särndahl E, Ernerudh J, Jonasson L. Annexin A1 in blood mononuclear cells from patients with coronary artery disease: Its association with inflammatory status and glucocorticoid sensitivity. PLoS ONE. 2017;12:e0174177 pubmed publisher
  304. Romani B, Kavyanifard A, Allahbakhshi E. Functional conservation and coherence of HIV-1 subtype A Vpu alleles. Sci Rep. 2017;7:44894 pubmed publisher
  305. Descours B, Petitjean G, López Zaragoza J, Bruel T, Raffel R, Psomas C, et al. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Nature. 2017;543:564-567 pubmed publisher
  306. Su S, Liao J, Liu J, Huang D, He C, Chen F, et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017;27:461-482 pubmed publisher
  307. Nishimura Y, Gautam R, Chun T, Sadjadpour R, Foulds K, Shingai M, et al. Early antibody therapy can induce long-lasting immunity to SHIV. Nature. 2017;543:559-563 pubmed publisher
  308. Klinker M, Marklein R, Lo Surdo J, Wei C, Bauer S. Morphological features of IFN-γ-stimulated mesenchymal stromal cells predict overall immunosuppressive capacity. Proc Natl Acad Sci U S A. 2017;114:E2598-E2607 pubmed publisher
  309. Li R, Rezk A, Li H, Gommerman J, Prat A, Bar Or A. Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses. J Immunol. 2017;198:3245-3254 pubmed publisher
  310. Pfaender S, Walter S, Grabski E, Todt D, Bruening J, Romero Brey I, et al. Immune protection against reinfection with nonprimate hepacivirus. Proc Natl Acad Sci U S A. 2017;114:E2430-E2439 pubmed publisher
  311. Botting R, Bertram K, Baharlou H, Sandgren K, Fletcher J, Rhodes J, et al. Phenotypic and functional consequences of different isolation protocols on skin mononuclear phagocytes. J Leukoc Biol. 2017;101:1393-1403 pubmed publisher
  312. Pinto Cardoso S, Lozupone C, Briceno O, Alva Hernández S, Téllez N, Adriana A, et al. Fecal Bacterial Communities in treated HIV infected individuals on two antiretroviral regimens. Sci Rep. 2017;7:43741 pubmed publisher
  313. Pardi N, Secreto A, Shan X, Debonera F, Glover J, Yi Y, et al. Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. Nat Commun. 2017;8:14630 pubmed publisher
  314. van der Geest K, Wang Q, Eijsvogels T, Koenen H, Joosten I, Brouwer E, et al. Changes in peripheral immune cell numbers and functions in octogenarian walkers - an acute exercise study. Immun Ageing. 2017;14:5 pubmed publisher
  315. Eyquem J, Mansilla Soto J, Giavridis T, van der Stegen S, Hamieh M, Cunanan K, et al. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection. Nature. 2017;543:113-117 pubmed publisher
  316. Szabo P, Goswami A, Mazzuca D, Kim K, O Gorman D, Hess D, et al. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. J Immunol. 2017;198:2805-2818 pubmed publisher
  317. Sullivan A, Wang E, Farrell J, Whitaker P, Faulkner L, Peckham D, et al. ?-Lactam hypersensitivity involves expansion of circulating and skin-resident TH22 cells. J Allergy Clin Immunol. 2018;141:235-249.e8 pubmed publisher
  318. Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang S, Marquardt N, et al. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity. 2017;46:287-300 pubmed publisher
  319. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed publisher
  320. Wouters K, Gaens K, Bijnen M, Verboven K, Jocken J, Wetzels S, et al. Circulating classical monocytes are associated with CD11c+ macrophages in human visceral adipose tissue. Sci Rep. 2017;7:42665 pubmed publisher
  321. Su S, Zou Z, Chen F, Ding N, Du J, Shao J, et al. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. Oncoimmunology. 2017;6:e1249558 pubmed publisher
  322. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  323. Watanabe N, Bajgain P, Sukumaran S, Ansari S, Heslop H, Rooney C, et al. Fine-tuning the CAR spacer improves T-cell potency. Oncoimmunology. 2016;5:e1253656 pubmed publisher
  324. Jeffery H, Jeffery L, Lutz P, Corrigan M, Webb G, Hirschfield G, et al. Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. Clin Exp Immunol. 2017;188:394-411 pubmed publisher
  325. Mylvaganam G, Rios D, Abdelaal H, Iyer S, Tharp G, Mavigner M, et al. Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection. Proc Natl Acad Sci U S A. 2017;114:1976-1981 pubmed publisher
  326. Asano T, Meguri Y, Yoshioka T, Kishi Y, Iwamoto M, Nakamura M, et al. PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy. Blood. 2017;129:2186-2197 pubmed publisher
  327. Rao D, Gurish M, Marshall J, Slowikowski K, Fonseka C, Liu Y, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542:110-114 pubmed publisher
  328. Martin Gayo E, Cronin J, Hickman T, Ouyang Z, Lindqvist M, Kolb K, et al. Circulating CXCR5+CXCR3+PD-1lo Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth. JCI Insight. 2017;2:e89574 pubmed publisher
  329. Parrot T, Oger R, Benlalam H, Raingeard de la Blétière D, Jouand N, Coutolleau A, et al. CD40L confers helper functions to human intra-melanoma class-I-restricted CD4+CD8+ double positive T cells. Oncoimmunology. 2016;5:e1250991 pubmed publisher
  330. Salvatori G, Foligno S, Sirleto P, Genovese S, Russo S, Coletti V, et al. Sometimes it is better to wait: First Italian case of a newborn with transient abnormal myelopoiesis and a favorable prognosis. Oncol Lett. 2017;13:191-195 pubmed publisher
  331. Shan Y, Qi C, Liu Y, Gao H, Zhao D, Jiang Y. Increased frequency of peripheral blood follicular helper T cells and elevated serum IL?21 levels in patients with knee osteoarthritis. Mol Med Rep. 2017;15:1095-1102 pubmed publisher
  332. An Q, Wang Y, Hu S, Fang D, Xuan C, Xu S, et al. Clinical significance of lymphocyte subset changes in hemophagocytic lymphohistiocytosis of children. Exp Ther Med. 2016;12:3549-3552 pubmed publisher
  333. Raposo R, de Mulder Rougvie M, Paquin Proulx D, Brailey P, Cabido V, Zdinak P, et al. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight. 2017;2:e85811 pubmed publisher
  334. Kim J, Kwon C, Joh J, Sinn D, Choi G, Park J, et al. Differences in Peripheral Blood Lymphocytes between Brand-Name and Generic Tacrolimus Used in Stable Liver Transplant Recipients. Med Princ Pract. 2017;26:221-228 pubmed publisher
  335. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  336. Nasu K, Yamaguchi K, Takanashi T, Tamai K, Sato I, Ine S, et al. Crucial role of carbonic anhydrase IX in tumorigenicity of xenotransplanted adult T-cell leukemia-derived cells. Cancer Sci. 2017;108:435-443 pubmed publisher
  337. Wonderlich E, Swan Z, Bissel S, Hartman A, Carney J, O Malley K, et al. Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques. J Immunol. 2017;198:1616-1626 pubmed publisher
  338. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed publisher
  339. Bolzoni M, Ronchetti D, Storti P, Donofrio G, Marchica V, Costa F, et al. IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts. Haematologica. 2017;102:773-784 pubmed publisher
  340. Kinosada H, Yasunaga J, Shimura K, Miyazato P, Onishi C, Iyoda T, et al. HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors. PLoS Pathog. 2017;13:e1006120 pubmed publisher
  341. Roberts E, Carnathan D, Li H, Shaw G, Silvestri G, Betts M. Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques. PLoS Pathog. 2016;12:e1006135 pubmed publisher
  342. Boardman D, Philippeos C, Fruhwirth G, Ibrahim M, Hannen R, Cooper D, et al. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection. Am J Transplant. 2017;17:931-943 pubmed publisher
  343. Stanfield B, Pahar B, Chouljenko V, Veazey R, Kousoulas K. Vaccination of rhesus macaques with the live-attenuated HSV-1 vaccine VC2 stimulates the proliferation of mucosal T cells and germinal center responses resulting in sustained production of highly neutralizing antibodies. Vaccine. 2017;35:536-543 pubmed publisher
  344. Berry N, Manoussaka M, Ham C, Ferguson D, Tudor H, Mattiuzzo G, et al. Role of Occult and Post-acute Phase Replication in Protective Immunity Induced with a Novel Live Attenuated SIV Vaccine. PLoS Pathog. 2016;12:e1006083 pubmed publisher
  345. Wahl S, Drong A, Lehne B, Loh M, Scott W, Kunze S, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature. 2017;541:81-86 pubmed publisher
  346. Van Puyenbroeck V, Claeys E, Schols D, Bell T, Vermeire K. A Proteomic Survey Indicates Sortilin as a Secondary Substrate of the ER Translocation Inhibitor Cyclotriazadisulfonamide (CADA). Mol Cell Proteomics. 2017;16:157-167 pubmed publisher
  347. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  348. Spivak A, Larragoite E, Coletti M, Macedo A, Martins L, Bosque A, et al. Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivo. Retrovirology. 2016;13:88 pubmed publisher
  349. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed publisher
  350. Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, et al. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017;127:260-268 pubmed publisher
  351. Matsuoka Y, Takahashi M, Sumide K, Kawamura H, Nakatsuka R, Fujioka T, et al. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells. Cell Transplant. 2017;26:1043-1058 pubmed publisher
  352. Lévy R, Okada S, Béziat V, Moriya K, Liu C, Chai L, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci U S A. 2016;113:E8277-E8285 pubmed publisher
  353. Zhu H, Hu F, Sun X, Zhang X, Zhu L, Liu X, et al. CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus. Front Immunol. 2016;7:512 pubmed
  354. Zhu Y, Li M, Bo C, Liu X, Zhang J, Li Z, et al. Prognostic significance of the lymphocyte-to-monocyte ratio and the tumor-infiltrating lymphocyte to tumor-associated macrophage ratio in patients with stage T3N0M0 esophageal squamous cell carcinoma. Cancer Immunol Immunother. 2017;66:343-354 pubmed publisher
  355. Wei C, Mei J, Tang L, Liu Y, Li D, Li M, et al. 1-Methyl-tryptophan attenuates regulatory T cells differentiation due to the inhibition of estrogen-IDO1-MRC2 axis in endometriosis. Cell Death Dis. 2016;7:e2489 pubmed publisher
  356. Ribeiro S, Tesio M, Ribot J, Macintyre E, Barata J, Silva Santos B. Casein kinase 2 controls the survival of normal thymic and leukemic ?? T cells via promotion of AKT signaling. Leukemia. 2017;31:1603-1610 pubmed publisher
  357. Briceno O, Pinto Cardoso S, Rodríguez Bernabe N, Murakami Ogasawara A, Reyes Teran G. Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment. PLoS ONE. 2016;11:e0166496 pubmed publisher
  358. Cecchinato V, Bernasconi E, Speck R, Proietti M, Sauermann U, D Agostino G, et al. Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization. J Immunol. 2017;198:184-195 pubmed
  359. Rathod K, Kapil V, Velmurugan S, Khambata R, Siddique U, Khan S, et al. Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans. J Clin Invest. 2017;127:169-182 pubmed publisher
  360. Snyder Mackler N, Sanz J, Kohn J, Brinkworth J, Morrow S, Shaver A, et al. Social status alters immune regulation and response to infection in macaques. Science. 2016;354:1041-1045 pubmed
  361. He J, Lian C, Fang Y, Wu J, Zhou H, Ye X. The influence of exendin-4 intervention on -obese diabetic mouse blood and the pancreatic tissue immune microenvironment. Exp Ther Med. 2016;12:2893-2898 pubmed
  362. Baker J, Nederveen J, Parise G. Aerobic exercise in humans mobilizes HSCs in an intensity-dependent manner. J Appl Physiol (1985). 2017;122:182-190 pubmed publisher
  363. Ye C, Wang W, Cheng L, Li G, Wen M, Wang Q, et al. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice. J Virol. 2017;91: pubmed publisher
  364. Siegers G, Barreira C, Postovit L, Dekaban G. CD11d ?2 integrin expression on human NK, B, and ?? T cells. J Leukoc Biol. 2017;101:1029-1035 pubmed publisher
  365. Garcia Mesa Y, Jay T, Checkley M, Luttge B, Dobrowolski C, Valadkhan S, et al. Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system. J Neurovirol. 2017;23:47-66 pubmed publisher
  366. Riou C, Bunjun R, Müller T, Kiravu A, Ginbot Z, Oni T, et al. Selective reduction of IFN-γ single positive mycobacteria-specific CD4+ T cells in HIV-1 infected individuals with latent tuberculosis infection. Tuberculosis (Edinb). 2016;101:25-30 pubmed publisher
  367. Hippen K, Watkins B, Tkachev V, Lemire A, Lehnen C, Riddle M, et al. Preclinical Testing of Antihuman CD28 Fab' Antibody in a Novel Nonhuman Primate Small Animal Rodent Model of Xenogenic Graft-Versus-Host Disease. Transplantation. 2016;100:2630-2639 pubmed publisher
  368. Li J, Shayan G, Avery L, Jie H, Gildener Leapman N, Schmitt N, et al. Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk. Oncoimmunology. 2016;5:e1200778 pubmed
  369. Galindo Albarrán A, López Portales O, Gutiérrez Reyna D, Rodríguez Jorge O, Sánchez Villanueva J, Ramirez Pliego O, et al. CD8+ T Cells from Human Neonates Are Biased toward an Innate Immune Response. Cell Rep. 2016;17:2151-2160 pubmed publisher
  370. Weingartner E, Courneya J, Keegan A, Golding A. A novel method for assaying human regulatory T cell direct suppression of B cell effector function. J Immunol Methods. 2017;441:1-7 pubmed publisher
  371. Sherbenou D, Aftab B, Su Y, Behrens C, Wiita A, Logan A, et al. Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. J Clin Invest. 2016;126:4640-4653 pubmed publisher
  372. Ju X, Silveira P, Hsu W, Elgundi Z, Alingcastre R, Verma N, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016;197:4613-4625 pubmed
  373. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  374. Chen D, Ireland S, Remington G, Alvarez E, Racke M, Greenberg B, et al. CD40-Mediated NF-?B Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics. J Immunol. 2016;197:4257-4265 pubmed
  375. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  376. Michailidou I, Naessens D, Hametner S, Guldenaar W, Kooi E, Geurts J, et al. Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis. Glia. 2017;65:264-277 pubmed publisher
  377. Kaewkangsadan V, Verma C, Eremin J, Cowley G, Ilyas M, Eremin O. Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer. J Immunol Res. 2016;2016:4757405 pubmed
  378. Adair J, Waters T, Haworth K, Kubek S, Trobridge G, Hocum J, et al. Semi-automated closed system manufacturing of lentivirus gene-modified haematopoietic stem cells for gene therapy. Nat Commun. 2016;7:13173 pubmed publisher
  379. Nagase H, Takeoka T, Urakawa S, Morimoto Okazawa A, Kawashima A, Iwahori K, et al. ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140:686-695 pubmed publisher
  380. Byrareddy S, Arthos J, Cicala C, Villinger F, Ortiz K, Little D, et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy. Science. 2016;354:197-202 pubmed
  381. Swaminathan G, Thoryk E, Cox K, Smith J, Wolf J, Gindy M, et al. A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates. Sci Rep. 2016;6:34215 pubmed publisher
  382. Oon S, Huynh H, Tai T, Ng M, Monaghan K, Biondo M, et al. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 2016;1:e86131 pubmed publisher
  383. Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, et al. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. Proc Natl Acad Sci U S A. 2016;113:E6467-E6475 pubmed
  384. Roybal K, Williams J, Morsut L, Rupp L, Kolinko I, Choe J, et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016;167:419-432.e16 pubmed publisher
  385. Puerta Arias J, Pino Tamayo P, Arango J, Gonzalez A. Depletion of Neutrophils Promotes the Resolution of Pulmonary Inflammation and Fibrosis in Mice Infected with Paracoccidioides brasiliensis. PLoS ONE. 2016;11:e0163985 pubmed publisher
  386. Trautz B, Pierini V, Wombacher R, Stolp B, Chase A, Pizzato M, et al. The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor. J Virol. 2016;90:10915-10927 pubmed publisher
  387. Maria N, Steenwijk E, IJpma A, van Helden Meeuwsen C, Vogelsang P, Beumer W, et al. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome. Ann Rheum Dis. 2017;76:721-730 pubmed publisher
  388. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  389. Sugita S, Iwasaki Y, Makabe K, Kimura T, Futagami T, Suegami S, et al. Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors. Stem Cell Reports. 2016;7:619-634 pubmed publisher
  390. Klarquist J, Tobin K, Farhangi Oskuei P, Henning S, Fernandez M, Dellacecca E, et al. Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma. Cancer Res. 2016;76:6230-6240 pubmed
  391. Wahid R, Fresnay S, Levine M, Sztein M. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Clin Immunol. 2016;173:87-95 pubmed publisher
  392. Gaido C, Stone S, Chopra A, Thomas W, LE SOUEF P, Hales B. Immunodominant T-Cell Epitopes in the VP1 Capsid Protein of Rhinovirus Species A and C. J Virol. 2016;90:10459-10471 pubmed publisher
  393. Foerster F, Bamberger D, Schupp J, Weilbächer M, Kaps L, Strobl S, et al. Dextran-based therapeutic nanoparticles for hepatic drug delivery. Nanomedicine (Lond). 2016;11:2663-2677 pubmed
  394. George J, Saito M, Tsuta K, Iwakawa R, Shiraishi K, Scheel A, et al. Genomic Amplification of CD274 (PD-L1) in Small-Cell Lung Cancer. Clin Cancer Res. 2017;23:1220-1226 pubmed publisher
  395. Nerdal P, Peters C, Oberg H, Zlatev H, Lettau M, Quabius E, et al. Butyrophilin 3A/CD277-Dependent Activation of Human ?? T Cells: Accessory Cell Capacity of Distinct Leukocyte Populations. J Immunol. 2016;197:3059-3068 pubmed
  396. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed publisher
  397. Kim W, Jung H, Nam S, Kim T, Heo D, Kim C, et al. Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis. Virchows Arch. 2016;469:581-590 pubmed
  398. Zenarruzabeitia O, Vitallé J, Garcia Obregon S, Astigarraga I, Eguizabal C, Santos S, et al. The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults. Sci Rep. 2016;6:32693 pubmed publisher
  399. Deng Y, Cheng J, Fu B, Liu W, Chen G, Zhang Q, et al. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Oncogene. 2017;36:1090-1101 pubmed publisher
  400. Ferre E, Rose S, Rosenzweig S, Burbelo P, Romito K, Niemela J, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016;1: pubmed
  401. Jiang J, Chen X, An H, Yang B, Zhang F, Cheng X. Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling. Sci Rep. 2016;6:32320 pubmed publisher
  402. Ilkovitch D, Ferris L. Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules. Mol Med Rep. 2016;14:3935-40 pubmed publisher
  403. Landtwing V, Raykova A, Pezzino G, Beziat V, Marcenaro E, Graf C, et al. Cognate HLA absence in trans diminishes human NK cell education. J Clin Invest. 2016;126:3772-3782 pubmed publisher
  404. Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, et al. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J Clin Invest. 2016;126:3479-94 pubmed publisher
  405. Kmiec D, Iyer S, Stürzel C, Sauter D, Hahn B, Kirchhoff F. Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance. MBio. 2016;7: pubmed publisher
  406. Chopra M, Biehl M, Steinfatt T, Brandl A, Kums J, Amich J, et al. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J Exp Med. 2016;213:1881-900 pubmed publisher
  407. Daud A, Loo K, Pauli M, Sanchez Rodriguez R, Sandoval P, Taravati K, et al. Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma. J Clin Invest. 2016;126:3447-52 pubmed publisher
  408. La Porta J, Matus Nicodemos R, Valentin Acevedo A, Covey L. The RNA-Binding Protein, Polypyrimidine Tract-Binding Protein 1 (PTBP1) Is a Key Regulator of CD4 T Cell Activation. PLoS ONE. 2016;11:e0158708 pubmed publisher
  409. Xing Y, Cao R, Hu H. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles). Cell Death Dis. 2016;7:e2322 pubmed publisher
  410. Manickam C, Rajakumar P, Wachtman L, Kramer J, Martinot A, Varner V, et al. Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection. J Virol. 2016;90:9153-62 pubmed publisher
  411. Godinho Santos A, Hance A, Gonçalves J, Mammano F. CIB1 and CIB2 are HIV-1 helper factors involved in viral entry. Sci Rep. 2016;6:30927 pubmed publisher
  412. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed publisher
  413. Cheng H, Gaddis D, Wu R, McSkimming C, Haynes L, Taylor A, et al. Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J Clin Invest. 2016;126:3236-46 pubmed publisher
  414. Paquin Proulx D, Gibbs A, Bachle S, Checa A, Introini A, Leeansyah E, et al. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion. J Immunol. 2016;197:1843-51 pubmed publisher
  415. Debliquis A, Voirin J, Harzallah I, Maurer M, Lerintiu F, Drenou B, et al. Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B-cell lymphoma of the central nervous system. Cytometry B Clin Cytom. 2018;94:182-188 pubmed publisher
  416. Chen H, Händel N, Ngeow J, Muller J, Huhn M, Yang H, et al. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol. 2017;139:607-620.e15 pubmed publisher
  417. Hirayama M, Tomita Y, Yuno A, Tsukamoto H, Senju S, Imamura Y, et al. An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs. Oncoimmunology. 2016;5:e1123368 pubmed publisher
  418. Ashizawa T, Iizuka A, Nonomura C, Kondou R, Maeda C, Miyata H, et al. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse. Clin Cancer Res. 2017;23:149-158 pubmed publisher
  419. DeGottardi M, Okoye A, Vaidya M, Talla A, Konfe A, Reyes M, et al. Effect of Anti-IL-15 Administration on T Cell and NK Cell Homeostasis in Rhesus Macaques. J Immunol. 2016;197:1183-98 pubmed publisher
  420. Fromentin R, Bakeman W, Lawani M, Khoury G, Hartogensis W, DaFonseca S, et al. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART. PLoS Pathog. 2016;12:e1005761 pubmed publisher
  421. Suliman S, Geldenhuys H, Johnson J, Hughes J, Smit E, Murphy M, et al. Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses. J Immunol. 2016;197:1100-1110 pubmed publisher
  422. Piepenbrink M, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, et al. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS ONE. 2016;11:e0158641 pubmed publisher
  423. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed publisher
  424. Brinkman C, Iwami D, Hritzo M, Xiong Y, Ahmad S, Simon T, et al. Treg engage lymphotoxin beta receptor for afferent lymphatic transendothelial migration. Nat Commun. 2016;7:12021 pubmed publisher
  425. Williams D, Engle E, Shirk E, Queen S, Gama L, Mankowski J, et al. Splenic Damage during SIV Infection: Role of T-Cell Depletion and Macrophage Polarization and Infection. Am J Pathol. 2016;186:2068-2087 pubmed publisher
  426. Fu T, Yang W, Zhang X, Xu X. Peripheral T-cell lymphoma unspecified type presenting with a pneumothorax as the initial manifestation: A case report and literature review. Oncol Lett. 2016;11:4069-4076 pubmed
  427. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  428. Xu Y, Chaudhury A, Zhang M, Savoldo B, Metelitsa L, Rodgers J, et al. Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J Clin Invest. 2016;126:2678-88 pubmed publisher
  429. Coulon P, Richetta C, Rouers A, Blanchet F, Urrutia A, Guerbois M, et al. HIV-Infected Dendritic Cells Present Endogenous MHC Class II-Restricted Antigens to HIV-Specific CD4+ T Cells. J Immunol. 2016;197:517-32 pubmed publisher
  430. Domingues R, de Carvalho G, Aoki V, da Silva Duarte A, Sato M. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus. J Transl Med. 2016;14:171 pubmed publisher
  431. Seumois G, Zapardiel Gonzalo J, White B, Singh D, Schulten V, Dillon M, et al. Transcriptional Profiling of Th2 Cells Identifies Pathogenic Features Associated with Asthma. J Immunol. 2016;197:655-64 pubmed publisher
  432. Ramos C, Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, et al. Clinical responses with T lymphocytes targeting malignancy-associated ? light chains. J Clin Invest. 2016;126:2588-96 pubmed publisher
  433. Ma Q, Garber H, Lu S, He H, Tallis E, Ding X, et al. A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells. Cytotherapy. 2016;18:985-94 pubmed publisher
  434. Najjar A, Manuri P, Olivares S, Flores L, Mi T, Huls H, et al. Imaging of Sleeping Beauty-Modified CD19-Specific T Cells Expressing HSV1-Thymidine Kinase by Positron Emission Tomography. Mol Imaging Biol. 2016;18:838-848 pubmed
  435. van der Heiden M, van Zelm M, Bartol S, de Rond L, Berbers G, Boots A, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6:26892 pubmed publisher
  436. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  437. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed publisher
  438. Hall G, Cullen E, Sawmynaden K, Arnold J, Fox S, Cowan R, et al. Structure of a Potential Therapeutic Antibody Bound to Interleukin-16 (IL-16): MECHANISTIC INSIGHTS AND NEW THERAPEUTIC OPPORTUNITIES. J Biol Chem. 2016;291:16840-8 pubmed publisher
  439. Chu H, Khosravi A, Kusumawardhani I, Kwon A, Vasconcelos A, Cunha L, et al. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science. 2016;352:1116-20 pubmed publisher
  440. Wang H, Schuetz C, Arima A, Chihaya Y, Weinbauer G, Habermann G, et al. Assessment of placental transfer and the effect on embryo-fetal development of a humanized monoclonal antibody targeting lymphotoxin-alpha in non-human primates. Reprod Toxicol. 2016;63:82-95 pubmed publisher
  441. Akyol Erikci A, Karagoz B, Bilgi O. Regulatory T Cells in Patients with Idiopathic Thrombocytopenic Purpura. Turk J Haematol. 2016;33:153-5 pubmed publisher
  442. Patel M, Kim J, Theodros D, Tam A, Velarde E, Kochel C, et al. Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma. J Immunother Cancer. 2016;4:28 pubmed publisher
  443. Dou D, Calvanese V, Sierra M, Nguyen A, Minasian A, Saarikoski P, et al. Medial HOXA genes demarcate haematopoietic stem cell fate during human development. Nat Cell Biol. 2016;18:595-606 pubmed publisher
  444. Theorell J, Bryceson Y. Analysis of Intracellular Ca(2+) Mobilization in Human NK Cell Subsets by Flow Cytometry. Methods Mol Biol. 2016;1441:117-30 pubmed publisher
  445. LaMere S, Thompson R, Komori H, Mark A, Salomon D. Promoter H3K4 methylation dynamically reinforces activation-induced pathways in human CD4 T cells. Genes Immun. 2016;17:283-97 pubmed publisher
  446. Stikvoort A, Sundin M, Uzunel M, Gertow J, Sundberg B, Schaffer M, et al. Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?. PLoS ONE. 2016;11:e0154737 pubmed publisher
  447. Ruibal P, Oestereich L, Lüdtke A, Becker Ziaja B, Wozniak D, Kerber R, et al. Unique human immune signature of Ebola virus disease in Guinea. Nature. 2016;533:100-4 pubmed publisher
  448. Cook A, McDonnell A, Lake R, Nowak A. Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology. 2016;5:e1066062 pubmed
  449. Harper I, Ali J, Harper S, Wlodek E, Alsughayyir J, Negus M, et al. Augmentation of Recipient Adaptive Alloimmunity by Donor Passenger Lymphocytes within the Transplant. Cell Rep. 2016;15:1214-27 pubmed publisher
  450. Liao R, Jiang N, Tang Z, Li D, Huang P, Luo S, et al. Systemic and intratumoral balances between monocytes/macrophages and lymphocytes predict prognosis in hepatocellular carcinoma patients after surgery. Oncotarget. 2016;7:30951-61 pubmed publisher
  451. Rapiteanu R, Davis L, Williamson J, Timms R, Paul Luzio J, Lehner P. A Genetic Screen Identifies a Critical Role for the WDR81-WDR91 Complex in the Trafficking and Degradation of Tetherin. Traffic. 2016;17:940-58 pubmed publisher
  452. Siddiqui I, Erreni M, van Brakel M, Debets R, Allavena P. Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient. J Immunother Cancer. 2016;4:21 pubmed publisher
  453. Fu D, Song X, Hu H, Sun M, Li Z, Tian Z. Downregulation of RUNX3 moderates the frequency of Th17 and Th22 cells in patients with psoriasis. Mol Med Rep. 2016;13:4606-12 pubmed publisher
  454. Yamashita K, Kawata K, Matsumiya H, Kamekura R, Jitsukawa S, Nagaya T, et al. Bob1 limits cellular frequency of T-follicular helper cells. Eur J Immunol. 2016;46:1361-70 pubmed publisher
  455. Zurawski G, Zurawski S, Flamar A, Richert L, Wagner R, Tomaras G, et al. Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques. PLoS ONE. 2016;11:e0153484 pubmed publisher
  456. Goldstein J, Burlion A, Zaragoza B, Sendeyo K, Polansky J, Huehn J, et al. Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression. PLoS ONE. 2016;11:e0153682 pubmed publisher
  457. Mohiuddin M, Singh A, Corcoran P, Thomas Iii M, Clark T, Lewis B, et al. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft. Nat Commun. 2016;7:11138 pubmed publisher
  458. Nakatsugawa M, Rahman M, Yamashita Y, Ochi T, Wnuk P, Tanaka S, et al. CD4(+) and CD8(+) TCR? repertoires possess different potentials to generate extraordinarily high-avidity T cells. Sci Rep. 2016;6:23821 pubmed publisher
  459. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
  460. Slebioda T, Bojarska Junak A, Cyman M, Landowski P, Kaminska B, Celinski K, et al. Expression of death receptor 3 on peripheral blood mononuclear cells differes in adult IBD patients and children with newly diagnosed IBD. Cytometry B Clin Cytom. 2017;92:165-169 pubmed publisher
  461. Macdonald K, Hoeppli R, Huang Q, Gillies J, Luciani D, Orban P, et al. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor. J Clin Invest. 2016;126:1413-24 pubmed publisher
  462. Moura J, Rodrigues J, Goncalves M, Amaral C, Lima M, Carvalho E. Impaired T-cell differentiation in diabetic foot ulceration. Cell Mol Immunol. 2017;14:758-769 pubmed publisher
  463. van der Burgh R, Meeldijk J, Jongeneel L, Frenkel J, Bovenschen N, van Gijn M, et al. Reduced serpinB9-mediated caspase-1 inhibition can contribute to autoinflammatory disease. Oncotarget. 2016;7:19265-71 pubmed publisher
  464. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  465. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed publisher
  466. Vermeulen J, Van Hecke W, Spliet W, Villacorta Hidalgo J, Fisch P, Broekhuizen R, et al. Pediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme Inhibitors. PLoS ONE. 2016;11:e0151465 pubmed publisher
  467. Matsumoto H, Thike A, Li H, Yeong J, Koo S, Dent R, et al. Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer. Breast Cancer Res Treat. 2016;156:237-47 pubmed publisher
  468. Thibaudin M, Chaix M, Boidot R, Végran F, Derangère V, Limagne E, et al. Human ectonucleotidase-expressing CD25high Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions. Oncoimmunology. 2016;5:e1055444 pubmed
  469. Leitch C, Natafji E, Yu C, Abdul Ghaffar S, Madarasingha N, Venables Z, et al. Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. J Allergy Clin Immunol. 2016;138:482-490.e7 pubmed publisher
  470. Hogan L, Jones D, Allen R. Expression of the innate immune receptor LILRB5 on monocytes is associated with mycobacteria exposure. Sci Rep. 2016;6:21780 pubmed publisher
  471. Liu L, Sommermeyer D, Cabanov A, Kosasih P, Hill T, Riddell S. Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapy. Nat Biotechnol. 2016;34:430-4 pubmed publisher
  472. Clemente Casares X, Blanco J, Ambalavanan P, Yamanouchi J, Singha S, Fandos C, et al. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature. 2016;530:434-40 pubmed publisher
  473. Procaccini C, Carbone F, Di Silvestre D, Brambilla F, De Rosa V, Galgani M, et al. The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements. Immunity. 2016;44:406-21 pubmed publisher
  474. Phuah J, Wong E, Gideon H, Maiello P, Coleman M, Hendricks M, et al. Effects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques. Infect Immun. 2016;84:1301-1311 pubmed publisher
  475. Trivedi P, Bruns T, Ward S, Mai M, Schmidt C, Hirschfield G, et al. Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity. J Autoimmun. 2016;68:98-104 pubmed publisher
  476. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed publisher
  477. Muller L, Mitsuhashi M, Simms P, Gooding W, Whiteside T. Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets. Sci Rep. 2016;6:20254 pubmed publisher
  478. Veazey R, Pilch Cooper H, Hope T, Alter G, Carias A, Sips M, et al. Prevention of SHIV transmission by topical IFN-β treatment. Mucosal Immunol. 2016;9:1528-1536 pubmed publisher
  479. Llibre A, López Macías C, Marafioti T, Mehta H, Partridge A, Kanzig C, et al. LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation. J Immunol. 2016;196:2085-94 pubmed publisher
  480. Su S, Hu B, Shao J, Shen B, Du J, Du Y, et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep. 2016;6:20070 pubmed publisher
  481. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed publisher
  482. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed publisher
  483. Di Meglio P, Villanova F, Navarini A, Mylonas A, Tosi I, Nestle F, et al. Targeting CD8(+) T cells prevents psoriasis development. J Allergy Clin Immunol. 2016;138:274-276.e6 pubmed publisher
  484. Vargas Inchaustegui D, Demers A, Shaw J, Kang G, Ball D, Tuero I, et al. Vaccine Induction of Lymph Node-Resident Simian Immunodeficiency Virus Env-Specific T Follicular Helper Cells in Rhesus Macaques. J Immunol. 2016;196:1700-10 pubmed publisher
  485. Dieckmann N, Hackmann Y, Aricò M, Griffiths G. Munc18-2 is required for Syntaxin 11 Localization on the Plasma Membrane in Cytotoxic T-Lymphocytes. Traffic. 2015;16:1330-41 pubmed publisher
  486. Hosseini A, Hirota J, Hackett T, McNagny K, Wilson S, Carlsten C. Morphometric analysis of inflammation in bronchial biopsies following exposure to inhaled diesel exhaust and allergen challenge in atopic subjects. Part Fibre Toxicol. 2016;13:2 pubmed publisher
  487. Soh K, Tario J, Colligan S, Maguire O, Pan D, Minderman H, et al. Simultaneous, Single-Cell Measurement of Messenger RNA, Cell Surface Proteins, and Intracellular Proteins. Curr Protoc Cytom. 2016;75:7.45.1-7.45.33 pubmed publisher
  488. Yasuma K, Yasunaga J, Takemoto K, Sugata K, Mitobe Y, Takenouchi N, et al. HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT). PLoS Pathog. 2016;12:e1005372 pubmed publisher
  489. Gonzalez S, Taborda N, Correa L, Castro G, Hernandez J, Montoya C, et al. Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS. Immunol Res. 2016;64:765-74 pubmed publisher
  490. Bjerg Christensen A, Dige A, Vad Nielsen J, Brinkmann C, Bendix M, Østergaard L, et al. Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients. Mediators Inflamm. 2015;2015:120605 pubmed publisher
  491. Egan C, Sodhi C, Good M, Lin J, Jia H, Yamaguchi Y, et al. Toll-like receptor 4-mediated lymphocyte influx induces neonatal necrotizing enterocolitis. J Clin Invest. 2016;126:495-508 pubmed
  492. Paris R, Petrovas C, Ferrando Martinez S, Moysi E, Boswell K, Archer E, et al. Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression. PLoS ONE. 2015;10:e0144767 pubmed publisher
  493. von Moltke J, Ji M, Liang H, Locksley R. Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit. Nature. 2016;529:221-5 pubmed publisher
  494. Westman J, Papareddy P, Dahlgren M, Chakrakodi B, Norrby Teglund A, Smeds E, et al. Extracellular Histones Induce Chemokine Production in Whole Blood Ex Vivo and Leukocyte Recruitment In Vivo. PLoS Pathog. 2015;11:e1005319 pubmed publisher
  495. Yamagishi M, Katano H, Hishima T, Shimoyama T, Ota Y, Nakano K, et al. Coordinated loss of microRNA group causes defenseless signaling in malignant lymphoma. Sci Rep. 2015;5:17868 pubmed publisher
  496. Bolton D, Pegu A, Wang K, McGinnis K, Nason M, Foulds K, et al. Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs. J Virol. 2016;90:1321-32 pubmed publisher
  497. Günther S, Ostheimer C, Stangl S, Specht H, Mózes P, Jesinghaus M, et al. Correlation of Hsp70 Serum Levels with Gross Tumor Volume and Composition of Lymphocyte Subpopulations in Patients with Squamous Cell and Adeno Non-Small Cell Lung Cancer. Front Immunol. 2015;6:556 pubmed publisher
  498. Langer S, Hopfensperger K, Iyer S, Kreider E, Learn G, Lee L, et al. A Naturally Occurring rev1-vpu Fusion Gene Does Not Confer a Fitness Advantage to HIV-1. PLoS ONE. 2015;10:e0142118 pubmed publisher
  499. Vierboom M, Breedveld E, Kap Y, Mary C, Poirier N, t Hart B, et al. Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis. Clin Exp Immunol. 2016;183:405-18 pubmed publisher
  500. Deisting W, Raum T, Kufer P, Baeuerle P, Münz M. Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110. PLoS ONE. 2015;10:e0141669 pubmed publisher
  501. Laborel Préneron E, Bianchi P, Boralevi F, Lehours P, Fraysse F, Morice Picard F, et al. Effects of the Staphylococcus aureus and Staphylococcus epidermidis Secretomes Isolated from the Skin Microbiota of Atopic Children on CD4+ T Cell Activation. PLoS ONE. 2015;10:e0141067 pubmed publisher
  502. Arvey A, van der Veeken J, Plitas G, Rich S, Concannon P, Rudensky A. Genetic and epigenetic variation in the lineage specification of regulatory T cells. elife. 2015;4:e07571 pubmed publisher
  503. Ren H, Li F, Tian C, Nie H, Wang L, Li H, et al. Inhibition of Proteasome Activity by Low-dose Bortezomib Attenuates Angiotensin II-induced Abdominal Aortic Aneurysm in Apo E(-/-) Mice. Sci Rep. 2015;5:15730 pubmed publisher
  504. van Nierop G, Janssen M, Mitterreiter J, van de Vijver D, De Swart R, Haagmans B, et al. Intrathecal CD4(+) and CD8(+) T-cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients. Eur J Immunol. 2016;46:347-53 pubmed publisher
  505. Reeder J, Kwak Y, McNamara R, Forst C, D Orso I. HIV Tat controls RNA Polymerase II and the epigenetic landscape to transcriptionally reprogram target immune cells. elife. 2015;4: pubmed publisher
  506. Akhmetzyanova I, Drabczyk M, Neff C, Gibbert K, Dietze K, Werner T, et al. PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing. PLoS Pathog. 2015;11:e1005224 pubmed publisher
  507. Spiesberger K, Paulfranz F, Egger A, Reiser J, Vogl C, Rudolf Scholik J, et al. Large-Scale Purification of r28M: A Bispecific scFv Antibody Targeting Human Melanoma Produced in Transgenic Cattle. PLoS ONE. 2015;10:e0140471 pubmed publisher
  508. Heigele A, Joas S, Regensburger K, Kirchhoff F. Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levels. Retrovirology. 2015;12:86 pubmed publisher
  509. Monahan R, Stein A, Gibbs K, Bank M, Bloom O. Circulating T cell subsets are altered in individuals with chronic spinal cord injury. Immunol Res. 2015;63:3-10 pubmed publisher
  510. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed publisher
  511. Zhao L, Li C, Jin P, Ng C, Lin Z, Li Y, et al. Histopathological features of sinonasal inverted papillomas in chinese patients. Laryngoscope. 2016;126:E141-7 pubmed publisher
  512. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed publisher
  513. Banat G, Tretyn A, Pullamsetti S, Wilhelm J, Weigert A, Olesch C, et al. Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma. PLoS ONE. 2015;10:e0139073 pubmed publisher
  514. Frederiksen J, Buggert M, Noyan K, Nowak P, Sönnerborg A, Lund O, et al. Multidimensional Clusters of CD4+ T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV Infection. PLoS ONE. 2015;10:e0137635 pubmed publisher
  515. Bézie S, Picarda E, Ossart J, Tesson L, Usal C, Renaudin K, et al. IL-34 is a Treg-specific cytokine and mediates transplant tolerance. J Clin Invest. 2015;125:3952-64 pubmed publisher
  516. Bego M, Côté Ã, Cohen Ã. Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System. J Vis Exp. 2015;: pubmed publisher
  517. Rodríguez Muñoz R, Cárdenas Aguayo M, Alemán V, Osorio B, Chávez González O, Rendon A, et al. Novel Nuclear Protein Complexes of Dystrophin 71 Isoforms in Rat Cultured Hippocampal GABAergic and Glutamatergic Neurons. PLoS ONE. 2015;10:e0137328 pubmed publisher
  518. Broos C, van Nimwegen M, Kleinjan A, Ten Berge B, Muskens F, In t Veen J, et al. Impaired survival of regulatory T cells in pulmonary sarcoidosis. Respir Res. 2015;16:108 pubmed publisher
  519. Gao Y, Zhang M, Li J, Yang M, Liu Y, Guo X, et al. Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation. PLoS ONE. 2015;10:e0137881 pubmed publisher
  520. Campi Azevedo A, Costa Pereira C, Antonelli L, Fonseca C, Teixeira Carvalho A, Villela Rezende G, et al. Booster dose after 10 years is recommended following 17DD-YF primary vaccination. Hum Vaccin Immunother. 2016;12:491-502 pubmed publisher
  521. Andersson K, Brisslert M, Cavallini N, Svensson M, Welin A, Erlandsson M, et al. Survivin co-ordinates formation of follicular T-cells acting in synergy with Bcl-6. Oncotarget. 2015;6:20043-57 pubmed
  522. Gao T, Ng C, Li C, Li Y, Duan C, Shen L, et al. Smoking is an independent association of squamous metaplasia in Chinese nasal polyps. Int Forum Allergy Rhinol. 2016;6:66-74 pubmed publisher
  523. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed publisher
  524. Japp A, Kursunel M, Meier S, Mälzer J, Li X, Rahman N, et al. Dysfunction of PSA-specific CD8+ T cells in prostate cancer patients correlates with CD38 and Tim-3 expression. Cancer Immunol Immunother. 2015;64:1487-94 pubmed publisher
  525. Chen X, Li W, Zhang Y, Song X, Xu L, Xu Z, et al. Distribution of Peripheral Memory T Follicular Helper Cells in Patients with Schistosomiasis Japonica. PLoS Negl Trop Dis. 2015;9:e0004015 pubmed publisher
  526. Dunham J, Lee L, van Driel N, Laman J, Ni I, Zhai W, et al. Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis. J Neuroimmune Pharmacol. 2016;11:73-83 pubmed publisher
  527. Yoon K, Byun S, Kwon E, Hwang S, Chu K, Hiraki M, et al. Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53. Science. 2015;349:1261669 pubmed publisher
  528. Weist B, Wehler P, El Ahmad L, Schmueck Henneresse M, Millward J, Nienen M, et al. A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients. Kidney Int. 2015;88:1293-1303 pubmed publisher
  529. Schnorfeil F, Lichtenegger F, Emmerig K, Schlueter M, Neitz J, Draenert R, et al. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. J Hematol Oncol. 2015;8:93 pubmed publisher
  530. Riou C, Tanko R, Soares A, Masson L, Werner L, Garrett N, et al. Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype. J Immunol. 2015;195:2273-2281 pubmed publisher
  531. Owens G, Erickson K, Malone C, Pan C, Huynh M, Chang J, et al. Evidence for the involvement of gamma delta T cells in the immune response in Rasmussen encephalitis. J Neuroinflammation. 2015;12:134 pubmed publisher
  532. Moslem M, Eberle I, Weber I, Henschler R, Cantz T. Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34(pos) Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction. Stem Cells Int. 2015;2015:843058 pubmed publisher
  533. Patyka M, Malamud D, Weissman D, Abrams W, Kurago Z. Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study. PLoS ONE. 2015;10:e0132942 pubmed publisher
  534. Martins L, Bonczkowski P, Spivak A, De Spiegelaere W, Novis C, DePaula Silva A, et al. Modeling HIV-1 Latency in Primary T Cells Using a Replication-Competent Virus. AIDS Res Hum Retroviruses. 2016;32:187-93 pubmed publisher
  535. Biylgi O, Karagöz B, Türken O, Gültepe M, Özgün A, Tunçel T, et al. CD4+CD25(high), CD8+CD28- cells and thyroid autoantibodies in breast cancer patients. Cent Eur J Immunol. 2014;39:338-44 pubmed publisher
  536. Wang Y, Zhong H, Xie X, Chen C, Huang D, Shen L, et al. Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection. Proc Natl Acad Sci U S A. 2015;112:E3883-92 pubmed publisher
  537. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed publisher
  538. Marshall M, Pattu V, Halimani M, Maier Peuschel M, Müller M, Becherer U, et al. VAMP8-dependent fusion of recycling endosomes with the plasma membrane facilitates T lymphocyte cytotoxicity. J Cell Biol. 2015;210:135-51 pubmed publisher
  539. Mikucki M, Fisher D, Matsuzaki J, Skitzki J, Gaulin N, Muhitch J, et al. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints. Nat Commun. 2015;6:7458 pubmed publisher
  540. Adoro S, Cubillos Ruiz J, Chen X, Deruaz M, Vrbanac V, Song M, et al. IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection. Nat Commun. 2015;6:7562 pubmed publisher
  541. Stenger E, Chiang K, Haight A, Qayed M, Kean L, Horan J. Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases. Biol Blood Marrow Transplant. 2015;21:1845-52 pubmed publisher
  542. Wu D, Thomas A, Fromm J. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma. Cytometry B Clin Cytom. 2016;90:424-32 pubmed publisher
  543. Perriard G, Mathias A, Enz L, Canales M, Schluep M, Gentner M, et al. Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes. J Neuroinflammation. 2015;12:119 pubmed publisher
  544. Chowdhury A, Hayes T, Bosinger S, Lawson B, Vanderford T, Schmitz J, et al. Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques. J Virol. 2015;89:8677-86 pubmed publisher
  545. Grieco A, Billett H, Green N, Driscoll M, Bouhassira E. Variation in Gamma-Globin Expression before and after Induction with Hydroxyurea Associated with BCL11A, KLF1 and TAL1. PLoS ONE. 2015;10:e0129431 pubmed publisher
  546. McCully M, Collins P, Hughes T, Thomas C, Billen J, O Donnell V, et al. Skin Metabolites Define a New Paradigm in the Localization of Skin Tropic Memory T Cells. J Immunol. 2015;195:96-104 pubmed publisher
  547. McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C, et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914 pubmed publisher
  548. Mock U, Machowicz R, Hauber I, Horn S, Abramowski P, Berdien B, et al. mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5. Nucleic Acids Res. 2015;43:5560-71 pubmed publisher
  549. de Winde C, Zuidscherwoude M, Vasaturo A, van der Schaaf A, Figdor C, van Spriel A. Multispectral imaging reveals the tissue distribution of tetraspanins in human lymphoid organs. Histochem Cell Biol. 2015;144:133-46 pubmed publisher
  550. Partlová S, Bouček J, Kloudová K, Lukešová E, Zábrodský M, Grega M, et al. Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma. Oncoimmunology. 2015;4:e965570 pubmed
  551. Byrareddy S, Sidell N, Arthos J, Cicala C, Zhao C, Little D, et al. Species-specific differences in the expression and regulation of α4β7 integrin in various nonhuman primates. J Immunol. 2015;194:5968-79 pubmed publisher
  552. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed publisher
  553. Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Pérals C, et al. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol. 2015;16:628-34 pubmed publisher
  554. Lee J, Jeong I, Joh J, Jung Y, Sim S, Choi B, et al. Differential expression of CD57 in antigen-reactive CD4+ T cells between active and latent tuberculosis infection. Clin Immunol. 2015;159:37-46 pubmed publisher
  555. DaFonseca S, Niessl J, Pouvreau S, Wacleche V, Gosselin A, Cleret Buhot A, et al. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 2015;12:38 pubmed publisher
  556. Lenz N, Schindler T, Kagina B, Zhang J, Lukindo T, Mpina M, et al. Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4+ T Cells. Clin Vaccine Immunol. 2015;22:688-96 pubmed publisher
  557. Deng N, Mosmann T. Optimization of the cytokine secretion assay for human IL-2 in single and combination assays. Cytometry A. 2015;87:777-83 pubmed publisher
  558. Anandasabapathy N, Breton G, Hurley A, Caskey M, Trumpfheller C, Sarma P, et al. Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers. Bone Marrow Transplant. 2015;50:924-30 pubmed publisher
  559. Jeon Y, Kim J, Sung J, Han J, Ko Y. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features. Hum Pathol. 2015;46:981-90 pubmed publisher
  560. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed publisher
  561. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed publisher
  562. Spurlock C, Tossberg J, Guo Y, Collier S, Crooke P, Aune T. Expression and functions of long noncoding RNAs during human T helper cell differentiation. Nat Commun. 2015;6:6932 pubmed publisher
  563. Førsvoll J, Janssen E, Møller I, Wathne N, Skaland I, Klos J, et al. Reduced Number of CD8+ Cells in Tonsillar Germinal Centres in Children with the Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis Syndrome. Scand J Immunol. 2015;82:76-83 pubmed publisher
  564. Martner A, Wiktorin H, Lenox B, Ewald Sander F, Aydin E, Aurelius J, et al. Histamine promotes the development of monocyte-derived dendritic cells and reduces tumor growth by targeting the myeloid NADPH oxidase. J Immunol. 2015;194:5014-21 pubmed publisher
  565. Katz S, Burga R, McCormack E, Wang L, Mooring W, Point G, et al. Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases. Clin Cancer Res. 2015;21:3149-59 pubmed publisher
  566. Vassena L, Giuliani E, Koppensteiner H, Bolduan S, Schindler M, Doria M. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes. J Virol. 2015;89:5687-700 pubmed publisher
  567. Rajnai H, Teleki I, Kiszner G, Meggyesházi N, Balla P, Vancsik T, et al. Connexin 43 communication channels in follicular dendritic cell development and in follicular lymphomas. J Immunol Res. 2015;2015:528098 pubmed publisher
  568. Trabanelli S, Lecciso M, Salvestrini V, Cavo M, Očadlíková D, Lemoli R, et al. PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response. J Immunol Res. 2015;2015:253191 pubmed publisher
  569. Yukl S, Shergill A, Girling V, Li Q, Killian M, Epling L, et al. Site-specific differences in T cell frequencies and phenotypes in the blood and gut of HIV-uninfected and ART-treated HIV+ adults. PLoS ONE. 2015;10:e0121290 pubmed publisher
  570. Hong M, Sandalova E, Low D, Gehring A, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588 pubmed publisher
  571. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia. Hum Immunol. 2015;76:329-338 pubmed publisher
  572. Chen J, Tibroni N, Sauter D, Galaski J, Miura T, Alter G, et al. Modest attenuation of HIV-1 Vpu alleles derived from elite controller plasma. PLoS ONE. 2015;10:e0120434 pubmed publisher
  573. Ohnuma K, Hatano R, Aune T, Otsuka H, Iwata S, Dang N, et al. Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes. J Immunol. 2015;194:3697-712 pubmed publisher
  574. Laing K, Russell R, Dong L, Schmid D, Stern M, Magaret A, et al. Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus. J Infect Dis. 2015;212:1022-31 pubmed publisher
  575. Tian X, Zhang A, Qiu C, Wang W, Yang Y, Qiu C, et al. The upregulation of LAG-3 on T cells defines a subpopulation with functional exhaustion and correlates with disease progression in HIV-infected subjects. J Immunol. 2015;194:3873-82 pubmed publisher
  576. St Gelais C, Roger J, Wu L. Non-POU Domain-Containing Octamer-Binding Protein Negatively Regulates HIV-1 Infection in CD4(+) T Cells. AIDS Res Hum Retroviruses. 2015;31:806-16 pubmed publisher
  577. Bowcutt R, Malter L, Chen L, Wolff M, Robertson I, Rifkin D, et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods. 2015;421:27-35 pubmed publisher
  578. Dudek Perić A, Ferreira G, Muchowicz A, Wouters J, Prada N, Martin S, et al. Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin. Cancer Res. 2015;75:1603-14 pubmed publisher
  579. Pratama A, Srivastava M, Williams N, Papa I, Lee S, Dinh X, et al. MicroRNA-146a regulates ICOS-ICOSL signalling to limit accumulation of T follicular helper cells and germinal centres. Nat Commun. 2015;6:6436 pubmed publisher
  580. Chung T, Christopher Stine L, Paik J, Corse A, MAMMEN A. The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy. Muscle Nerve. 2015;52:189-95 pubmed publisher
  581. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed publisher
  582. van Gijsel Bonnello M, Acar N, Molino Y, Bretillon L, Khrestchatisky M, De Reggi M, et al. Pantethine Alters Lipid Composition and Cholesterol Content of Membrane Rafts, With Down-Regulation of CXCL12-Induced T Cell Migration. J Cell Physiol. 2015;230:2415-25 pubmed publisher
  583. Severson J, Serracino H, Mateescu V, Raeburn C, McIntyre R, Sams S, et al. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res. 2015;3:620-30 pubmed publisher
  584. Elliott G, Hong C, Xing X, Zhou X, Li D, Coarfa C, et al. Intermediate DNA methylation is a conserved signature of genome regulation. Nat Commun. 2015;6:6363 pubmed publisher
  585. Torres Cabala C, Curry J, Li Ning Tapia E, Ramos C, Tetzlaff M, Prieto V, et al. HTLV-1-associated infective dermatitis demonstrates low frequency of FOXP3-positive T-regulatory lymphocytes. J Dermatol Sci. 2015;77:150-5 pubmed publisher
  586. Bhargava P, Gocke A, Calabresi P. 1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controls. J Neuroimmunol. 2015;279:20-4 pubmed publisher
  587. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed publisher
  588. Lehnhardt A, Strecker M, Eiermann T, Marget M, Thaiss F, Nashan B, et al. High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab induction. Clin Transplant. 2015;29:359-64 pubmed publisher
  589. Gideon H, Phuah J, Myers A, Bryson B, Rodgers M, Coleman M, et al. Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization. PLoS Pathog. 2015;11:e1004603 pubmed publisher
  590. Däster S, Eppenberger Castori S, Hirt C, Zlobec I, Delko T, Nebiker C, et al. High frequency of CD8 positive lymphocyte infiltration correlates with lack of lymph node involvement in early rectal cancer. Dis Markers. 2014;2014:792183 pubmed publisher
  591. Du Z, Abedalthagafi M, Aizer A, McHenry A, Sun H, Bray M, et al. Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma. Oncotarget. 2015;6:4704-16 pubmed
  592. Harrer A, Pilz G, Wipfler P, Oppermann K, Sellner J, Hitzl W, et al. High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis. Clin Exp Immunol. 2015;180:383-92 pubmed publisher
  593. Abdel Mohsen M, Wang C, Strain M, Lada S, Deng X, Cockerham L, et al. Select host restriction factors are associated with HIV persistence during antiretroviral therapy. AIDS. 2015;29:411-20 pubmed publisher
  594. Hannani D, Vétizou M, Enot D, Rusakiewicz S, Chaput N, Klatzmann D, et al. Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Cell Res. 2015;25:208-24 pubmed publisher
  595. Afshar M, Richards S, Mann D, Cross A, Smith G, Netzer G, et al. Acute immunomodulatory effects of binge alcohol ingestion. Alcohol. 2015;49:57-64 pubmed publisher
  596. Vettermann C, Timblin G, Lim V, Lai E, Schlissel M. The proximal J kappa germline-transcript promoter facilitates receptor editing through control of ordered recombination. PLoS ONE. 2015;10:e0113824 pubmed publisher
  597. Watson M, Hedley D. Whole blood measurement of histone modifications linked to the epigenetic regulation of gene expression. Curr Protoc Cytom. 2015;71:6.36.1-9 pubmed publisher
  598. Karlsson F, Hassan Zahraee M. Quantification of Th1 and Th17 Cells with Intracellular Staining Following PMA/Ionomycin Stimulation. Curr Protoc Cytom. 2015;71:6.35.1-7 pubmed publisher
  599. Singh S, Nehete P, Yang G, He H, Nehete B, Hanley P, et al. Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant. Vaccines (Basel). 2014;2:686-706 pubmed publisher
  600. Li F, Ji L, Wang W, Hua F, Zhan Y, Zou S, et al. Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients. Immunol Res. 2015;61:269-80 pubmed publisher
  601. Nguyen L, Pan J, Dinh T, Hadeiba H, O Hara E, Ebtikar A, et al. Role and species-specific expression of colon T cell homing receptor GPR15 in colitis. Nat Immunol. 2015;16:207-213 pubmed publisher
  602. Kagina B, Mansoor N, Kpamegan E, Penn Nicholson A, Nemes E, Smit E, et al. Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry. J Immunol Methods. 2015;417:22-33 pubmed publisher
  603. Nemes E, Kagina B, Smit E, Africa H, Steyn M, Hanekom W, et al. Differential leukocyte counting and immunophenotyping in cryopreserved ex vivo whole blood. Cytometry A. 2015;87:157-65 pubmed publisher
  604. Konadu K, Chu J, Huang M, Amancha P, Armstrong W, Powell M, et al. Association of Cytokines With Exosomes in the Plasma of HIV-1-Seropositive Individuals. J Infect Dis. 2015;211:1712-6 pubmed publisher
  605. Li H, Evans T, Gillis J, Connole M, Reeves R. Bone marrow-imprinted gut-homing of plasmacytoid dendritic cells (pDCs) in acute simian immunodeficiency virus infection results in massive accumulation of hyperfunctional CD4+ pDCs in the mucosae. J Infect Dis. 2015;211:1717-25 pubmed publisher
  606. Weihrauch M, Richly H, von Bergwelt Baildon M, Becker H, Schmidt M, Hacker U, et al. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur J Cancer. 2015;51:146-56 pubmed publisher
  607. Hokuto D, Sho M, Yamato I, Yasuda S, Obara S, Nomi T, et al. Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma. Eur J Cancer. 2015;51:157-65 pubmed publisher
  608. Bell C, Sun Y, Nowak U, Clark J, Howlett S, Pekalski M, et al. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells. J Autoimmun. 2015;56:66-80 pubmed publisher
  609. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed publisher
  610. Cousens L, Najafian N, Martin W, De Groot A. Tregitope: Immunomodulation powerhouse. Hum Immunol. 2014;75:1139-46 pubmed publisher
  611. Renauer P, Coit P, Sawalha A. The DNA methylation signature of human TCRαβ+CD4-CD8- double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune response. Clin Immunol. 2015;156:19-27 pubmed publisher
  612. Crompton J, Sukumar M, Roychoudhuri R, Clever D, Gros A, Eil R, et al. Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. Cancer Res. 2015;75:296-305 pubmed publisher
  613. Stacchini A, Pacchioni D, Demurtas A, Aliberti S, Cassenti A, Isolato G, et al. Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas. Cytometry B Clin Cytom. 2015;88:320-9 pubmed publisher
  614. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed publisher
  615. de Carvalho J, de Castro R, da Silva E, Silveira P, da Silva Januário M, Arruda E, et al. Nef neutralizes the ability of exosomes from CD4+ T cells to act as decoys during HIV-1 infection. PLoS ONE. 2014;9:e113691 pubmed publisher
  616. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed publisher
  617. Chow I, Yang J, Gates T, James E, Mai D, Greenbaum C, et al. Assessment of CD4+ T cell responses to glutamic acid decarboxylase 65 using DQ8 tetramers reveals a pathogenic role of GAD65 121-140 and GAD65 250-266 in T1D development. PLoS ONE. 2014;9:e112882 pubmed publisher
  618. Meissner T, Mandal P, Ferreira L, Rossi D, Cowan C. Genome editing for human gene therapy. Methods Enzymol. 2014;546:273-95 pubmed publisher
  619. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed publisher
  620. Thompson I, Mann E, Stokes M, English N, Knight S, Williamson D. Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection. PLoS ONE. 2014;9:e109720 pubmed publisher
  621. Venalis P, Kumánovics G, Schulze Koops H, Distler A, Dees C, Zerr P, et al. Cardiomyopathy in murine models of systemic sclerosis. Arthritis Rheumatol. 2015;67:508-16 pubmed publisher
  622. Titti F, Maggiorella M, Ferrantelli F, Sernicola L, Bellino S, Collacchi B, et al. Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccines. PLoS ONE. 2014;9:e111360 pubmed publisher
  623. Fujita T, Burwitz B, Chew G, Reed J, Pathak R, Seger E, et al. Expansion of dysfunctional Tim-3-expressing effector memory CD8+ T cells during simian immunodeficiency virus infection in rhesus macaques. J Immunol. 2014;193:5576-83 pubmed publisher
  624. Freeman A, Bridge J, Maruthayanar P, Overgaard N, Jung J, Simpson F, et al. Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage. PLoS ONE. 2014;9:e110928 pubmed publisher
  625. Luetke Eversloh M, Hammer Q, Durek P, Nordström K, Gasparoni G, Pink M, et al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog. 2014;10:e1004441 pubmed publisher
  626. Lambert J, Whitson R, Iczkowski K, La Rosa F, Smith M, Wilson R, et al. Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the prostate. Prostate. 2015;75:255-65 pubmed publisher
  627. Weed D, Vella J, Reis I, De La Fuente A, Gomez C, Sargi Z, et al. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma. Clin Cancer Res. 2015;21:39-48 pubmed publisher
  628. Gerna G, Lilleri D, Fornara C, Bruno F, Gabanti E, Cane I, et al. Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host. J Gen Virol. 2015;96:360-9 pubmed publisher
  629. Wilson E, Bial J, Tarlow B, Bial G, Jensen B, Greiner D, et al. Extensive double humanization of both liver and hematopoiesis in FRGN mice. Stem Cell Res. 2014;13:404-12 pubmed publisher
  630. O Regan N, Steinfelder S, Venugopal G, Rao G, Lucius R, Srikantam A, et al. Brugia malayi microfilariae induce a regulatory monocyte/macrophage phenotype that suppresses innate and adaptive immune responses. PLoS Negl Trop Dis. 2014;8:e3206 pubmed publisher
  631. Lemos M, Lama J, Karuna S, Fong Y, Montano S, Ganoza C, et al. The inner foreskin of healthy males at risk of HIV infection harbors epithelial CD4+ CCR5+ cells and has features of an inflamed epidermal barrier. PLoS ONE. 2014;9:e108954 pubmed publisher
  632. Lundholm M, Schröder M, Nagaeva O, Baranov V, Widmark A, Mincheva Nilsson L, et al. Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion. PLoS ONE. 2014;9:e108925 pubmed publisher
  633. Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193:4335-43 pubmed publisher
  634. Mylvaganam G, Velu V, Hong J, Sadagopal S, Kwa S, Basu R, et al. Diminished viral control during simian immunodeficiency virus infection is associated with aberrant PD-1hi CD4 T cell enrichment in the lymphoid follicles of the rectal mucosa. J Immunol. 2014;193:4527-36 pubmed publisher
  635. Willis E, Eberle R, Wolf R, White G, McFarlane D. The effects of age and cytomegalovirus on markers of inflammation and lymphocyte populations in captive baboons. PLoS ONE. 2014;9:e107167 pubmed publisher
  636. Perino G, Ricciardi B, Jerabek S, Martignoni G, Wilner G, Maass D, et al. Implant based differences in adverse local tissue reaction in failed total hip arthroplasties: a morphological and immunohistochemical study. BMC Clin Pathol. 2014;14:39 pubmed publisher
  637. Kudernatsch R, Letsch A, Guerreiro M, Löbel M, Bauer S, Volk H, et al. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. Eur J Immunol. 2014;44:3532-42 pubmed publisher
  638. Hassan U, Bashir R. Coincidence detection of heterogeneous cell populations from whole blood with coplanar electrodes in a microfluidic impedance cytometer. Lab Chip. 2014;14:4370-81 pubmed publisher
  639. Valentin A, McKinnon K, Li J, Rosati M, Kulkarni V, Pilkington G, et al. Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaques. Clin Immunol. 2014;155:91-107 pubmed publisher
  640. Lepperhof V, Polchynski O, Kruttwig K, Brüggemann C, Neef K, Drey F, et al. Bioluminescent imaging of genetically selected induced pluripotent stem cell-derived cardiomyocytes after transplantation into infarcted heart of syngeneic recipients. PLoS ONE. 2014;9:e107363 pubmed publisher
  641. Perreau M, Vigano S, Bellanger F, Pellaton C, Buss G, Comte D, et al. Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders. J Exp Med. 2014;211:2033-45 pubmed publisher
  642. Renand A, Newbrough S, Wambre E, Delong J, Robinson D, Kwok W. Arginine kinase Pen m 2 as an important shrimp allergen recognized by TH2 cells. J Allergy Clin Immunol. 2014;134:1456-1459.e7 pubmed publisher
  643. Kagina B, Tameris M, Geldenhuys H, Hatherill M, Abel B, Hussey G, et al. The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses. Vaccine. 2014;32:5908-17 pubmed publisher
  644. Yu J, Zuo Z, Zhang W, Yang Q, Zhang Y, Tang Y, et al. Identification of immunophenotypic subtypes with different prognoses in extranodal natural killer/T-cell lymphoma, nasal type. Hum Pathol. 2014;45:2255-62 pubmed publisher
  645. Hu H, Eller M, Zafar S, Zhou Y, Gu M, Wei Z, et al. Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals. Proc Natl Acad Sci U S A. 2014;111:13439-44 pubmed publisher
  646. Del Prete G, Shoemaker R, Oswald K, Lara A, Trubey C, Fast R, et al. Effect of suberoylanilide hydroxamic acid (SAHA) administration on the residual virus pool in a model of combination antiretroviral therapy-mediated suppression in SIVmac239-infected indian rhesus macaques. Antimicrob Agents Chemother. 2014;58:6790-806 pubmed publisher
  647. Abramowski P, Ogrodowczyk C, Martin R, Pongs O. A truncation variant of the cation channel P2RX5 is upregulated during T cell activation. PLoS ONE. 2014;9:e104692 pubmed publisher
  648. Antsiferova O, Müller A, Rämer P, Chijioke O, Chatterjee B, Raykova A, et al. Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice. PLoS Pathog. 2014;10:e1004333 pubmed publisher
  649. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed publisher
  650. Steiner S, Daniel C, Fischer A, Atreya I, Hirschmann S, Waldner M, et al. Cyclosporine A regulates pro-inflammatory cytokine production in ulcerative colitis. Arch Immunol Ther Exp (Warsz). 2015;63:53-63 pubmed publisher
  651. Kreiser S, Eckhardt J, Kuhnt C, Stein M, Krzyzak L, Seitz C, et al. Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo. Immunobiology. 2015;220:270-9 pubmed publisher
  652. Reichwald K, Jørgensen T, Skov S. TL1A increases expression of CD25, LFA-1, CD134 and CD154, and induces IL-22 and GM-CSF production from effector CD4 T-cells. PLoS ONE. 2014;9:e105627 pubmed publisher
  653. Schneider Hohendorf T, Rossaint J, Mohan H, Böning D, Breuer J, Kuhlmann T, et al. VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells. J Exp Med. 2014;211:1833-46 pubmed publisher
  654. Onaindia A, Montes Moreno S, Rodriguez Pinilla S, Batlle A, Gonzalez de Villambrosia S, Rodriguez A, et al. Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features. Histopathology. 2015;66:846-55 pubmed publisher
  655. Bennaceur K, Atwill M, Al Zhrany N, Hoffmann J, Keavney B, BREAULT D, et al. Atorvastatin induces T cell proliferation by a telomerase reverse transcriptase (TERT) mediated mechanism. Atherosclerosis. 2014;236:312-20 pubmed publisher
  656. Ohue Y, Kurose K, Mizote Y, Matsumoto H, Nishio Y, Isobe M, et al. Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody. Clin Cancer Res. 2014;20:5052-63 pubmed publisher
  657. Wu C, He S, Peng Y, Kushwaha K, Lin J, Dong J, et al. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice. J Mol Cell Cardiol. 2014;76:33-45 pubmed publisher
  658. Frencher J, Shen H, Yan L, Wilson J, Freitag N, Rizzo A, et al. HMBPP-deficient Listeria mutant immunization alters pulmonary/systemic responses, effector functions, and memory polarization of Vγ2Vδ2 T cells. J Leukoc Biol. 2014;96:957-67 pubmed publisher
  659. Jin J, Zhang W, Wong K, Kwak M, van Driel I, Yu Q. Inhibition of breast cancer resistance protein (ABCG2) in human myeloid dendritic cells induces potent tolerogenic functions during LPS stimulation. PLoS ONE. 2014;9:e104753 pubmed publisher
  660. Bae J, Lee S, Park C, Lee Y, Chun T. Trafficking of LAG-3 to the surface on activated T cells via its cytoplasmic domain and protein kinase C signaling. J Immunol. 2014;193:3101-12 pubmed publisher
  661. Bending D, Pesenacker A, Ursu S, Wu Q, Lom H, Thirugnanabalan B, et al. Hypomethylation at the regulatory T cell-specific demethylated region in CD25hi T cells is decoupled from FOXP3 expression at the inflamed site in childhood arthritis. J Immunol. 2014;193:2699-708 pubmed publisher
  662. Arlehamn C, Seumois G, Gerasimova A, Huang C, Fu Z, Yue X, et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol. 2014;193:2931-40 pubmed publisher
  663. Saresella M, Piancone F, Marventano I, La Rosa F, Tortorella P, Caputo D, et al. A role for the TIM-3/GAL-9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis. FASEB J. 2014;28:5000-9 pubmed publisher
  664. Meier D, Docena G, Ramisch D, Toscanini U, Berardi G, Gondolesi G, et al. Immunological status of isolated lymphoid follicles after intestinal transplantation. Am J Transplant. 2014;14:2148-58 pubmed publisher
  665. Cavaretta J, Sherer K, Lee K, Kim E, Issema R, Chung H. Polarized axonal surface expression of neuronal KCNQ potassium channels is regulated by calmodulin interaction with KCNQ2 subunit. PLoS ONE. 2014;9:e103655 pubmed publisher
  666. Li G, Cheng M, Nunoya J, Cheng L, Guo H, Yu H, et al. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 2014;10:e1004291 pubmed publisher
  667. Kivisakk P, Francois K, Mbianda J, Gandhi R, Weiner H, Khoury S. Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis. PLoS ONE. 2014;9:e103716 pubmed publisher
  668. Han L, Yang J, Wang X, Wu Q, Yin S, Li Z, et al. The E3 deubiquitinase USP17 is a positive regulator of retinoic acid-related orphan nuclear receptor ?t (ROR?t) in Th17 cells. J Biol Chem. 2014;289:25546-55 pubmed publisher
  669. Weist B, Schmueck M, Fuehrer H, Sattler A, Reinke P, Babel N. The role of CD4(+) T cells in BKV-specific T cell immunity. Med Microbiol Immunol. 2014;203:395-408 pubmed publisher
  670. Chung Y, Kim E, Abdel Wahab O. Femoral bone marrow aspiration in live mice. J Vis Exp. 2014;: pubmed publisher
  671. Wu D, Allen C, Fromm J. Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue. Cytometry B Clin Cytom. 2015;88:58-63 pubmed publisher
  672. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed publisher
  673. Buggert M, Tauriainen J, Yamamoto T, Frederiksen J, Ivarsson M, Michaelsson J, et al. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS Pathog. 2014;10:e1004251 pubmed publisher
  674. Uhlenbrock F, Hagemann Jensen M, Kehlet S, Andresen L, Pastorekova S, Skov S. The NKG2D ligand ULBP2 is specifically regulated through an invariant chain-dependent endosomal pathway. J Immunol. 2014;193:1654-65 pubmed publisher
  675. Butcher L, Garcia M, Arnold M, Ueno H, Goel A, Boland C. Immune response to JC virus T antigen in patients with and without colorectal neoplasia. Gut Microbes. 2014;5:468-75 pubmed publisher
  676. Pegram H, Purdon T, van Leeuwen D, Curran K, Giralt S, Barker J, et al. IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia. Leukemia. 2015;29:415-22 pubmed publisher
  677. Kobie J, Treanor J, Ritchlin C. Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody. Immunol Invest. 2014;43:606-15 pubmed publisher
  678. Jacquelin B, Petitjean G, Kunkel D, Liovat A, Jochems S, Rogers K, et al. Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection. PLoS Pathog. 2014;10:e1004241 pubmed publisher
  679. Noyan F, Lee Y, Zimmermann K, Hardtke Wolenski M, Taubert R, Warnecke G, et al. Isolation of human antigen-specific regulatory T cells with high suppressive function. Eur J Immunol. 2014;44:2592-602 pubmed publisher
  680. Ye S, Li Z, Luo D, Huang B, Chen Y, Zhang X, et al. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget. 2014;5:5439-52 pubmed
  681. Campion S, Brodie T, Fischer W, Korber B, Rossetti A, Goonetilleke N, et al. Proteome-wide analysis of HIV-specific naive and memory CD4(+) T cells in unexposed blood donors. J Exp Med. 2014;211:1273-80 pubmed publisher
  682. Azzimonti B, Zavattaro E, Provasi M, Vidali M, Conca A, Catalano E, et al. Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+ CD25+ ratio. Br J Dermatol. 2015;172:64-73 pubmed publisher
  683. Hong J, Amancha P, Rogers K, Courtney C, Havenar Daughton C, Crotty S, et al. Early lymphoid responses and germinal center formation correlate with lower viral load set points and better prognosis of simian immunodeficiency virus infection. J Immunol. 2014;193:797-806 pubmed publisher
  684. Pastille E, Bardini K, Fleissner D, Adamczyk A, Frede A, Wadwa M, et al. Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer. Cancer Res. 2014;74:4258-69 pubmed publisher
  685. Payne T, Blackinton J, Frisbee A, Pickeral J, Sawant S, Vandergrift N, et al. Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition. J Virol. 2014;88:9514-28 pubmed publisher
  686. Chan W, Suwannasaen D, Throm R, Li Y, Eldridge P, Houston J, et al. Chimeric antigen receptor-redirected CD45RA-negative T cells have potent antileukemia and pathogen memory response without graft-versus-host activity. Leukemia. 2015;29:387-95 pubmed publisher
  687. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  688. Bedke T, Iannitti R, De Luca A, Giovannini G, Fallarino F, Berges C, et al. Distinct and complementary roles for Aspergillus fumigatus-specific Tr1 and Foxp3+ regulatory T cells in humans and mice. Immunol Cell Biol. 2014;92:659-70 pubmed publisher
  689. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed publisher
  690. Vargas A, Zhou S, Ethier Chiasson M, Flipo D, Lafond J, Gilbert C, et al. Syncytin proteins incorporated in placenta exosomes are important for cell uptake and show variation in abundance in serum exosomes from patients with preeclampsia. FASEB J. 2014;28:3703-19 pubmed publisher
  691. Helm O, Mennrich R, Petrick D, Goebel L, Freitag Wolf S, Roder C, et al. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma. PLoS ONE. 2014;9:e94357 pubmed publisher
  692. Luciano A, Arbona Ramirez I, Ruiz R, Llorens Bonilla B, Martinez Lopez D, Funderburg N, et al. Alterations in regulatory T cell subpopulations seen in preterm infants. PLoS ONE. 2014;9:e95867 pubmed publisher
  693. Deng N, Weaver J, Mosmann T. Cytokine diversity in the Th1-dominated human anti-influenza response caused by variable cytokine expression by Th1 cells, and a minor population of uncommitted IL-2+IFN?- Thpp cells. PLoS ONE. 2014;9:e95986 pubmed publisher
  694. Chattergoon M, Latanich R, Quinn J, Winter M, Buckheit R, Blankson J, et al. HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon. PLoS Pathog. 2014;10:e1004082 pubmed publisher
  695. Hebel K, Weinert S, Kuropka B, Knolle J, Kosak B, Jorch G, et al. CD4+ T cells from human neonates and infants are poised spontaneously to run a nonclassical IL-4 program. J Immunol. 2014;192:5160-70 pubmed publisher
  696. Tarbox J, Keppel M, Topcagic N, Mackin C, Ben Abdallah M, Baszis K, et al. Elevated double negative T cells in pediatric autoimmunity. J Clin Immunol. 2014;34:594-9 pubmed publisher
  697. Schuler P, Saze Z, Hong C, Muller L, Gillespie D, Cheng D, et al. Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells. Clin Exp Immunol. 2014;177:531-43 pubmed publisher
  698. Mao C, Mou X, Zhou Y, Yuan G, Xu C, Liu H, et al. Tumor-activated TCR??? T cells from gastric cancer patients induce the antitumor immune response of TCR??? T cells via their antigen-presenting cell-like effects. J Immunol Res. 2014;2014:593562 pubmed publisher
  699. Buggert M, Norstr m M, Salemi M, Hecht F, Karlsson A. Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progression. J Immunol. 2014;192:4685-96 pubmed publisher
  700. Ye W, Xing Y, Paustian C, van de Ven R, Moudgil T, Hilton T, et al. Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cells. J Transl Med. 2014;12:100 pubmed publisher
  701. Marie J, Kovacs D, Pain C, Jouary T, Cota C, Vergier B, et al. Inflammasome activation and vitiligo/nonsegmental vitiligo progression. Br J Dermatol. 2014;170:816-23 pubmed publisher
  702. Cartwright E, McGary C, Cervasi B, Micci L, Lawson B, Elliott S, et al. Divergent CD4+ T memory stem cell dynamics in pathogenic and nonpathogenic simian immunodeficiency virus infections. J Immunol. 2014;192:4666-73 pubmed publisher
  703. Ito S, Bollard C, Carlsten M, Melenhorst J, Biancotto A, Wang E, et al. Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers. Mol Ther. 2014;22:1388-1395 pubmed publisher
  704. Abramowski P, Otto B, Martin R. The orally available, synthetic ether lipid edelfosine inhibits T cell proliferation and induces a type I interferon response. PLoS ONE. 2014;9:e91970 pubmed publisher
  705. Hodara V, Parodi L, Chavez D, Smith L, Lanford R, Giavedoni L. Characterization of ??T cells in naïve and HIV-infected chimpanzees and their responses to T-cell activators in vitro. J Med Primatol. 2014;43:258-71 pubmed publisher
  706. Lanteri M, Diamond M, Law J, Chew G, Wu S, Inglis H, et al. Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection. PLoS ONE. 2014;9:e92134 pubmed publisher
  707. Haldar M, Kohyama M, So A, Kc W, Wu X, Briseño C, et al. Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages. Cell. 2014;156:1223-1234 pubmed publisher
  708. Berney Meyer L, Hung N, Slatter T, Schollum J, Kitching A, Walker R. Omeprazole-induced acute interstitial nephritis: a possible Th1-Th17-mediated injury?. Nephrology (Carlton). 2014;19:359-65 pubmed publisher
  709. Chesarino N, McMichael T, Hach J, Yount J. Phosphorylation of the antiviral protein interferon-inducible transmembrane protein 3 (IFITM3) dually regulates its endocytosis and ubiquitination. J Biol Chem. 2014;289:11986-92 pubmed publisher
  710. Le Saout C, Hasley R, Imamichi H, Tcheung L, Hu Z, Luckey M, et al. Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasis. PLoS Pathog. 2014;10:e1003976 pubmed publisher
  711. Saayman S, Ackley A, Turner A, Famiglietti M, Bosque A, Clemson M, et al. An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription. Mol Ther. 2014;22:1164-1175 pubmed publisher
  712. de Hair M, van de Sande M, Ramwadhdoebe T, Hansson M, Landewe R, van der Leij C, et al. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol. 2014;66:513-22 pubmed publisher
  713. Peguillet I, Milder M, Louis D, Vincent Salomon A, Dorval T, Piperno Neumann S, et al. High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer. Cancer Res. 2014;74:2204-16 pubmed publisher
  714. Rizzo S, Basso C, Troost D, Aronica E, Frigo A, Driessen A, et al. T-cell-mediated inflammatory activity in the stellate ganglia of patients with ion-channel disease and severe ventricular arrhythmias. Circ Arrhythm Electrophysiol. 2014;7:224-9 pubmed publisher
  715. Martin P, Golden B, Okerblom J, Camboni M, Chandrasekharan K, Xu R, et al. A comparative study of N-glycolylneuraminic acid (Neu5Gc) and cytotoxic T cell (CT) carbohydrate expression in normal and dystrophin-deficient dog and human skeletal muscle. PLoS ONE. 2014;9:e88226 pubmed publisher
  716. Wertheimer A, Bennett M, Park B, Uhrlaub J, Martinez C, Pulko V, et al. Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol. 2014;192:2143-55 pubmed publisher
  717. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed publisher
  718. Kulkarni V, Valentin A, Rosati M, Alicea C, Singh A, Jalah R, et al. Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques. PLoS ONE. 2014;9:e86254 pubmed publisher
  719. Guan S, Liu J, Fang E, Ng T, Lian Y, Ge H. Chronic unpredictable mild stress impairs erythrocyte immune function and changes T-lymphocyte subsets in a rat model of stress-induced depression. Environ Toxicol Pharmacol. 2014;37:414-22 pubmed publisher
  720. Wong E, Akilimali N, Govender P, Sullivan Z, Cosgrove C, Pillay M, et al. Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection. PLoS ONE. 2013;8:e83474 pubmed publisher
  721. Narita T, Ishida T, Masaki A, Suzuki S, Ito A, Mori F, et al. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation. J Immunol. 2014;192:940-7 pubmed publisher
  722. Nicholas K, Zern E, Barnett L, Smith R, Lorey S, Copeland C, et al. B cell responses to HIV antigen are a potent correlate of viremia in HIV-1 infection and improve with PD-1 blockade. PLoS ONE. 2013;8:e84185 pubmed publisher
  723. Galindo Albarrán A, Ramirez Pliego O, Labastida Conde R, Melchy Pérez E, Liquitaya Montiel A, Esquivel Guadarrama F, et al. CD43 signals prepare human T cells to receive cytokine differentiation signals. J Cell Physiol. 2014;229:172-80 pubmed
  724. Watkins N, Hassan U, Damhorst G, Ni H, Vaid A, Rodriguez W, et al. Microfluidic CD4+ and CD8+ T lymphocyte counters for point-of-care HIV diagnostics using whole blood. Sci Transl Med. 2013;5:214ra170 pubmed publisher
  725. Jones H, Gold M, Giannico G, Troutman A, Vnencak Jones C, Schultenover S, et al. Lymphoepithelioma-like carcinoma of the endometrium: immunophenotypic characterization of a rare tumor with microsatellite instability testing. Int J Gynecol Pathol. 2014;33:64-73 pubmed publisher
  726. Mao C, Brovarney M, Dabbagh K, Birnböck H, Richter W, Del Nagro C. Subcutaneous versus intravenous administration of rituximab: pharmacokinetics, CD20 target coverage and B-cell depletion in cynomolgus monkeys. PLoS ONE. 2013;8:e80533 pubmed publisher
  727. Zouk H, d Hennezel E, Du X, Ounissi Benkalha H, Piccirillo C, Polychronakos C. Functional evaluation of the role of C-type lectin domain family 16A at the chromosome 16p13 locus. Clin Exp Immunol. 2014;175:485-97 pubmed publisher
  728. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed publisher
  729. Lutwama F, Kagina B, Wajja A, Waiswa F, Mansoor N, Kirimunda S, et al. Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants. J Infect Dis. 2014;209:887-97 pubmed publisher
  730. Didigu C, Wilen C, Wang J, Duong J, Secreto A, Danet Desnoyers G, et al. Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection. Blood. 2014;123:61-9 pubmed publisher
  731. Cornwell W, Lewis M, Fan X, Rappaport J, Rogers T. Effect of chronic morphine administration on circulating T cell population dynamics in rhesus macaques. J Neuroimmunol. 2013;265:43-50 pubmed publisher
  732. Timblin G, Schlissel M. Ebf1 and c-Myb repress rag transcription downstream of Stat5 during early B cell development. J Immunol. 2013;191:4676-87 pubmed publisher
  733. Nussbaum J, Van Dyken S, von Moltke J, Cheng L, Mohapatra A, Molofsky A, et al. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature. 2013;502:245-8 pubmed publisher
  734. Tan A, Hoang L, Chin D, Rasmussen E, Lopatin U, Hart S, et al. Reduction of HBV replication prolongs the early immunological response to IFN? therapy. J Hepatol. 2014;60:54-61 pubmed publisher
  735. Sumitomo S, Fujio K, Okamura T, Morita K, Ishigaki K, Suzukawa K, et al. Transcription factor early growth response 3 is associated with the TGF-?1 expression and the regulatory activity of CD4-positive T cells in vivo. J Immunol. 2013;191:2351-9 pubmed publisher
  736. Stacchini A, Aliberti S, Pacchioni D, Demurtas A, Isolato G, Gazzera C, et al. Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology. 2014;25:231-40 pubmed publisher
  737. Pattacini L, Murnane P, Kahle E, Bolton M, Delrow J, Lingappa J, et al. Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals. AIDS Res Hum Retroviruses. 2013;29:1321-9 pubmed publisher
  738. Pala P, Serwanga J, Watera C, Ritchie A, Moodie Z, Wang M, et al. Quantitative and qualitative differences in the T cell response to HIV in uninfected Ugandans exposed or unexposed to HIV-infected partners. J Virol. 2013;87:9053-63 pubmed publisher
  739. Melis L, Van Praet L, Pircher H, Venken K, Elewaut D. Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-? production by interaction with its soluble E-cadherin ligand in chronically inflamed joints. Ann Rheum Dis. 2014;73:1223-31 pubmed publisher
  740. Dintwe O, Day C, Smit E, Nemes E, Gray C, Tameris M, et al. Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function. Eur J Immunol. 2013;43:2409-20 pubmed publisher
  741. TAN C, Broge T, Seung E, Vrbanac V, Viscidi R, Gordon J, et al. Detection of JC virus-specific immune responses in a novel humanized mouse model. PLoS ONE. 2013;8:e64313 pubmed publisher
  742. Greig B, Stetler Stevenson M, Lea J. Stabilization media increases recovery in paucicellular cerebrospinal fluid specimens submitted for flow cytometry testing. Cytometry B Clin Cytom. 2014;86:135-8 pubmed publisher
  743. Kluge S, Sauter D, Vogl M, Peeters M, Li Y, Bibollet Ruche F, et al. The transmembrane domain of HIV-1 Vpu is sufficient to confer anti-tetherin activity to SIVcpz and SIVgor Vpu proteins: cytoplasmic determinants of Vpu function. Retrovirology. 2013;10:32 pubmed publisher
  744. Paich H, Sheridan P, Handy J, Karlsson E, Schultz Cherry S, Hudgens M, et al. Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity (Silver Spring). 2013;21:2377-86 pubmed publisher
  745. Parzych E, Li H, Yin X, Liu Q, Wu T, Podsakoff G, et al. Effects of immunosuppression on circulating adeno-associated virus capsid-specific T cells in humans. Hum Gene Ther. 2013;24:431-42 pubmed publisher
  746. Introini A, Vanpouille C, Lisco A, Grivel J, Margolis L. Interleukin-7 facilitates HIV-1 transmission to cervico-vaginal tissue ex vivo. PLoS Pathog. 2013;9:e1003148 pubmed publisher
  747. Palin A, Ramachandran V, Acharya S, Lewis D. Human neonatal naive CD4+ T cells have enhanced activation-dependent signaling regulated by the microRNA miR-181a. J Immunol. 2013;190:2682-91 pubmed publisher
  748. Canary L, Vinton C, Morcock D, Pierce J, Estes J, Brenchley J, et al. Rate of AIDS progression is associated with gastrointestinal dysfunction in simian immunodeficiency virus-infected pigtail macaques. J Immunol. 2013;190:2959-65 pubmed publisher
  749. McArthur M, Sztein M. Unexpected heterogeneity of multifunctional T cells in response to superantigen stimulation in humans. Clin Immunol. 2013;146:140-52 pubmed publisher
  750. Marin N, Paris S, Rojas M, Garcia L. Functional profile of CD4+ and CD8+ T cells in latently infected individuals and patients with active TB. Tuberculosis (Edinb). 2013;93:155-66 pubmed publisher
  751. Sauter D, Unterweger D, Vogl M, Usmani S, Heigele A, Kluge S, et al. Human tetherin exerts strong selection pressure on the HIV-1 group N Vpu protein. PLoS Pathog. 2012;8:e1003093 pubmed publisher
  752. Lelic A, Verschoor C, Ventresca M, Parsons R, Evelegh C, Bowdish D, et al. The polyfunctionality of human memory CD8+ T cells elicited by acute and chronic virus infections is not influenced by age. PLoS Pathog. 2012;8:e1003076 pubmed publisher
  753. Wong W, Sigvardsson M, Astrand Grundström I, Hogge D, Larsson J, Qian H, et al. Expression of integrin ?2 receptor in human cord blood CD34+CD38-CD90+ stem cells engrafting long-term in NOD/SCID-IL2R?(c) null mice. Stem Cells. 2013;31:360-71 pubmed publisher
  754. Mitchell P, Afzali B, Fazekasova H, Chen D, Ali N, Powell N, et al. Helicobacter pylori induces in-vivo expansion of human regulatory T cells through stimulating interleukin-1β production by dendritic cells. Clin Exp Immunol. 2012;170:300-9 pubmed publisher
  755. He Y, He X, Guo P, Du M, Shao J, Li M, et al. The decidual stromal cells-secreted CCL2 induces and maintains decidual leukocytes into Th2 bias in human early pregnancy. Clin Immunol. 2012;145:161-73 pubmed publisher
  756. Sharma S, Pichichero M. Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination. Clin Exp Immunol. 2012;169:281-91 pubmed publisher
  757. Wolff M, Leung J, Davenport M, Poles M, Cho I, Loke P. TH17, TH22 and Treg cells are enriched in the healthy human cecum. PLoS ONE. 2012;7:e41373 pubmed publisher
  758. Prabowo A, Anink J, Lammens M, Nellist M, van den Ouweland A, Adle Biassette H, et al. Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation. Brain Pathol. 2013;23:45-59 pubmed publisher
  759. Kvistborg P, Shu C, Heemskerk B, Fankhauser M, Thrue C, Toebes M, et al. TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients. Oncoimmunology. 2012;1:409-418 pubmed
  760. Qi Y, Operario D, Georas S, Mosmann T. The acute environment, rather than T cell subset pre-commitment, regulates expression of the human T cell cytokine amphiregulin. PLoS ONE. 2012;7:e39072 pubmed publisher
  761. McArthur M, Sztein M. Heterogeneity of multifunctional IL-17A producing S. Typhi-specific CD8+ T cells in volunteers following Ty21a typhoid immunization. PLoS ONE. 2012;7:e38408 pubmed publisher
  762. Klatt N, Estes J, Sun X, Ortiz A, Barber J, Harris L, et al. Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol. 2012;5:646-57 pubmed publisher
  763. Jeon Y, Go H, Nam S, Keam B, Kim T, Jung K, et al. Expression of the promyelocytic leukemia zinc-finger in T-lymphoblastic lymphoma and leukemia has strong implications for their cellular origin and greater association with initial bone marrow involvement. Mod Pathol. 2012;25:1236-45 pubmed publisher
  764. Li X, Miao H, Henn A, Topham D, Wu H, Zand M, et al. Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination. Vaccine. 2012;30:4581-4 pubmed publisher
  765. de Souza M, Ratto Kim S, Chuenarom W, Schuetz A, Chantakulkij S, Nuntapinit B, et al. The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope. J Immunol. 2012;188:5166-76 pubmed publisher
  766. Caserta S, Nausch N, Sawtell A, Drummond R, Barr T, MacDonald A, et al. Chronic infection drives expression of the inhibitory receptor CD200R, and its ligand CD200, by mouse and human CD4 T cells. PLoS ONE. 2012;7:e35466 pubmed publisher
  767. St Gelais C, Coleman C, Wang J, Wu L. HIV-1 Nef enhances dendritic cell-mediated viral transmission to CD4+ T cells and promotes T-cell activation. PLoS ONE. 2012;7:e34521 pubmed publisher
  768. Jankowska M, Marszałł M, Debska Slizien A, Carrero J, Lindholm B, Czarnowski W, et al. Vitamin B6 and the immunity in kidney transplant recipients. J Ren Nutr. 2013;23:57-64 pubmed publisher
  769. Man S, Tucky B, Cotleur A, Drazba J, Takeshita Y, Ransohoff R. CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier. Sci Transl Med. 2012;4:119ra14 pubmed publisher
  770. West N, Milne K, Truong P, MacPherson N, Nelson B, Watson P. Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. Breast Cancer Res. 2011;13:R126 pubmed publisher
  771. Teirlinck A, McCall M, Roestenberg M, Scholzen A, Woestenenk R, de Mast Q, et al. Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathog. 2011;7:e1002389 pubmed publisher
  772. Liang H, Reinhardt R, Bando J, Sullivan B, Ho I, Locksley R. Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nat Immunol. 2011;13:58-66 pubmed publisher
  773. Xu H, Ye J, Chen Y, Zhang L, Huang J, Xian J, et al. Changes in the proportions of CD4(+)T cell subsets defined by CD127 and CD25 expression during HBV infection. Immunol Invest. 2012;41:290-303 pubmed publisher
  774. Turner A, Ackley A, Matrone M, Morris K. Characterization of an HIV-targeted transcriptional gene-silencing RNA in primary cells. Hum Gene Ther. 2012;23:473-83 pubmed publisher
  775. Taaffe J, Bosinger S, Del Prete G, Else J, Ratcliffe S, Ward C, et al. CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques. J Med Primatol. 2012;41:24-42 pubmed publisher
  776. Crawford T, Ndhlovu L, Tan A, Carvidi A, Hecht F, Sinclair E, et al. HIV-1 infection abrogates CD8+ T cell mitogen-activated protein kinase signaling responses. J Virol. 2011;85:12343-50 pubmed publisher
  777. Luiza Silva M, Campi Azevedo A, Batista M, Martins M, Avelar R, da Silveira Lemos D, et al. Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody. J Infect Dis. 2011;204:873-83 pubmed publisher
  778. Barbosa R, Silva S, Silva S, Melo A, Pedro E, Barbosa M, et al. Primary B-cell deficiencies reveal a link between human IL-17-producing CD4 T-cell homeostasis and B-cell differentiation. PLoS ONE. 2011;6:e22848 pubmed publisher
  779. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed publisher
  780. Day C, Abrahams D, Lerumo L, Janse van Rensburg E, Stone L, O rie T, et al. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J Immunol. 2011;187:2222-32 pubmed publisher
  781. West N, Panet Raymond V, Truong P, Alexander C, Babinszky S, Milne K, et al. Intratumoral Immune Responses Can Distinguish New Primary and True Recurrence Types of Ipsilateral Breast Tumor Recurrences (IBTR). Breast Cancer (Auckl). 2011;5:105-15 pubmed publisher
  782. Clement M, Ladell K, Ekeruche Makinde J, Miles J, Edwards E, Dolton G, et al. Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining. J Immunol. 2011;187:654-63 pubmed publisher
  783. Li H, Lasaro M, Jia B, Lin S, Haut L, High K, et al. Capsid-specific T-cell responses to natural infections with adeno-associated viruses in humans differ from those of nonhuman primates. Mol Ther. 2011;19:2021-30 pubmed publisher
  784. Coleman C, Spearman P, Wu L. Tetherin does not significantly restrict dendritic cell-mediated HIV-1 transmission and its expression is upregulated by newly synthesized HIV-1 Nef. Retrovirology. 2011;8:26 pubmed publisher
  785. Lee J, Hayman E, Pegram H, Santos E, Heller G, Sadelain M, et al. In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy. Cancer Res. 2011;71:2871-81 pubmed publisher
  786. Petrilli G, Lorenzi L, Paracchini R, Ubiali A, Schumacher R, Cabassa P, et al. Epstein-Barr virus-associated adrenal smooth muscle tumors and disseminated diffuse large B-cell lymphoma in a child with common variable immunodeficiency: a case report and review of the literature. Int J Surg Pathol. 2014;22:712-21 pubmed publisher
  787. Mamedov I, Britanova O, Bolotin D, Chkalina A, Staroverov D, Zvyagin I, et al. Quantitative tracking of T cell clones after haematopoietic stem cell transplantation. EMBO Mol Med. 2011;3:201-7 pubmed publisher
  788. Wu Y, Ren M, Yang R, Liang X, Ma Y, Tang Y, et al. Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+ Th/Treg cell subset imbalance in ankylosing spondylitis. Arthritis Res Ther. 2011;13:R29 pubmed publisher
  789. Gardam S, Turner V, Anderton H, Limaye S, Basten A, Koentgen F, et al. Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response. Blood. 2011;117:4041-51 pubmed publisher
  790. Watkins N, Sridhar S, Cheng X, Chen G, Toner M, Rodriguez W, et al. A microfabricated electrical differential counter for the selective enumeration of CD4+ T lymphocytes. Lab Chip. 2011;11:1437-47 pubmed publisher
  791. de Almeida C, de Lima T, Castro D, Torres K, da Silva Braga W, Peruhype Magalhães V, et al. Immunological/virological peripheral blood biomarkers and distinct patterns of sleeping quality in chronic hepatitis C patients. Scand J Immunol. 2011;73:486-95 pubmed publisher
  792. Scheible K, Zhang G, Baer J, Azadniv M, Lambert K, Pryhuber G, et al. CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses. Vaccine. 2011;29:2159-68 pubmed publisher
  793. Berthoud T, Hamill M, Lillie P, Hwenda L, Collins K, Ewer K, et al. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin Infect Dis. 2011;52:1-7 pubmed publisher
  794. Antonelli L, Mahnke Y, Hodge J, Porter B, Barber D, DerSimonian R, et al. Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. Blood. 2010;116:3818-27 pubmed publisher
  795. Schenkel J, Zloza A, Li W, Narasipura S, Al Harthi L. Beta-catenin signaling mediates CD4 expression on mature CD8+ T cells. J Immunol. 2010;185:2013-9 pubmed publisher
  796. Elsner L, Flügge P, Lozano J, Muppala V, Eiz Vesper B, Demiroglu S, et al. The endogenous danger signals HSP70 and MICA cooperate in the activation of cytotoxic effector functions of NK cells. J Cell Mol Med. 2010;14:992-1002 pubmed publisher
  797. Magalhaes I, Vudattu N, Ahmed R, Kuhlmann Berenzon S, Ngo Y, Sizemore D, et al. High content cellular immune profiling reveals differences between rhesus monkeys and men. Immunology. 2010;131:128-40 pubmed publisher
  798. Markley J, Sadelain M. IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice. Blood. 2010;115:3508-19 pubmed publisher
  799. Klatt N, Shudo E, Ortiz A, Engram J, Paiardini M, Lawson B, et al. CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells. PLoS Pathog. 2010;6:e1000747 pubmed publisher
  800. Amarnath S, Costanzo C, Mariotti J, Ullman J, Telford W, Kapoor V, et al. Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1. PLoS Biol. 2010;8:e1000302 pubmed publisher
  801. Liang M, Morizono K, Pariente N, Kamata M, Lee B, Chen I. Targeted transduction via CD4 by a lentiviral vector uses a clathrin-mediated entry pathway. J Virol. 2009;83:13026-31 pubmed publisher
  802. Alexander L, Zhang S, McAuliffe B, Connors D, Zhou N, Wang T, et al. Inhibition of envelope-mediated CD4+-T-cell depletion by human immunodeficiency virus attachment inhibitors. Antimicrob Agents Chemother. 2009;53:4726-32 pubmed publisher
  803. Sivasankar B, Longhi M, Gallagher K, Betts G, Morgan B, Godkin A, et al. CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy?. J Immunol. 2009;182:5203-7 pubmed publisher
  804. Kapoor V, Hakim F, Rehman N, Gress R, Telford W. Quantum dots thermal stability improves simultaneous phenotype-specific telomere length measurement by FISH-flow cytometry. J Immunol Methods. 2009;344:6-14 pubmed publisher
  805. Harmon M, Tew J, Best A, Hahn C. Mature dendritic cells in inflamed human pulps beneath deep caries. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:727-32 pubmed publisher
  806. Park C, Majeti R, Weissman I. In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord blood. Nat Protoc. 2008;3:1932-40 pubmed publisher
  807. Karagoz B, Bilgi O, Gumus M, Erikci A, Sayan O, Turken O, et al. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients. Med Oncol. 2010;27:29-33 pubmed publisher
  808. Contreras X, Schweneker M, Chen C, McCune J, Deeks S, Martin J, et al. Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. J Biol Chem. 2009;284:6782-9 pubmed publisher
  809. Wang J, Kobie J, Zhang L, Cochran M, Mosmann T, Ritchlin C, et al. An 11-color flow cytometric assay for identifying, phenotyping, and assessing endocytic ability of peripheral blood dendritic cell subsets in a single platform. J Immunol Methods. 2009;341:106-16 pubmed publisher
  810. Milne K, Barnes R, Girardin A, Mawer M, Nesslinger N, Ng A, et al. Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer. PLoS ONE. 2008;3:e3409 pubmed publisher
  811. Molhoek K, McSkimming C, Olson W, Brautigan D, Slingluff C. Apoptosis of CD4(+)CD25(high) T cells in response to Sirolimus requires activation of T cell receptor and is modulated by IL-2. Cancer Immunol Immunother. 2009;58:867-76 pubmed publisher
  812. Sodsai P, Hirankarn N, Avihingsanon Y, Palaga T. Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity. Lupus. 2008;17:645-53 pubmed publisher
  813. Lunemann J, Frey O, Eidner T, Baier M, Roberts S, Sashihara J, et al. Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis. J Immunol. 2008;181:991-1000 pubmed
  814. Gurer C, Strowig T, Brilot F, Pack M, Trumpfheller C, Arrey F, et al. Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood. 2008;112:1231-9 pubmed publisher
  815. Yates J, Whittington A, Mitchell P, Lechler R, Lightstone L, Lombardi G. Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin Exp Immunol. 2008;153:44-55 pubmed publisher
  816. Grahmann P, Braun R. A new protocol for multiple inhalation of IFN-gamma successfully treats MDR-TB: a case study. Int J Tuberc Lung Dis. 2008;12:636-44 pubmed
  817. Schweneker M, Favre D, Martin J, Deeks S, McCune J. HIV-induced changes in T cell signaling pathways. J Immunol. 2008;180:6490-500 pubmed
  818. Carvalho K, Maeda S, Marti L, Yamashita J, Haslett P, Kallas E. Immune cellular parameters of leprosy and human immunodeficiency virus-1 co-infected subjects. Immunology. 2008;124:206-14 pubmed publisher
  819. Sathler Avelar R, Vitelli Avelar D, Massara R, de Lana M, Pinto Dias J, Teixeira Carvalho A, et al. Etiological treatment during early chronic indeterminate Chagas disease incites an activated status on innate and adaptive immunity associated with a type 1-modulated cytokine pattern. Microbes Infect. 2008;10:103-13 pubmed publisher
  820. Yamada H, Nakashima Y, Okazaki K, Mawatari T, Fukushi J, Kaibara N, et al. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67:1299-304 pubmed
  821. Hiyoshi M, Suzu S, Yoshidomi Y, Hassan R, Harada H, Sakashita N, et al. Interaction between Hck and HIV-1 Nef negatively regulates cell surface expression of M-CSF receptor. Blood. 2008;111:243-50 pubmed
  822. Kang S, Lim H, Andrisani O, Broxmeyer H, Kim C. Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J Immunol. 2007;179:3724-33 pubmed
  823. Milush J, Reeves J, Gordon S, Zhou D, Muthukumar A, Kosub D, et al. Virally induced CD4+ T cell depletion is not sufficient to induce AIDS in a natural host. J Immunol. 2007;179:3047-56 pubmed
  824. Shi Y, Feng Y, Kang J, Liu C, Li Z, Li D, et al. Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1. Nat Immunol. 2007;8:817-24 pubmed
  825. Yates J, Rovis F, Mitchell P, Afzali B, Tsang J, Garin M, et al. The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. Int Immunol. 2007;19:785-99 pubmed
  826. Zuber J, Viguier M, Lemaitre F, Senée V, Patey N, Elain G, et al. Severe FOXP3+ and naïve T lymphopenia in a non-IPEX form of autoimmune enteropathy combined with an immunodeficiency. Gastroenterology. 2007;132:1694-704 pubmed
  827. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007;110:1225-32 pubmed
  828. Thedrez A, de Lalla C, Allain S, Zaccagnino L, Sidobre S, Garavaglia C, et al. CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells. Blood. 2007;110:251-8 pubmed
  829. Martins M, Silva M, Marciano A, Peruhype Magalhães V, Eloi Santos S, Ribeiro J, et al. Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?. Clin Exp Immunol. 2007;148:90-100 pubmed
  830. Diaz Blanco E, Bruns I, Neumann F, Fischer J, Graef T, Rosskopf M, et al. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia. 2007;21:494-504 pubmed
  831. De Fanis U, Mori F, Kurnat R, Lee W, Bova M, Adkinson N, et al. GATA3 up-regulation associated with surface expression of CD294/CRTH2: a unique feature of human Th cells. Blood. 2007;109:4343-50 pubmed
  832. Clarke S, Betts G, Plant A, Wright K, El Shanawany T, Harrop R, et al. CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLoS ONE. 2006;1:e129 pubmed
  833. Kolar G, Mehta D, Pelayo R, Capra J. A novel human B cell subpopulation representing the initial germinal center population to express AID. Blood. 2007;109:2545-52 pubmed
  834. Garin M, Chu C, Golshayan D, Cernuda Morollón E, Wait R, Lechler R. Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood. 2007;109:2058-65 pubmed
  835. Yaddanapudi K, Palacios G, Towner J, Chen I, Sariol C, Nichol S, et al. Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses. FASEB J. 2006;20:2519-30 pubmed publisher
  836. Kolar G, Mehta D, Wilson P, Capra J. Diversity of the Ig repertoire is maintained with age in spite of reduced germinal centre cells in human tonsil lymphoid tissue. Scand J Immunol. 2006;64:314-24 pubmed
  837. Lim H, Broxmeyer H, Kim C. Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells. J Immunol. 2006;177:840-51 pubmed
  838. Jamieson C, Gotlib J, Durocher J, Chao M, Mariappan M, Lay M, et al. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci U S A. 2006;103:6224-9 pubmed
  839. Chen L, Cohen A, Lewis D. Impaired allogeneic activation and T-helper 1 differentiation of human cord blood naive CD4 T cells. Biol Blood Marrow Transplant. 2006;12:160-71 pubmed
  840. Barsov E, Andersen H, Coalter V, Carrington M, Lifson J, Ott D. Capture of antigen-specific T lymphocytes from human blood by selective immortalization to establish long-term T-cell lines maintaining primary cell characteristics. Immunol Lett. 2006;105:26-37 pubmed
  841. Olivier A, Lauret E, Gonin P, Galy A. The Notch ligand delta-1 is a hematopoietic development cofactor for plasmacytoid dendritic cells. Blood. 2006;107:2694-701 pubmed
  842. Marei A, Ghaemmaghami A, Renshaw P, Wiselka M, Barer M, Carr M, et al. Superior T cell activation by ESAT-6 as compared with the ESAT-6-CFP-10 complex. Int Immunol. 2005;17:1439-46 pubmed
  843. Schwendemann J, Choi C, Schirrmacher V, Beckhove P. Dynamic differentiation of activated human peripheral blood CD8+ and CD4+ effector memory T cells. J Immunol. 2005;175:1433-9 pubmed
  844. Humphreys T, Baldridge L, Billings S, Campbell J, Spinola S. Trafficking pathways and characterization of CD4 and CD8 cells recruited to the skin of humans experimentally infected with Haemophilus ducreyi. Infect Immun. 2005;73:3896-902 pubmed
  845. Game D, Rogers N, Lechler R. Acquisition of HLA-DR and costimulatory molecules by T cells from allogeneic antigen presenting cells. Am J Transplant. 2005;5:1614-25 pubmed
  846. Lozza L, Lilleri D, Percivalle E, Fornara C, Comolli G, Revello M, et al. Simultaneous quantification of human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells. Eur J Immunol. 2005;35:1795-804 pubmed
  847. Brown E, Lyles D. Pseudotypes of vesicular stomatitis virus with CD4 formed by clustering of membrane microdomains during budding. J Virol. 2005;79:7077-86 pubmed
  848. Contamin H, Loizon S, Bourreau E, Michel J, Garraud O, Mercereau Puijalon O, et al. Flow cytometry identification and characterization of mononuclear cell subsets in the neotropical primate Saimiri sciureus (squirrel monkey). J Immunol Methods. 2005;297:61-71 pubmed
  849. Shimonkevitz R, Northrop J, Harris L, Craun M, Bar Or D. Interleukin-16 expression in the peripheral blood and CD8 T lymphocytes after traumatic injury. J Trauma. 2005;58:252-8 pubmed
  850. Kim J, Lim H, Kang S, Hillsamer P, Kim C. Human CD57+ germinal center-T cells are the major helpers for GC-B cells and induce class switch recombination. BMC Immunol. 2005;6:3 pubmed
  851. Taylor R, Schols D, Wooley D. Restricted entry of R5 HIV Type 1 strains into eosinophilic cells. AIDS Res Hum Retroviruses. 2004;20:1244-53 pubmed
  852. Tavano R, Gri G, Molon B, Marinari B, Rudd C, Tuosto L, et al. CD28 and lipid rafts coordinate recruitment of Lck to the immunological synapse of human T lymphocytes. J Immunol. 2004;173:5392-7 pubmed
  853. Ku C, Zerboni L, Ito H, Graham B, Wallace M, Arvin A. Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha. J Exp Med. 2004;200:917-25 pubmed
  854. Viguier M, Lemaitre F, Verola O, Cho M, Gorochov G, Dubertret L, et al. Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol. 2004;173:1444-53 pubmed
  855. Fasth A, Cao D, van Vollenhoven R, Trollmo C, Malmstrom V. CD28nullCD4+ T cells--characterization of an effector memory T-cell population in patients with rheumatoid arthritis. Scand J Immunol. 2004;60:199-208 pubmed
  856. Lee M, Hanspers K, Barker C, Korn A, McCune J. Gene expression profiles during human CD4+ T cell differentiation. Int Immunol. 2004;16:1109-24 pubmed
  857. Camara N, Sebille F, Lechler R. Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation. Eur J Immunol. 2003;33:3473-83 pubmed
  858. Schreiner B, Wischhusen J, Mitsdoerffer M, Schneider D, Bornemann A, Melms A, et al. Expression of the B7-related molecule ICOSL by human glioma cells in vitro and in vivo. Glia. 2003;44:296-301 pubmed
  859. Zhang Y, Lu H, LiWang P, Sili U, Templeton N. Optimization of gene expression in nonactivated circulating lymphocytes. Mol Ther. 2003;8:629-36 pubmed
  860. Braun R, Foerster M, Grahmann P, Haefner D, Workalemahu G, Kroegel C. Phenotypic and molecular characterization of CD103+ CD4+ T cells in bronchoalveolar lavage from patients with interstitial lung diseases. Cytometry B Clin Cytom. 2003;54:19-27 pubmed
  861. Stacchini A, Demurtas A, Godio L, Martini G, Antinoro V, Palestro G. Flow cytometry in the bone marrow staging of mature B-cell neoplasms. Cytometry B Clin Cytom. 2003;54:10-8 pubmed
  862. Jiang S, Camara N, Lombardi G, Lechler R. Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. Blood. 2003;102:2180-6 pubmed
  863. Game D, Hernandez Fuentes M, Chaudhry A, Lechler R. CD4+CD25+ regulatory T cells do not significantly contribute to direct pathway hyporesponsiveness in stable renal transplant patients. J Am Soc Nephrol. 2003;14:1652-61 pubmed
  864. Roessner K, Wolfe J, Shi C, Sigal L, Huber S, Budd R. High expression of Fas ligand by synovial fluid-derived gamma delta T cells in Lyme arthritis. J Immunol. 2003;170:2702-10 pubmed
  865. Biswas P, Mantelli B, Sica A, Malnati M, Panzeri C, Saccani A, et al. Expression of CD4 on human peripheral blood neutrophils. Blood. 2003;101:4452-6 pubmed
  866. Soler D, Humphreys T, Spinola S, Campbell J. CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. Blood. 2003;101:1677-82 pubmed
  867. Loza M, Perussia B. Peripheral immature CD2-/low T cell development from type 2 to type 1 cytokine production. J Immunol. 2002;169:3061-8 pubmed
  868. Litvinova E, Maury S, Boyer O, Bruel S, Benard L, Boisserie G, et al. Graft-versus-leukemia effect after suicide-gene-mediated control of graft-versus-host disease. Blood. 2002;100:2020-5 pubmed
  869. Manz M, Miyamoto T, Akashi K, Weissman I. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A. 2002;99:11872-7 pubmed
  870. Maximov A, Bezprozvanny I. Synaptic targeting of N-type calcium channels in hippocampal neurons. J Neurosci. 2002;22:6939-52 pubmed
  871. Otsu M, Hershfield M, Tuschong L, Muul L, Onodera M, Ariga T, et al. Flow cytometry analysis of adenosine deaminase (ADA) expression: a simple and reliable tool for the assessment of ADA-deficient patients before and after gene therapy. Hum Gene Ther. 2002;13:425-32 pubmed
  872. Venkatesan S, Petrovic A, Van Ryk D, Locati M, Weissman D, Murphy P. Reduced cell surface expression of CCR5 in CCR5Delta 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestration. J Biol Chem. 2002;277:2287-301 pubmed
  873. Venkatesan S, Petrovic A, Locati M, Kim Y, Weissman D, Murphy P. A membrane-proximal basic domain and cysteine cluster in the C-terminal tail of CCR5 constitute a bipartite motif critical for cell surface expression. J Biol Chem. 2001;276:40133-45 pubmed
  874. Telford W, Moss M, Morseman J, Allnutt F. Cryptomonad algal phycobiliproteins as fluorochromes for extracellular and intracellular antigen detection by flow cytometry. Cytometry. 2001;44:16-23 pubmed
  875. Sharron M, Pohlmann S, Price K, Lolis E, Tsang M, Kirchhoff F, et al. Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes. Blood. 2000;96:41-9 pubmed
  876. Converso M, Bertero M, Vallario A, Caligaris Cappio F. Analysis of T-cell clones in systemic lupus erythematosus. Haematologica. 2000;85:118-23 pubmed
  877. Le Cleach L, Delaire S, Boumsell L, Bagot M, Bourgault Villada I, Bensussan A, et al. Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol. 2000;119:225-30 pubmed
  878. Lee B, Sharron M, Montaner L, Weissman D, Doms R. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1999;96:5215-20 pubmed
  879. Cron R, Bort S, Wang Y, Brunvand M, Lewis D. T cell priming enhances IL-4 gene expression by increasing nuclear factor of activated T cells. J Immunol. 1999;162:860-70 pubmed
  880. Waterfall M, Black A, Riley E. Gammadelta+ T cells preferentially respond to live rather than killed malaria parasites. Infect Immun. 1998;66:2393-8 pubmed
  881. Verhasselt B, De Smedt M, Verhelst R, Naessens E, Plum J. Retrovirally transduced CD34++ human cord blood cells generate T cells expressing high levels of the retroviral encoded green fluorescent protein marker in vitro. Blood. 1998;91:431-40 pubmed
  882. Yeaman G, Guyre P, Fanger M, Collins J, White H, Rathbun W, et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol. 1997;61:427-35 pubmed
  883. Mojcik C, Salomon D, Chang A, Shevach E. Differential expression of integrins on human thymocyte subpopulations. Blood. 1995;86:4206-17 pubmed